Please wait...

UBS Group

Third quarter 2022 report

Picture of Ralph Hamers, Group CEO
We delivered a good result of USD 2.3bn PBT in a challenging environment. Our clients turned to us for advice and entrusted us with USD 17bn of net new fee- generating assets. Our globally diversified and client centric model combined with a balance sheet for all seasons is a competitive advantage, enabling us to deliver attractive and sustainable returns to shareholders.
Ralph Hamers, Group CEO

Selected financials

USD billion
2.3
Profit
before tax
USD
0.52
Diluted earnings
per share
%
15.5
Return on
CET1 capital
%
71.8
Cost/income ratio
%
14.4
CET1 capital
ratio

Our key figures

  As of or for the quarter ended As of or year-to-date
USD m, except where indicated 30.9.22 30.6.22 31.12.21 30.9.21 30.9.22 30.9.21
Group results
Total revenues 8,236 8,917 8,705 9,115 26,534 26,689
Credit loss expense / (release) (3) 7 (27) (14) 22 (121)
Operating expenses 5,916 6,295 7,003 6,264 18,845 19,054
Operating profit / (loss) before tax 2,323 2,615 1,729 2,865 7,667 7,755
Net profit / (loss) attributable to shareholders 1,733 2,108 1,348 2,279 5,977 6,109
Diluted earnings per share (USD)1 0.52 0.61 0.38 0.63 1.74 1.68
Profitability and growth2
Return on equity (%) 12.3 14.6 8.9 15.3 13.7 13.8
Return on tangible equity (%) 13.9 16.4 10.0 17.2 15.4 15.5
Return on common equity tier 1 capital (%) 15.5 18.9 11.9 20.8 17.8 19.5
Return on leverage ratio denominator, gross (%) 3.3 3.4 3.3 3.5 3.4 3.4
Cost / income ratio (%) 71.8 70.6 80.5 68.7 71.0 71.4
Effective tax rate (%) 25.0 19.0 21.4 20.1 21.7 21.0
Net profit growth (%) (24.0) 5.1 (17.6) 8.9 (2.2) 24.2
Resources2
Total assets 1,111,753 1,113,193 1,117,182 1,088,773 1,111,753 1,088,773
Equity attributable to shareholders 55,756 56,845 60,662 60,219 55,756 60,219
Common equity tier 1 capital3 44,664 44,798 45,281 45,022 44,664 45,022
Risk-weighted assets3 310,615 315,685 302,209 302,426 310,615 302,426
Common equity tier 1 capital ratio (%)3 14.4 14.2 15.0 14.9 14.4 14.9
Going concern capital ratio (%)3 19.1 19.0 20.0 20.0 19.1 20.0
Total loss-absorbing capacity ratio (%)3 33.7 33.7 34.7 34.0 33.7 34.0
Leverage ratio denominator3 989,787 1,025,422 1,068,862 1,044,916 989,787 1,044,916
Common equity tier 1 leverage ratio (%)3 4.51 4.37 4.24 4.31 4.51 4.31
Liquidity coverage ratio (%) 162.7 160.8 155.5 157.3 162.7 157.3
Net stable funding ratio (%) 120.4 120.9 118.5 118.1 120.4 118.1
Other
Invested assets (USD bn)4 3,706 3,912 4,596 4,432 3,706 4,432
Personnel (full-time equivalents) 72,009 71,294 71,385 71,427 72,009 71,427
Market capitalization1 46,674 52,475 61,230 55,423 46,674 55,423
Total book value per share (USD)1 17.52 17.45 17.84 17.48 17.52 17.48
Tangible book value per share (USD)1 15.57 15.51 15.97 15.62 15.57 15.62
  1. Refer to the “Share information and earnings per share” section of this report for more information.
  2. Refer to the “Targets, aspirations and capital guidance” section of our Annual Report 2021 for more information about our performance targets.
  3. Based on the Swiss systemically relevant bank framework as of 1 January 2020. Refer to the “Capital management” section of this report for more information.
  4. Consists of invested assets for Global Wealth Management, Asset Management and Personal & Corporate Banking. Refer to “Note 32 Invested assets and net new money” in the “Consolidated financial statements” section of our Annual Report 2021 for more information.
Alternative performance measures

An alternative performance measure (an APM) is a financial measure of historical or future financial performance, financial position or cash flows other than a financial measure defined or specified in the applicable recognized accounting standards or in other applicable regulations. We report a number of APMs in the discussion of the financial and operating performance of the Group, our business divisions and our Group Functions. We use APMs to provide a more complete picture of our operating performance and to reflect management’s view of the fundamental drivers of our business results. A definition of each APM, the method used to calculate it and the information content are presented under “Alternative performance measures” in the appendix to this report. Our APMs may qualify as non-GAAP measures as defined by US Securities and Exchange Commission (SEC) regulations.

Contacts & Terms

Corporate calendar UBS Group AG

Publication of the fourth quarter 2022 report: Tuesday, 31 January 2023

Publication of the Annual Report 2022: Monday, 6 March 2023

Publication of the Sustainability Report 2022: Friday, 10 March 2023

Annual General Meeting 2023: Wednesday, 5 April 2023

Publication of the first quarter 2023 report: Tuesday, 25 April 2023

Corporate calendar UBS AG

Publication of the third quarter 2022 report: Friday, 28 October 2022

Publication dates of future quarterly and annual reports and results are made available as part of the corporate calendar of UBS AG at ubs.com/investors.

Contacts
Switchboards

For all general inquiries
ubs.com/contact

Zurich +41-44-234 1111
London +44-207-567 8000
New York +1-212-821 3000
Hong Kong SAR +852-2971 8888
Singapore +65-6495 8000

Investor Relations

UBS’s Investor Relations team manages relationships with institutional investors, research analysts and credit rating agencies.

ubs.com/investors

Zurich +41-44-234 4100
New York +1-212-882 5734

Media Relations

UBS’s Media Relations team manages relationships with global media and journalists.

ubs.com/media

Zurich +41-44-234 8500
mediarelations@ubs.com

London +44-20-7567 4714
ubs-media-relations@ubs.com

New York +1-212-882 5858
mediarelations@ubs.com

Hong Kong SAR +852-2971 8200
sh-mediarelations-ap@ubs.com

Office of the Group Company Secretary

The Group Company Secretary handles
inquiries directed to the Chairman or to other members of the Board of Directors.

UBS Group AG, Office of the Group Company Secretary P.O. Box, CH-8098 Zurich, Switzerland

sh-company-secretary@ubs.com

Zurich +41-44-235 6652

Shareholder Services

UBS’s Shareholder Services team, a unit of the Group Company Secretary’s office, manages relationships with shareholders and the registration of UBS Group AG registered shares.

UBS Group AG, Shareholder Services
P.O. Box, CH-8098 Zurich, Switzerland

sh-shareholder-services@ubs.com

Zurich +41-44-235 6652

US Transfer Agent

For global registered share-related
inquiries in the US.

Computershare Trust Company NA
P.O. Box 505000
Louisville, KY 40233-5000, USA

Shareholder online inquiries:
www-us.computershare.com/​investor/​contact

Shareholder website:
computershare.com/investor

Calls from the US
+1-866-305-9566

Calls from outside the US
+1-781-575-2623

TDD for hearing impaired
+1-800-231-5469

TDD for foreign shareholders
+1-201-680-6610

Imprint

Publisher: UBS Group AG, Zurich, Switzerland | ubs.com
Language: English

© UBS 2022. The key symbol and UBS are among the registered and unregistered trademarks of UBS. All rights reserved.

Terms used in this report, unless the context requires otherwise
“UBS,” “UBS Group,” “UBS Group AG consolidated,” “Group,” “the Group,” “we,” “us” and “our” UBS Group AG and its consolidated subsidiaries
“UBS AG consolidated” UBS AG and its consolidated subsidiaries
“UBS Group AG” and “UBS Group AG standalone” UBS Group AG on a standalone basis
“UBS AG” and “UBS AG standalone” UBS AG on a standalone basis
“UBS Switzerland AG” and “UBS Switzerland AG standalone” UBS Switzerland AG on a standalone basis
“UBS Europe SE consolidated” UBS Europe SE and its consolidated subsidiaries
“UBS Americas Holding LLC” and “UBS Americas Holding LLC consolidated” UBS Americas Holding LLC and its consolidated subsidiaries
“1m” One million, i.e., 1,000,000
“1bn” One billion, i.e., 1,000,000,000
“1trn” One trillion, i.e., 1,000,000,000,000

UBS Group

Management report

Terms used in this report, unless the context requires otherwise
“UBS,” “UBS Group,” “UBS Group AG consolidated,” “Group,” “the Group,” “we,” “us” and “our” UBS Group AG and its consolidated subsidiaries
“UBS AG consolidated” UBS AG and its consolidated subsidiaries
“UBS Group AG” and “UBS Group AG standalone” UBS Group AG on a standalone basis
“UBS AG” and “UBS AG standalone” UBS AG on a standalone basis
“UBS Switzerland AG” and “UBS Switzerland AG standalone” UBS Switzerland AG on a standalone basis
“UBS Europe SE consolidated” UBS Europe SE and its consolidated subsidiaries
“UBS Americas Holding LLC” and “UBS Americas Holding LLC consolidated” UBS Americas Holding LLC and its consolidated subsidiaries
“1m” One million, i.e., 1,000,000
“1bn” One billion, i.e., 1,000,000,000
“1trn” One trillion, i.e., 1,000,000,000,000

Recent developments

Macroeconomic developments

In the context of high inflation and tight labor markets, central banks in most major economies have raised interest rates at an accelerated pace, which has increased the concerns about recessions in those economies and which may lead to further significant levels of volatility in equities, currencies and interest rates. In addition, the implications of the ongoing war in Ukraine, including a deepening energy crisis in Europe, as well as the continuing effects of the COVID-19 pandemic and related restrictions in Asia Pacific, have continued to add uncertainty to future economic and market developments.

The war in Ukraine

The war in Ukraine has led to one of the largest humanitarian crises in decades, a mass exodus of businesses from Russia and heightened volatility across global markets. Sanctions that were imposed on Russia and Belarus and certain Russian and Belarusian entities and nationals in the first half of 2022 by various jurisdictions, including the US, the EU, the UK and Switzerland, continue to be expanded. The long-term consequences of the war are still difficult to assess, but the global ramifications are likely to be felt for some time.

We are not conducting any new business in Russia or with Russia-domiciled clients.

Our direct country risk exposure to Russia decreased to USD 0.2bn as of 30 September 2022, compared with USD 0.6bn as of 31 December 2021. We had no material direct country risk exposures to Ukraine or to Belarus as of 30 September 2022. Reliance on Russian, Ukrainian or Belarusian assets as collateral for secured financing is negligible.

Since the first quarter of 2022, the EU and Switzerland have prohibited acceptance of deposits in excess of EUR 100,000 from Russian persons not entitled to residency in the European Economic Area (the EEA) or Switzerland. Around 0.3% of our invested assets in our Global Wealth Management business division as of 30 September 2022 related to such clients.

We are monitoring potential second-order impacts on our clients and other counterparties, including those that may result from an escalation of hostilities. These may include, but are not limited to, effects of supply chain disruptions and impacts on industry sectors that are affected by energy and other commodity prices or dependent on specific geographies.

We continue to monitor settlement risk on certain open transactions with Russian bank and non-bank counterparties or Russian underlyings, as market closures and the imposition of exchange controls, sanctions or other measures may further limit our ability to settle transactions or to realize collateral if required, which may result in unexpected increases in exposures.

The war in Ukraine and the imposition of sanctions on Russia and Belarus have increased the risk of cyberattacks from foreign state actors, activists or other parties.

Regulatory and legal developments
Swiss political developments regarding sustainability and climate risk

In September 2022, the Swiss Parliament adopted a new federal law on climate protection, including provisions related to emission-reduction pathways and interim targets. The law provides the legal basis for measures to support the transition to net zero in different economic sectors, including the financial sector. Subject to a potential referendum that would take place in 2023, the new law is expected to enter into force in 2024.

Swiss Federal Council consults on the implementation of global minimum taxation in Switzerland

In August 2022, the Swiss Federal Council launched the consultation of the ordinance on the national implementation of a global minimum corporate tax rate stipulated by the Global Anti-Base Erosion Model Rules (Pillar 2) of the Organisation for Economic Co-operation and Development (the OECD).

The Federal Council has proposed a minimum tax rate of 15% for Swiss firms with global earnings above EUR 750m from 1 January 2024.

The OECD model rules will be transformed into Swiss national law following a constitutional amendment, which is subject to a mandatory referendum expected by June 2023. The Federal Council will examine the progress that other countries have made in the implementation of the tax reform before setting the final law into effect (expected 1 January 2024). The consultation runs until 17 November 2022. We do not expect the proposed implementation of global minimum taxation in Switzerland to materially impact our effective tax rate.

Swiss Federal Council approves the revised Anti-Money Laundering Act

In August 2022, the Swiss Federal Council brought the revised Anti-Money Laundering Act (AMLA) and the amended Anti-Money Laundering Ordinance (AMLO) into force, with effect from 1 January 2023.

Among others, the revised provisions will affect reporting requirements, as well as requirements to periodically review all clients and client data.

Revision of the Swiss liquidity requirements

The revision of the Swiss Liquidity Ordinance became effective on 1 July 2022. The changes increase the regulatory minimum liquidity requirements for systemically important banks, including UBS, from 1 January 2024. The specific increase for UBS remains uncertain pending supervisory guidance from the Swiss Financial Market Supervisory Authority (FINMA). Related new and revised regulatory reporting requirements have become effective from the fourth quarter of 2022 onward.

Update on 2022 capital returns

We have adjusted our accrual for the 2022 ordinary dividend from USD 0.51 to USD 0.55 per share, which represents an increase of 10% compared with the previous year. The Board intends to propose the dividend for approval by shareholders at the Annual General Meeting to be held in April 2023.

We expect share repurchases to be approximately USD 5.5bn for 2022. We will provide guidance on next year’s capital return at the fourth quarter earnings presentation and expect to continue to have share repurchases and a progressive dividend.

Other developments
Wealthfront

In August 2022, UBS and Wealthfront mutually agreed to terminate their merger agreement, under which Wealthfront was to be acquired by UBS Americas Inc. In the third quarter of 2022, UBS purchased a USD 69.7m note convertible into Wealthfront shares.

Sale of UBS Swiss Financial Advisers AG

In the third quarter of 2022, we completed the sale of our wholly owned subsidiary UBS Swiss Financial Advisers AG (SFA) to Vontobel, as announced in December 2021. We will continue to refer US clients that want to have discretionary portfolio management or investment advisory services booked in Switzerland to Vontobel SFA. Upon completion of the sale, we recorded a pre-tax gain of USD 86m in Global Wealth Management.

Sale of our domestic wealth management business in Spain

We completed the sale of our domestic wealth management business in Spain to Singular Bank in the third quarter of 2022. This resulted in a pre-tax gain of USD 133m in Global Wealth Management.

Group performance

Income statement
  For the quarter ended % change from Year-to-date
USD m 30.9.22 30.6.22 30.9.21 2Q22 3Q21 30.9.22 30.9.21
Net interest income 1,596 1,665 1,693 (4) (6) 5,032 4,934
Other net income from financial instruments measured at fair value through profit or loss 1,796 1,619 1,697 11 6 5,641 4,485
Net fee and commission income 4,481 4,774 5,610 (6) (20) 14,608 16,858
Other income 363 859 115 (58) 216 1,254 412
Total revenues 8,236 8,917 9,115 (8) (10) 26,534 26,689
 
Credit loss expense / (release) (3) 7 (14) (79) 22 (121)
 
Personnel expenses 4,216 4,422 4,598 (5) (8) 13,559 14,170
General and administrative expenses 1,192 1,370 1,148 (13) 4 3,769 3,340
Depreciation, amortization and impairment of non-financial assets 508 503 518 1 (2) 1,517 1,544
Operating expenses 5,916 6,295 6,264 (6) (6) 18,845 19,054
Operating profit / (loss) before tax 2,323 2,615 2,865 (11) (19) 7,667 7,755
Tax expense / (benefit) 580 497 576 17 1 1,662 1,629
Net profit / (loss) 1,742 2,118 2,289 (18) (24) 6,005 6,127
Net profit / (loss) attributable to non-controlling interests 9 10 9 (10) 2 28 18
Net profit / (loss) attributable to shareholders 1,733 2,108 2,279 (18) (24) 5,977 6,109
 
Comprehensive income
Total comprehensive income (48) 1,079 1,678 960 3,941
Total comprehensive income attributable to non-controlling interests (8) (17) (5) (55) 68 1 6
Total comprehensive income attributable to shareholders (40) 1,097 1,683 959 3,935
Results: 3Q22 vs 3Q21

Operating profit before tax decreased by USD 542m, or 19%, to USD 2,323m, reflecting a decrease in total revenues, partly offset by lower operating expenses. Total revenues decreased by USD 879m to USD 8,236m, which included negative foreign currency effects. Net fee and commission income decreased by USD 1,129m, mainly due to negative market performance and a decrease in the level of client activity. This USD 1,129m decrease was partly offset by a USD 248m increase in other income, largely driven by gains in Global Wealth Management of USD 133m on the sale of our domestic wealth management business in Spain and USD 86m on the sale of our wholly owned subsidiary UBS Swiss Financial Advisers AG, compared with a gain of USD 100m from the sale of our domestic wealth management business in Austria in the prior-year quarter. Operating expenses decreased by USD 348m, or 6%, to USD 5,916m, which included positive foreign currency effects. Personnel expenses decreased by USD 382m, mainly reflecting lower expenses for financial advisor and variable compensation, as well as a decrease in salary costs.

Total revenues: 3Q22 vs 3Q21
Net interest income and other net income from financial instruments measured at fair value through profit or loss

Total combined net interest income and other net income from financial instruments measured at fair value through profit or loss was broadly stable at USD 3,392m.

Global Wealth Management increased by USD 272m to USD 1,634m, largely due to higher net interest income. Deposit revenues increased, driven by higher deposit margins as a result of rising interest rates, and despite a decrease in deposit volumes. This increase was partly offset by lower loan revenues, driven by lower loan volumes and margins.

Group Functions was negative USD 229m compared with negative USD 49m, mainly reflecting the net effects of accounting asymmetries, including hedge accounting ineffectiveness, within Group Treasury.

The Investment Bank decreased by USD 73m to USD 1,360m, largely driven by a USD 132m decrease in Global Banking, mainly reflecting lower Leveraged Capital Markets revenues. This was partly offset by a USD 68m increase in Derivatives & Solutions, driven by Foreign Exchange and Rates, which benefited from elevated market volatility, partly offset by lower revenues in Equity Derivatives.

Refer to “Note 3 Net interest income” in the “Consolidated financial statements” section of this report for more information about net interest income
Net interest income and other net income from financial instruments measured at fair value through profit or loss
  For the quarter ended % change from Year-to-date
USD m 30.9.22 30.6.22 30.9.21 2Q22 3Q21 30.9.22 30.9.21
Net interest income from financial instruments measured at amortized cost and fair value through other comprehensive income 1,319 1,310 1,356 1 (3) 3,992 3,890
Net interest income from financial instruments measured at fair value through profit or loss 277 355 338 (22) (18) 1,040 1,044
Other net income from financial instruments measured at fair value through profit or loss 1,796 1,619 1,697 11 6 5,641 4,485
Total 3,392 3,284 3,391 3 0 10,673 9,419
Global Wealth Management 1,634 1,548 1,362 6 20 4,624 3,984
of which: net interest income 1,366 1,268 1,107 8 23 3,775 3,130
of which: transaction-based income from foreign exchange and other intermediary activity1 268 281 255 (4) 5 850 854
Personal & Corporate Banking 629 641 653 (2) (4) 1,934 1,900
of which: net interest income 502 522 538 (4) (7) 1,559 1,577
of which: transaction-based income from foreign exchange and other intermediary activity1 127 119 115 7 10 376 323
Asset Management (3) (10) (9) (71) (69) (14) (13)
Investment Bank2 1,360 1,370 1,433 (1) (5) 4,734 3,814
Global Banking 10 31 142 (69) (93) 156 442
Global Markets 1,351 1,339 1,291 1 5 4,578 3,372
Group Functions (229) (265) (49) (14) 364 (606) (268)
  1. Mainly includes spread-related income in connection with client-driven transactions, foreign currency translation effects and income and expenses from precious metals, which is included in the income statement line Other net income from financial instruments measured at fair value through profit or loss. The amounts reported on this line are one component of Transaction-based income in the management discussion and analysis in the “Global Wealth Management” and “Personal & Corporate Banking” sections of this report.
  2. Investment Bank information is provided at the business-line level rather than by financial statement reporting line, in order to reflect the underlying business activities, which is consistent with the structure of the management discussion and analysis in the “Investment Bank” section of this report.
Net fee and commission income

Net fee and commission income decreased by USD 1,129m to USD 4,481m.

Fees for portfolio management and related services and investment fund fees decreased by USD 339m and USD 255m, respectively, driven by Global Wealth Management and Asset Management. These decreases mainly reflect negative market performance, partly offset by incremental revenues from net new fee-generating assets in Global Wealth Management.

Net brokerage fees decreased by USD 230m to USD 733m, driven by Global Wealth Management, reflecting lower levels of client activity across all regions, and by the Investment Bank, mainly in relation to cash equities.

Underwriting fees decreased by USD 173m to USD 175m, driven by lower equity and debt underwriting revenues from public offerings in the Investment Bank.

M&A and corporate finance fees decreased by USD 163m to USD 152m, reflecting lower revenues from merger and acquisition transactions in our Global Banking business within the Investment Bank.

Refer to “Note 4 Net fee and commission income” in the “Consolidated financial statements” section of this report for more information
Other income

Other income was USD 363m, compared with USD 115m in the prior-year quarter. The increase was largely driven by gains in Global Wealth Management of USD 133m on the sale of our domestic wealth management business in Spain and USD 86m on the sale of our wholly owned subsidiary UBS Swiss Financial Advisers AG, as well as a USD 70m gain related to a legacy litigation settlement. In comparison, the third quarter of 2021 included a gain of USD 100m from the sale of our domestic wealth management business in Austria.

Refer to the “Recent developments” section of this report for more information about the sale of our domestic wealth management business in Spain and the sale of UBS Swiss Financial Advisers AG
Credit loss expense / release: 3Q22 vs 3Q21

Total net credit loss releases were USD 3m, compared with net credit loss releases of USD 14m in the prior-year quarter, reflecting USD 4m net credit loss expenses related to stage 1 and 2 positions and USD 7m net credit loss releases related to stage 3 positions.

Refer to “Note 7 Expected credit loss measurement” in the “Consolidated financial statements” section of this report for more information
Credit loss expense / (release)
USD m

Global

Wealth

Management

Personal &

Corporate

Banking

Asset

Management

Investment

Bank

Group

Functions

Total
For the quarter ended 30.9.22
Stages 1 and 2 6 (6) 0 4 0 4
Stage 3 1 (9) 0 1 0 (7)
Total credit loss expense / (release) 7 (15) 0 4 0 (3)
 
For the quarter ended 30.6.22
Stages 1 and 2 (8) 26 0 (2) 0 16
Stage 3 6 8 0 (26) 2 (9)
Total credit loss expense / (release) (3) 35 0 (28) 2 7
 
For the quarter ended 30.9.21
Stages 1 and 2 (9) 1 0 (2) 0 (11)
Stage 3 (2) (8) 0 7 0 (3)
Total credit loss expense / (release) (11) (7) 0 5 0 (14)
Operating expenses: 3Q22 vs 3Q21
Operating expenses
  For the quarter ended % change from Year-to-date
USD m 30.9.22 30.6.22 30.9.21 2Q22 3Q21 30.9.22 30.9.21
Personnel expenses 4,216 4,422 4,598 (5) (8) 13,559 14,170
of which: salaries and variable compensation 2,473 2,664 2,659 (7) (7) 8,085 8,475
of which: financial advisor compensation1 1,093 1,122 1,239 (3) (12) 3,436 3,592
of which: other personnel expenses2 650 637 700 2 (7) 2,038 2,103
General and administrative expenses 1,192 1,370 1,148 (13) 4 3,769 3,340
of which: net expenses for litigation, regulatory and similar matters 21 221 12 (91) 72 298 84
of which: other general and administrative expenses 1,171 1,149 1,136 2 3 3,471 3,256
Depreciation, amortization and impairment of non-financial assets 508 503 518 1 (2) 1,517 1,544
Total operating expenses 5,916 6,295 6,264 (6) (6) 18,845 19,054
  1. Financial advisor compensation consists of formulaic compensation based directly on compensable revenues generated by financial advisors and supplemental compensation calculated on the basis of financial advisor productivity, firm tenure, new assets and other variables. It also includes expenses related to compensation commitments with financial advisors entered into at the time of recruitment that are subject to vesting requirements.
  2. Consists of expenses related to contractors, social security, and post-employment benefit plans, as well as other personnel expenses.
Personnel expenses

Personnel expenses decreased by USD 382m to USD 4,216m, largely driven by lower financial advisor compensation following a decrease in compensable revenues, lower variable compensation, as well as a decrease in salary costs as foreign currency translation effects more than offset an underlying increase, resulting from higher salaries and an increase in the number of employees.

Refer to “Note 5 Personnel expenses” in the “Consolidated financial statements” section of this report for more information
General and administrative expenses

General and administrative expenses increased by USD 44m to USD 1,192m, mainly driven by higher expenses for travel and entertainment, IT, and consulting, partly offset by lower real estate costs.

We believe that the industry continues to operate in an environment in which expenses associated with litigation, regulatory and similar matters will remain elevated for the foreseeable future and we continue to be exposed to a number of significant claims and regulatory matters. The outcome of many of these matters, the timing of a resolution, and the potential effects of resolutions on our future business, financial results or financial condition are extremely difficult to predict.

Refer to “Note 6 General and administrative expenses” in the “Consolidated financial statements” section of this report for more information Refer to “Note 14 Provisions and contingent liabilities” in the “Consolidated financial statements” section of this report for more information about litigation, regulatory and similar matters Refer to the “Regulatory and legal developments” and “Risk factors” sections of our Annual Report 2021 for more information about litigation, regulatory and similar matters
Tax: 3Q22 vs 3Q21

We recognized income tax expenses of USD 580m for the third quarter of 2022, representing an effective tax rate of 25.0%, compared with USD 576m and an effective tax rate of 20.1% for the third quarter of 2021. Current tax expenses were USD 368m, compared with USD 432m, and related to taxable profits of UBS Switzerland AG and other entities. Deferred tax expenses were USD 213m, compared with USD 144m. These include an expense of USD 182m that primarily relates to the amortization of deferred tax assets previously recognized in relation to tax losses carried forward and deductible temporary differences of UBS Americas Inc. They also include an expense of USD 31m in respect of a decrease in the expected value of future tax deductions for deferred compensation awards, due to a decrease in the Group’s share price during the quarter.

Excluding any potential effects from the remeasurement of deferred tax assets in connection with this year’s business planning process and any material jurisdictional statutory tax rate changes that could be enacted, we expect a tax rate for the fourth quarter of 2022 of around 25%. The effective tax rate remains at the high end of its expected range, largely due to the potential for sustained market volatility giving rise to unbenefited losses recognized in certain entities that cannot be offset with profits of other entities in the Group, and to smaller available future deductions for deferred compensation to the extent that there is a further decrease in the Group’s share price.

Total comprehensive income attributable to shareholders

In the third quarter of 2022, total comprehensive income attributable to shareholders was negative USD 40m, reflecting net profit of USD 1,733m and other comprehensive income (OCI), net of tax, of negative USD 1,773m.

OCI related to cash flow hedges was negative USD 1,664m, mainly reflecting net unrealized losses on US dollar hedging derivatives resulting from significant increases in the relevant US dollar long-term interest rates.

Foreign currency translation OCI was negative USD 633m, mainly resulting from a weakening of the Swiss franc (3%) and the euro (6%) against the US dollar.

OCI related to own credit on financial liabilities designated at fair value was positive USD 335m, primarily due to a widening of our own credit spreads.

Defined benefit plan OCI was positive USD 177m, reflecting positive net pre-tax OCI related to our non-Swiss pension plans of USD 162m, mainly driven by the UK pension plan, and a tax benefit of USD 42m, partly offset by negative pre-tax OCI in our Swiss pension plan of USD 26m.

Refer to “Statement of comprehensive income” in the “Consolidated financial statements” section of this report for more information Refer to “Reconciliation of IFRS equity to Swiss SRB common equity tier 1 capital” in the “Capital management” section of this report for more information about the effects of OCI on common equity tier 1 capital Refer to “Note 21 Fair value measurement” in the “Consolidated financial statements” section of our Annual Report 2021 for more information about own credit on financial liabilities designated at fair value Refer to “Note 27 Post-employment benefit plans” in the “Consolidated financial statements” section of our Annual Report 2021 for more information about OCI related to defined benefit plans
Sensitivity to interest rate movements

As of 30 September 2022, we estimate that a parallel shift in yield curves by +100 basis points could lead to a combined increase in annual net interest income of approximately USD 1.6bn in Global Wealth Management and Personal & Corporate Banking in the first year after such a shift. Of this increase, approximately USD 0.7bn, USD 0.5bn and USD 0.2bn would result from changes in Swiss franc, US dollar and euro interest rates, respectively. A parallel shift in yield curves by –100 basis points could lead to a combined decrease in annual net interest income of approximately USD 1.5bn in Global Wealth Management and Personal & Corporate Banking in the first year after such a shift, showing similar currency contributions as for the aforementioned increase in rates.

These estimates are based on a hypothetical scenario of an immediate change in interest rates, equal across all currencies and relative to implied forward rates as of 30 September 2022 applied to our banking book. These estimates further assume no change to balance sheet size and structure, constant foreign exchange rates and no specific management action. The benefit of the negative rates exemption threshold provided by the Swiss National Bank is not included in this sensitivity. However, as average implied forward rates were above 100 basis points across all tenors as of 30 September 2022, the impact was not material as of that date. These estimates do not represent a forecast of our net interest income and actual changes in net interest income could differ significantly from the amounts referred to above.

Refer to the “Risk management and control” section of this report for information about the economic value of equity and net interest income sensitivity
Key figures and personnel

Below we provide an overview of selected key figures of the Group. For further information about key figures related to capital management, refer to the “Capital management” section of this report.

Cost / income ratio: 3Q22 vs 3Q21

The cost / income ratio was 71.8%, compared with 68.7%, mainly reflecting a decrease in total revenues, partly offset by a decrease in operating expenses.

Personnel: 3Q22 vs 2Q22

The number of personnel employed as of 30 September 2022 increased by 715 to 72,009 (full-time equivalents).

Equity, CET1 capital and returns
  As of or for the quarter ended Year-to-date
USD m, except where indicated 30.9.22 30.6.22 30.9.21 30.9.22 30.9.21
 
Net profit
Net profit attributable to shareholders 1,733 2,108 2,279 5,977 6,109
 
Equity
Equity attributable to shareholders 55,756 56,845 60,219 55,756 60,219
Less: goodwill and intangible assets 6,210 6,312 6,401 6,210 6,401
Tangible equity attributable to shareholders 49,546 50,533 53,819 49,546 53,819
Less: other CET1 deductions 4,882 5,734 8,797 4,882 8,797
CET1 capital 44,664 44,798 45,022 44,664 45,022
 
Returns
Return on equity (%) 12.3 14.6 15.3 13.7 13.8
Return on tangible equity (%) 13.9 16.4 17.2 15.4 15.5
Return on CET1 capital (%) 15.5 18.9 20.8 17.8 19.5
Return on CET1 capital: 3Q22 vs 3Q21

The annualized return on our common equity tier 1 (CET1) capital was 15.5%, compared with 20.8%, driven by lower net profit attributable to shareholders, partly offset by a decrease in average CET1 capital.

Common equity tier 1 capital: 3Q22 vs 2Q22

During the third quarter of 2022, our CET1 capital decreased by USD 0.1bn to USD 44.7bn, mainly as operating profit before tax of USD 2.3bn was more than offset by share repurchases of USD 1.0bn, negative effects from foreign currency translation of USD 0.6bn, dividend accruals of USD 0.4bn and current tax expenses of USD 0.4bn.

Risk-weighted assets: 3Q22 vs 2Q22

Risk-weighted assets (RWA) decreased by USD 5.1bn to USD 310.6bn, primarily driven by decreases of USD 5.1bn from currency effects and USD 2.5bn from asset size and other movements, partly offset by increases of USD 1.9bn from model updates and USD 0.6bn from regulatory add-ons.

Common equity tier 1 capital ratio: 3Q22 vs 2Q22

Our CET1 capital ratio increased to 14.4% from 14.2%, mainly reflecting the aforementioned decrease in RWA.

Leverage ratio denominator: 3Q22 vs 2Q22

The leverage ratio denominator (the LRD) decreased by USD 35.6bn to USD 989.8bn, driven by currency effects of USD 25.8bn and a USD 9.9bn decrease due to asset size and other movements.

Common equity tier 1 leverage ratio: 3Q22 vs 2Q22

Our CET1 leverage ratio increased to 4.51% from 4.37%, primarily due to the aforementioned decrease in the LRD.

Going concern leverage ratio: 3Q22 vs 2Q22

Our going concern leverage ratio increased to 6.0% from 5.8%, mainly reflecting the aforementioned decrease in the LRD.

Results 9M22 vs 9M21

Operating profit before tax decreased by USD 88m, or 1%, to USD 7,667m.

Total revenues decreased by USD 155m, or 1%, to USD 26,534m, which included negative foreign currency effects. Net fee and commission income decreased by USD 2,250m, mainly driven by lower investment fund fees and fees for portfolio management and related services, reflecting negative market performance and lower performance fees, partly offset by the effects of net new fee-generating assets and net new money generation in Global Wealth Management and Asset Management, respectively. Underwriting fees and net brokerage fees also decreased, reflecting lower levels of client activity.

These decreases were partly offset by an increase of USD 1,254m in total combined net interest income and other net income from financial instruments measured at fair value through profit or loss, mainly reflecting a USD 920m increase in revenues in the Investment Bank. The prior-year period included an USD 861m loss in Financing in relation to a default by a client of our prime brokerage business. In addition, Derivatives & Solutions increased by USD 386m, driven by Rates and Foreign Exchange, which benefited from elevated volatility due to inflationary concerns and the actions of central banks, partly offset by Credit and Equity Derivatives. These effects were offset in part by a USD 286m decrease in Global Banking, mainly due to lower revenues in Capital Markets. Global Wealth Management reported USD 640m higher revenues, largely due to an increase in net interest income, mostly reflecting higher deposit revenues, driven by increases in deposit margins. The increases in the Investment Bank and Global Wealth Management were partly offset by a USD 377m negative change in the Group Treasury result within Group Functions, driven by accounting asymmetries, including hedge accounting ineffectiveness.

Other income increased by USD 842m, largely driven by USD 810m higher gains on the sale of minority shareholdings in Asset Management. In addition, we recognized gains in Global Wealth Management of USD 133m on the sale of our domestic wealth management business in Spain and USD 86m on the sale of UBS Swiss Financial Advisers AG, compared with a gain of USD 100m from the sale of our domestic wealth management business in Austria in the prior-year period. Real estate-related losses of USD 44m were recognized in the first nine months of 2022, compared with gains of USD 100m in the same period of 2021.

Expected credit loss expenses were USD 22m, compared with releases of USD 121m in the prior-year period. Stage 1 and 2 net expenses were USD 31m and were partly offset by a USD 9m release of stage 3 allowances.

Operating expenses decreased by USD 209m, or 1%, to USD 18,845m, which included positive foreign currency effects. Personnel expenses decreased by USD 611m, largely driven by lower salary costs, mainly reflecting foreign currency translation effects, as well as lower financial advisor and variable compensation. This decrease was largely offset by a USD 429m increase in general and administrative expenses, mainly reflecting higher expenses for litigation, regulatory and similar matters, IT, and travel and entertainment.

Outlook

Persistently high inflation and tight labor markets in many countries have led central banks to raise interest rates at an accelerated pace, affecting the outlook for economic growth, asset valuations and market volatility. The implications of the ongoing war in Ukraine, including a deepening energy crisis in Europe, as well as the continuing effects of the COVID-19 pandemic and related restrictions in Asia Pacific, add additional uncertainty to the global economic outlook. Against this backdrop, client sentiment and activity levels among our private clients remained muted in the third quarter of 2022, while institutional trading activity remained strong. We expect these uncertainties to continue to affect client sentiment, which, combined with normal seasonality, may also affect client activity levels in the fourth quarter of 2022.

While lower asset valuations will have a negative impact on our recurring net fee income and weak client sentiment may affect net new assets in our asset-gathering businesses, we expect higher interest rates to positively affect our net interest income.

Our clients value our capital strength and expert guidance, particularly in these uncertain times, and we remain focused on supporting them with advice and solutions.

UBS business divisions and Group Functions

Management report

Global Wealth Management

Global Wealth Management1
  As of or for the quarter ended % change from Year-to-date
USD m, except where indicated 30.9.22 30.6.22 30.9.21 2Q22 3Q21 30.9.22 30.9.21
 
Results
Net interest income 1,366 1,268 1,107 8 23 3,775 3,130
Recurring net fee income2 2,464 2,614 2,872 (6) (14) 7,883 8,274
Transaction-based income2 732 793 894 (8) (18) 2,479 3,029
Other income 224 2 119 88 229 163
Total revenues 4,786 4,677 4,992 2 (4) 14,367 14,598
Credit loss expense / (release) 7 (3) (11) (3) (27)
Operating expenses 3,326 3,523 3,486 (6) (5) 10,450 10,405
Business division operating profit / (loss) before tax 1,453 1,157 1,516 26 (4) 3,919 4,220
 
Performance measures and other information
Pre-tax profit growth (year-on-year, %)2 (4.2) (10.6) 43.5 (7.1) 33.8
Cost / income ratio (%)2 69.5 75.3 69.8 72.7 71.3
Average attributed equity (USD bn)3 20.0 20.0 19.0 0 5 19.9 18.6
Return on attributed equity (%)23 29.1 23.2 31.9 26.2 30.2
Financial advisor compensation4 1,093 1,122 1,239 (3) (12) 3,436 3,592
Net new fee-generating assets (USD bn)2 17.1 0.4 18.8 36.9 80.0
Fee-generating assets (USD bn)2 1,182 1,244 1,412 (5) (16) 1,182 1,412
Fee-generating asset margin (bps)2 78.9 79.6 81.9 80.1 83.4
Invested assets (USD bn)2 2,655 2,811 3,198 (6) (17) 2,655 3,198
Loans, gross (USD bn)5 221.7 227.1 230.7 (2) (4) 221.7 230.7
Customer deposits (USD bn)5 336.0 349.3 351.8 (4) (4) 336.0 351.8
Impaired loan portfolio as a percentage of total loan portfolio, gross (%)26 0.2 0.3 0.2 0.2 0.2
Advisors (full-time equivalents) 9,230 9,224 9,399 0 (2) 9,230 9,399
  1. Comparatives may differ as a result of adjustments following organizational changes, restatements due to the retrospective adoption of new accounting standards or changes in accounting policies, and events after the reporting period.
  2. Refer to “Alternative performance measures” in the appendix to this report for the definition and calculation method. Since the second quarter of 2022, assets related to our Global Financial Intermediaries business have been excluded from fee-generating assets, given that fee-generating investment management products, such as mandates, are not central to this business. Furthermore, client commitments into closed-ended private-market investment funds are included as fee-generating assets once recurring fees are charged, rather than when commitments are funded. These changes have been applied prospectively.
  3. Refer to the “Capital management” section of this report for more information.
  4. Relates to licensed professionals with the ability to provide investment advice to clients in the Americas. Consists of formulaic compensation based directly on compensable revenues generated by financial advisors and supplemental compensation calculated on the basis of financial advisor productivity, firm tenure, new assets and other variables. It also includes expenses related to compensation commitments with financial advisors entered into at the time of recruitment that are subject to vesting requirements. Recruitment loans to financial advisors were USD 1,645m as of 30 September 2022.
  5. Loans and Customer deposits in this table include customer brokerage receivables and payables, respectively, which are presented in a separate reporting line on the balance sheet.
  6. Refer to the “Risk management and control” section of this report for more information about (credit-)impaired exposures. Excludes loans to financial advisors.
Results: 3Q22 vs 3Q21

Profit before tax decreased by USD 63m, or 4%, to USD 1,453m, mainly driven by lower total revenues, partly offset by lower operating expenses.

Total revenues

Total revenues decreased by USD 206m to USD 4,786m, mainly due to decreases across recurring net fee and transaction-based income, partly offset by increases in net interest income and other income.

Net interest income increased by USD 259m, or 23%, to USD 1,366m, mainly reflecting higher deposit revenues, which were driven by higher deposit margins, as a result of rising interest rates, and despite a decrease in deposit volumes. The increase was partly offset by lower loan revenues, driven by lower loan volumes and margins.

Recurring net fee income decreased by USD 408m, or 14%, to USD 2,464m, primarily driven by negative market performance and foreign currency effects, partly offset by incremental revenues from net new fee-generating assets.

Transaction-based income decreased by USD 162m, or 18%, to USD 732m, mainly driven by lower levels of client activity across all regions.

Other income increased by USD 105m, or 88%, to USD 224m, including a USD 133m gain from the sale of our domestic wealth management business in Spain to Singular Bank and an USD 86m gain from the sale of UBS Swiss Financial Advisers AG to Vontobel. The third quarter of 2021 included a USD 100m gain from the sale of our domestic wealth management business in Austria to LGT.

Credit loss expense / release

Net credit loss expenses were USD 7m, primarily related to stage 1 and 2 positions, compared with net releases of USD 11m in the third quarter of 2021.

Operating expenses

Operating expenses decreased by USD 160m to USD 3,326m, mainly driven by a decrease in personnel expenses, primarily as a result of lower financial advisor variable compensation. This was partly offset by higher technology expenses and an increase in provisions for litigation, regulatory and similar matters, as well as higher expenses for professional fees.

Fee-generating assets: 3Q22 vs 2Q22

Fee-generating assets decreased by USD 62.4bn, or 5%, to USD 1,182bn, driven by net negative market performance and foreign currency effects. Net new fee-generating asset inflows were USD 17.1bn, mainly driven by advisory mandates and resulting in an annualized net new fee-generating asset growth rate of 5.5%.

Loans: 3Q22 vs 2Q22

Loans decreased by USD 5.4bn to USD 221.7bn, mainly driven by negative foreign currency effects, as well as net new loan outflows of USD 1.3bn.

Customer deposits: 3Q22 vs 2Q22

Customer deposits decreased by USD 13.3bn to USD 336.0bn, mainly driven by US dollar deposit shifts into other products, as well as negative foreign currency effects.

Results: 9M22 vs 9M21

Profit before tax decreased by USD 301m, or 7%, to USD 3,919m, mainly reflecting lower total revenues, as well as higher operating expenses.

Total revenues decreased by USD 231m to USD 14,367m, mainly driven by lower transaction-based and recurring net fee income, partly offset by higher net interest and other income.

Net interest income increased by USD 645m, or 21%, to USD 3,775m, mostly due to higher deposit revenues, driven by increases in deposit margins.

Recurring net fee income decreased by USD 391m, or 5%, to USD 7,883m, mainly driven by negative market performance and foreign currency effects, as well as the effects of dispositions and moves into lower-margin products. This was partly offset by incremental revenues from net new fee-generating assets.

Transaction-based income decreased by USD 550m, or 18%, to USD 2,479m, mainly driven by lower levels of client activity, particularly in Asia Pacific and Americas.

Other income increased by USD 66m to USD 229m, mainly driven by the aforementioned sale of our domestic wealth management business in Spain to Singular Bank and UBS Swiss Financial Advisers AG to Vontobel. The first nine months of 2021 included the aforementioned sale of our domestic wealth management business in Austria to LGT. Additionally, the first nine months of 2022 included lower gains on our equity ownership of SIX Group and from sales of securities positions.

Net credit loss releases were USD 3m, compared with net releases of USD 27m.

Operating expenses increased by USD 45m, to USD 10,450m, mostly driven by an increase in provisions for litigation, regulatory and similar matters, and higher technology expenses, and expenses for professional fees. This was partly offset by lower personnel expenses, primarily driven by lower financial advisor variable compensation.

Regional breakdown of performance measures

As of or for the quarter ended 30.9.22

USD bn, except where indicated

Americas1 Switzerland EMEA2 Asia Pacific Global Wealth Management3
Total revenues (USD m) 2,661 428 1,072 620 4,786
Operating profit / (loss) before tax (USD m) 537 179 499 237 1,453
Cost / income ratio (%)4 79.8 56.6 53.2 62.0 69.5
Loans, gross 100.55 42.2 41.2 37.1 221.7
Net new loans 0.8 1.0 (0.1) (3.3) (1.3)
Fee-generating assets4 742 104 229 106 1,182
Net new fee-generating assets4 4.4 (0.1) 6.2 6.6 17.1
Net new fee-generating asset growth rate (%)4 2.3 (0.3) 9.7 25.3 5.5
Invested assets4 1,523 226 492 412 2,655
Advisors (full-time equivalents) 6,257 684 1,364 855 9,230
  1. Including the following business units: United States and Canada; and Latin America.
  2. Including the following business units: Europe; Central & Eastern Europe, Greece and Israel; and Middle East and Africa.
  3. Including minor functions, which are not included in the four regions individually presented in this table, with total revenues of USD 5m, USD 1m of operating profit before tax, USD 0.7bn of loans, USD 0.3bn of net new loan inflows, USD 0.8bn of fee-generating assets, USD 0.0bn of net new fee-generating asset outflows, USD 2bn of invested assets and 70 advisors in the third quarter of 2022.
  4. Refer to “Alternative performance measures” in the appendix to this report for the definition and calculation method.
  5. Loans include customer brokerage receivables, which are presented in a separate reporting line on the balance sheet.
Regional comments 3Q22 vs 3Q21, except where indicated
Americas

Profit before tax decreased by USD 22m to USD 537m. Total revenues decreased by USD 72m, or 3%, to USD 2,661m, driven by lower recurring net fee and transaction-based income, partly offset by higher net interest income. The cost / income ratio remained stable at 79.8%, despite lower total revenues. Loans increased 1% compared with the second quarter of 2022, to USD 100bn, reflecting USD 0.8bn of net new loans, which were mostly mortgages. Net new fee-generating assets were USD 4.4bn, resulting in an annualized net new fee-generating asset growth rate of 2.3%.

Switzerland

Profit before tax decreased by USD 43m to USD 179m. Total revenues decreased by USD 60m, or 12%, to USD 428m, mainly driven by lower recurring net fee income. The cost / income ratio increased to 56.6% from 54.6%. Loans decreased 1% compared with the second quarter of 2022, to USD 42bn, as USD 1.0bn of net new loans were offset by negative foreign currency effects. Net new fee-generating assets were negative USD 0.1bn, resulting in a negative annualized net new fee-generating asset growth rate of 0.3%.

EMEA

Profit before tax increased by USD 52m to USD 499m including the aforementioned sale gains. Total revenues increased by USD 7m, to USD 1,072m, as increases in other and net interest income were offset by lower recurring net fee and transaction-based income. The cost / income ratio decreased to 53.2% from 58.1%. Loans decreased 5% compared with the second quarter of 2022, to USD 41bn, mainly reflecting negative foreign currency effects and net new loan outflows. Net new fee-generating assets were USD 6.2bn, resulting in an annualized net new fee-generating asset growth rate of 9.7%.

Asia Pacific

Profit before tax decreased by USD 56m to USD 237m. Total revenues decreased by USD 81m, or 12%, to USD 620m, mainly driven by lower transaction-based income. The cost / income ratio increased to 62.0% from 58.5%. Loans decreased 10% compared with the second quarter of 2022, to USD 37bn, reflecting USD 3.3bn of net new loan outflows, as the current market uncertainty led to clients deleveraging. Net new fee-generating assets were USD 6.6bn, resulting in an annualized net new fee-generating asset growth rate of 25.3%.

Personal & Corporate Banking

Personal & Corporate Banking – in Swiss francs1
  As of or for the quarter ended % change from Year-to-date
CHF m, except where indicated 30.9.22 30.6.22 30.9.21 2Q22 3Q21 30.9.22 30.9.21
 
Results
Net interest income 489 502 494 (3) (1) 1,484 1,444
Recurring net fee income2 206 202 201 2 3 618 569
Transaction-based income2 285 300 281 (5) 2 885 808
Other income 20 13 19 50 3 32 98
Total revenues 1,000 1,018 995 (2) 0 3,020 2,919
Credit loss expense / (release) (15) 33 (6) 133 39 (70)
Operating expenses 585 587 563 0 4 1,758 1,736
Business division operating profit / (loss) before tax 430 398 439 8 (2) 1,222 1,253
 
Performance measures and other information
Pre-tax profit growth (year-on-year, %)2 (2.0) (12.8) 43.7 (2.4) 46.3
Cost / income ratio (%)2 58.5 57.7 56.6 58.2 59.5
Average attributed equity (CHF bn)3 8.9 8.9 8.4 0 5 8.8 8.3
Return on attributed equity (%)23 19.4 17.9 20.9 18.5 20.0
Net interest margin (bps)2 138 142 142 140 139
Fee and trading income for Corporate & Institutional Clients2 190 213 200 (11) (5) 624 602
Investment products for Personal Banking (CHF bn)2 20.7 21.4 22.9 (3) (9) 20.7 22.9
Net new investment products for Personal Banking (CHF bn)2 0.43 0.46 0.70 1.86 2.40
Active Digital Banking clients in Personal Banking (%)24 74.5 73.6 70.2 73.8 69.8
Active Mobile Banking clients in Personal Banking (%)2 57.9 54.9 47.4 55.0 45.8
Active Digital Banking clients in Corporate & Institutional Clients (%)2 79.6 79.6 78.9 79.8 79.1
Loans, gross (CHF bn) 142.7 141.5 138.9 1 3 142.7 138.9
Customer deposits (CHF bn) 162.4 160.3 159.8 1 2 162.4 159.8
Impaired loan portfolio as a percentage of total loan portfolio, gross (%)25 0.8 0.9 1.0 0.8 1.0
  1. Comparatives may differ as a result of adjustments following organizational changes, restatements due to the retrospective adoption of new accounting standards or changes in accounting policies, and events after the reporting period.
  2. Refer to “Alternative performance measures” in the appendix to this report for the definition and calculation method.
  3. Refer to the “Capital management” section of this report for more information.
  4. In the third quarter of 2022, 86.4% of clients of Personal Banking were “activated users” of Digital Banking (i.e., clients who had logged into Digital Banking at least once in the course of their relationship with UBS).
  5. Refer to the “Risk management and control” section of this report for more information about (credit-)impaired exposures.
Results: 3Q22 vs 3Q21

Profit before tax decreased by CHF 9m, or 2%, to CHF 430m, as higher net credit loss releases and total revenues were more than offset by higher operating expenses.

Total revenues

Total revenues increased by CHF 5m to CHF 1,000m, reflecting higher recurring net fee and transaction-based income, partly offset by slightly lower net interest income.

Net interest income decreased by CHF 5m to CHF 489m, mainly driven by a lower benefit from the Swiss National Bank (SNB) deposit exemption and lower deposit fees, largely offset by higher deposit margins as a result of rising interest rates. Growth in loan volumes more than offset the effects of pressure on loan margins.

Recurring net fee income increased by CHF 5m to CHF 206m, mostly driven by higher revenues from account fees.

Transaction-based income increased by CHF 4m to CHF 285m, mainly driven by higher revenues from foreign exchange and credit card transactions, including the effects of a continued increase in spending on travel by clients following the easing of COVID-19-related restrictions in most countries, as well as a CHF 9m gain in relation to the sale of an equity investment. These increases were partly offset by lower corporate client and brokerage fees.

Other income was broadly stable at CHF 20m.

Credit loss expense / release

Net credit loss releases were CHF 15m, compared with net releases of CHF 6m in the third quarter of 2021. Stage 1 and 2 net releases of CHF 6m included the net effect of model, portfolio quality and size changes, partly offset by scenario-update-related expenses, mainly from the update of interest rate forecasts. Stage 3 net credit loss releases were CHF 9m on various corporate lending positions.

Operating expenses

Operating expenses increased by CHF 22m, or 4%, to CHF 585m, mainly driven by higher investments in technology, expenses for marketing, and donations.

Results: 9M22 vs 9M21

Profit before tax decreased by CHF 31m, or 2%, to CHF 1,222m, mainly reflecting net credit loss expenses, compared with net credit loss releases in the first nine months of 2021, and slightly higher expenses, partly offset by higher total revenues.

Total revenues increased by CHF 101m, or 3%, to CHF 3,020m, reflecting a CHF 166m increase driven by strong business momentum, with higher transaction-based, recurring net fee and net interest income, partly offset by lower other income.

Net interest income increased by CHF 40m to CHF 1,484m, mainly driven by higher deposit margins as a result of rising interest rates, partly offset by a lower benefit from the SNB deposit exemption and lower deposit fees. Growth in loan volumes more than offset the effects of pressure on loan margins.

Recurring net fee income increased by CHF 49m to CHF 618m, primarily reflecting higher revenues from account fees, as well as from mandate and custody fees, mainly due to net new investment product inflows.

Transaction-based income increased by CHF 77m to CHF 885m, mainly driven by higher revenues from credit card and foreign exchange transactions, reflecting a continued increase in spending on travel by clients following the easing of COVID-19-related restrictions in most countries in the first nine months of 2022.

Other income decreased by CHF 66m to CHF 32m, mostly due to the first nine months of 2022 including a valuation loss of CHF 11m on our equity ownership of SIX Group, compared with a CHF 32m gain thereon in the first nine months of 2021. The prior-year period also included a CHF 26m gain from the sale of several properties across Switzerland.

Net credit loss expenses were CHF 39m, with net credit loss expenses primarily related to stage 1 and 2 positions, reflecting scenario-related net expenses mainly related to real estate lending, as well as net expenses from book quality and size changes, mainly across the corporate and real estate lending portfolios, partly offset by net releases from model changes. The first nine months of 2021 included net credit loss releases of CHF 70m.

Operating expenses increased by CHF 22m, or 1%, to CHF 1,758m, mainly driven by higher investments in technology and increases across a number of other expense lines. These drivers were partly offset by lower personnel expenses and real estate expenses, as the prior-year period included expenses due to accelerated depreciation resulting from the closure of 44 branches, which led to lower real estate expenses for our branch network in the first nine months of 2022.

Personal & Corporate Banking – in US dollars1
  As of or for the quarter ended % change from Year-to-date
USD m, except where indicated 30.9.22 30.6.22 30.9.21 2Q22 3Q21 30.9.22 30.9.21
 
Results
Net interest income 502 522 538 (4) (7) 1,559 1,577
Recurring net fee income2 212 210 219 1 (3) 649 622
Transaction-based income2 294 312 306 (6) (4) 931 882
Other income 20 14 21 49 (3) 33 106
Total revenues 1,028 1,058 1,084 (3) (5) 3,172 3,187
Credit loss expense / (release) (15) 35 (7) 114 42 (76)
Operating expenses 602 610 613 (1) (2) 1,847 1,897
Business division operating profit / (loss) before tax 442 413 478 7 (8) 1,283 1,366
 
Performance measures and other information
Pre-tax profit growth (year-on-year, %)2 (7.6) (17.1) 42.8 (6.1) 50.7
Cost / income ratio (%)2 58.5 57.7 56.6 58.2 59.5
Average attributed equity (USD bn)3 9.2 9.3 9.2 (1) 0 9.3 9.1
Return on attributed equity (%)23 19.3 17.8 20.8 18.4 19.9
Net interest margin (bps)2 137 139 144 139 141
Fee and trading income for Corporate & Institutional Clients2 195 221 218 (12) (11) 656 657
Investment products for Personal Banking (USD bn)2 21.0 22.4 24.6 (6) (14) 21.0 24.6
Net new investment products for Personal Banking (USD bn)2 0.44 0.48 0.77 1.97 2.62
Active Digital Banking clients in Personal Banking (%)24 74.5 73.6 70.2 73.8 69.8
Active Mobile Banking clients in Personal Banking (%)2 57.9 54.9 47.4 55.0 45.8
Active Digital Banking clients in Corporate & Institutional Clients (%)2 79.6 79.6 78.9 79.8 79.1
Loans, gross (USD bn) 144.6 148.2 148.9 (2) (3) 144.6 148.9
Customer deposits (USD bn) 164.6 167.8 171.4 (2) (4) 164.6 171.4
Impaired loan portfolio as a percentage of total loan portfolio, gross (%)25 0.8 0.9 1.0 0.8 1.0
  1. Comparatives may differ as a result of adjustments following organizational changes, restatements due to the retrospective adoption of new accounting standards or changes in accounting policies, and events after the reporting period.
  2. Refer to “Alternative performance measures” in the appendix to this report for the definition and calculation method.
  3. Refer to the “Capital management” section of this report for more information.
  4. In the third quarter of 2022, 86.4% of clients of Personal Banking were “activated users” of Digital Banking (i.e., clients who had logged into Digital Banking at least once in the course of their relationship with UBS).
  5. Refer to the “Risk management and control” section of this report for more information about (credit-)impaired exposures.

Asset Management

Asset Management1
  As of or for the quarter ended % change from Year-to-date
USD m, except where indicated 30.9.22 30.6.22 30.9.21 2Q22 3Q21 30.9.22 30.9.21
 
Results
Net management fees2 502 515 560 (2) (10) 1,579 1,692
Performance fees 14 9 33 46 (59) 40 166
Net gain from disposal of a joint venture / an associate 848 848 37
Total revenues 516 1,372 593 (62) (13) 2,466 1,896
Credit loss expense / (release) 0 0 0 0 0
Operating expenses 376 413 379 (9) (1) 1,193 1,199
Business division operating profit / (loss) before tax 140 959 214 (85) (34) 1,273 696
 
 
Performance measures and other information
Pre-tax profit growth (year-on-year, %)3 (34.5) 275.7 (71.0) 82.9 (33.9)
Cost / income ratio (%)3 72.8 30.1 63.9 48.4 63.3
Average attributed equity (USD bn)4 1.7 1.7 1.9 (2) (9) 1.7 2.1
Return on attributed equity (%)34 33.2 221.3 46.3 98.1 45.2
Gross margin on invested assets (bps)3 21 50 20 30 22
 
 
Information by business line / asset class
Net new money (USD bn)3
Equities (0.4) (10.4) 0.5 (13.2) 4.4
Fixed Income 19.7 (0.3) 3.0 23.6 15.2
of which: money market 16.0 0.5 0.4 10.0 (2.0)
Multi-asset & Solutions 0.0 1.4 (1.8) 5.4 5.7
Hedge Fund Businesses (1.4) (1.6) 0.8 (1.4) 4.3
Real Estate & Private Markets 0.0 (0.7) (1.0) (0.4) 0.2
Total net new money 17.9 (11.7) 1.5 14.0 29.9
of which: net new money excluding money market 2.0 (12.1) 1.1 4.0 31.8
 
 
Invested assets (USD bn)3
Equities 411 449 543 (9) (24) 411 543
Fixed Income 271 262 279 3 (3) 271 279
of which: money market 99 85 94 17 6 99 94
Multi-asset & Solutions 149 163 183 (9) (19) 149 183
Hedge Fund Businesses 51 53 53 (4) (4) 51 53
Real Estate & Private Markets 97 99 95 (1) 2 97 95
Total invested assets 979 1,026 1,154 (5) (15) 979 1,154
of which: passive strategies 408 440 497 (7) (18) 408 497
 
 
Information by region
Invested assets (USD bn)3
Americas 271 261 273 4 (1) 271 273
Asia Pacific 142 153 181 (8) (22) 142 181
Europe, Middle East and Africa (excluding Switzerland) 239 263 316 (9) (24) 239 316
Switzerland 328 349 383 (6) (15) 328 383
Total invested assets 979 1,026 1,154 (5) (15) 979 1,154
 
 
Information by channel
Invested assets (USD bn)3
Third-party institutional 563 593 671 (5) (16) 563 671
Third-party wholesale 108 119 139 (9) (23) 108 139
UBS’s wealth management businesses 309 314 344 (2) (10) 309 344
Total invested assets 979 1,026 1,154 (5) (15) 979 1,154
  1. Comparatives may differ as a result of adjustments following organizational changes, restatements due to the retrospective adoption of new accounting standards or changes in accounting policies, and events after the reporting period.
  2. Net management fees include transaction fees, fund administration revenues (including net interest and trading income from lending activities and foreign exchange hedging as part of the fund services offering), distribution fees, incremental fund-related expenses, gains or losses from seed money and co-investments, funding costs, the negative pass-through impact of third-party performance fees, and other items that are not Asset Management’s performance fees.
  3. Refer to “Alternative performance measures” in the appendix to this report for the definition and calculation method.
  4. Refer to the “Capital management” section of this report for more information.
Results: 3Q22 vs 3Q21

Profit before tax decreased by USD 74m, or 34%, to USD 140m, mainly reflecting lower net management and performance fees.

Total revenues

Total revenues decreased by USD 77m, or 13%, to USD 516m. Total revenues in the third quarter of 2021 included a loss of USD 28m related to an associate, reflected in net management fees.

Net management fees decreased by USD 58m, or 10%, to USD 502m, primarily reflecting negative market performance and foreign currency effects.

Performance fees decreased by USD 19m to USD 14m, mainly in our Hedge Fund Businesses and Equities.

Operating expenses

Operating expenses were broadly stable at USD 376m, with favorable foreign currency effects and lower litigation expenses being almost entirely offset by increases in expenses for technology, personnel and travel.

Invested assets: 3Q22 vs 2Q22

Invested assets decreased by USD 47bn to USD 979bn, reflecting both negative market performance of USD 35bn and foreign currency effects of USD 30bn, partly offset by net new money inflows of USD 18bn. Excluding money market flows, net new money inflows were USD 2bn.

Results: 9M22 vs 9M21

Profit before tax increased by USD 577m, or 83%, to USD 1,273m, driven by a gain of USD 848m from the sale of our shareholding in the Mitsubishi Corp.-UBS Realty Inc. joint venture. Profit before tax in the prior-year period included a post-tax gain of USD 37m related to the sale of our minority interest in Clearstream Fund Centre. Excluding these gains, profit before tax decreased by USD 233m, or 35%, to USD 426m, mainly reflecting lower performance and net management fees.

Total revenues increased by USD 570m, or 30%, to USD 2,466m. This included the aforementioned gains of USD 848m in the second quarter of 2022 and USD 37m in the prior-year period.

Net management fees decreased by USD 113m, or 7%, to USD 1,579m, reflecting negative market performance and foreign currency effects, partly offset by net new money generation over the past twelve months.

Performance fees decreased by USD 126m to USD 40m, mainly in our Hedge Fund Businesses and Equities, compared with the particularly high levels of performance fees in the first nine months of 2021.

Operating expenses were broadly stable at USD 1,193m, with favorable foreign currency effects, lower litigation expenses and lower personnel expenses being almost entirely offset by expenses relating to the sale of our shareholding in Mitsubishi Corp.-UBS Realty Inc., as well as increases in expenses for technology and travel.

Investment Bank

Investment Bank1
  As of or for the quarter ended % change from Year-to-date
USD m, except where indicated 30.9.22 30.6.22 30.9.21 2Q22 3Q21 30.9.22 30.9.21
 
Results
Advisory 136 209 270 (35) (49) 561 793
Capital Markets 193 168 522 15 (63) 695 1,669
Global Banking 329 377 792 (13) (58) 1,256 2,462
Execution Services 376 399 444 (6) (15) 1,271 1,442
Derivatives & Solutions 866 839 780 3 11 3,124 2,800
Financing 460 479 498 (4) (8) 1,384 531
Global Markets 1,702 1,718 1,723 (1) (1) 5,778 4,773
of which: Equities 1,108 1,274 1,360 (13) (19) 4,087 3,474
of which: Foreign Exchange, Rates and Credit 595 444 363 34 64 1,692 1,299
Total revenues 2,032 2,094 2,514 (3) (19) 7,034 7,235
Credit loss expense / (release) 4 (28) 5 (2) (20) (19)
Operating expenses 1,581 1,712 1,673 (8) (6) 5,269 5,337
Business division operating profit / (loss) before tax 447 410 837 9 (47) 1,785 1,917
 
Performance measures and other information
Pre-tax profit growth (year-on-year, %)2 (46.6) (38.7) 32.4 (6.9) (1.9)
Cost / income ratio (%)2 77.8 81.8 66.5 74.9 73.8
Average attributed equity (USD bn)3 12.8 13.3 12.7 (4) 1 13.1 12.9
Return on attributed equity (%)23 14.0 12.3 26.4 18.2 19.9
Average VaR (1-day, 95% confidence, 5 years of historical data) 10 11 11 (9) (8) 10 11
  1. Comparative figures in this table may differ as a result of adjustments following organizational changes, restatements due to the retrospective adoption of new accounting standards or changes in accounting policies, and events after the reporting period.
  2. Refer to “Alternative performance measures” in the appendix to this report for the definition and calculation method.
  3. Refer to the “Capital management” section of this report for more information.
Results: 3Q22 vs 3Q21

Profit before tax decreased by USD 390m, or 47%, to USD 447m, mainly driven by lower total revenues, partly offset by lower operating expenses.

Total revenues

Total revenues decreased by USD 482m, or 19%, to USD 2,032m, mainly reflecting lower revenues in Global Banking.

Global Banking

Global Banking revenues decreased by USD 463m, or 58%, to USD 329m, mostly driven by lower Capital Markets revenues, compared with a 51% decrease in the overall global fee pool.

Advisory revenues decreased by USD 134m, or 49%, to USD 136m, mostly due to lower revenues from merger and acquisition transactions, compared with a 39% reduction in the global merger and acquisition fee pool.

Capital Markets revenues decreased by USD 329m, or 63%, to USD 193m, primarily due to lower Equity Capital Markets (ECM) revenues which decreased by USD 141m, or 60%, compared with a 57% decrease in the global ECM fee pool. Leveraged Capital Markets (LCM) fee revenues decreased by USD 78m, or 62%, compared with a 73% decrease in the global LCM fee pool.

Global Markets

Global Markets revenues decreased by USD 21m, or 1%, to USD 1,702m, with lower Execution Services and Financing revenues being almost entirely offset by an increase in Derivatives & Solutions revenues.

Execution Services revenues decreased by USD 68m, or 15%, to USD 376m, mainly driven by lower Cash Equities revenues, partly offset by higher revenues from foreign exchange products that are traded over electronic platforms.

Derivatives & Solutions revenues increased by USD 86m, or 11%, to USD 866m, driven by Foreign Exchange and Rates, which benefited from elevated volatility due to inflationary concerns and the actions of central banks, partly offset by lower revenues in Equity Derivatives.

Financing revenues decreased by USD 38m, or 8%, to USD 460m, due to lower revenues in Equities Financing in Europe, the Middle East and Africa, partly offset by increases in Clearing.

Equities

Global Markets Equities revenues decreased by USD 252m, or 19%, to USD 1,108m, mainly driven by Equity Derivatives and Cash Equities.

Foreign Exchange, Rates and Credit

Global Markets Foreign Exchange, Rates and Credit revenues increased by USD 232m, or 64%, to USD 595m, mainly driven by Foreign Exchange and Rates, which benefited from elevated volatility due to inflationary concerns and the actions of central banks.

Credit loss expense / release

Net credit loss expenses were USD 4m, compared with net expenses of USD 5m in the third quarter of 2021.

Operating expenses

Operating expenses decreased by USD 92m, or 6%, to USD 1,581m, mainly driven by favorable foreign currency effects, partly offset by higher expenses on technology and increases across a number of other expense lines.

Results: 9M22 vs 9M21

Profit before tax decreased by USD 132m, or 7%, to USD 1,785m, mainly due to lower revenues in Global Banking. This was partly offset by the prior-year period including a loss related to the default of a client reported within Financing in Global Markets.

Total revenues decreased by USD 201m, or 3%, to USD 7,034m, reflecting lower revenues in Global Banking, largely offset by higher revenues in Global Markets.

Global Banking revenues decreased by USD 1,206m, or 49%, to USD 1,256m, reflecting lower revenues in Capital Markets and Advisory, compared with a 40% decrease in the overall global fee pool.

Advisory revenues decreased by USD 232m, or 29%, to USD 561m, due to lower revenues from merger and acquisition transactions, compared with a 14% decrease in the global merger and acquisition fee pool.

Capital Markets revenues decreased by USD 974m, or 58%, to USD 695m, mainly reflecting a USD 567m, or 70%, decrease in ECM revenues, compared with a decrease in the global ECM fee pool of 67%. LCM fee revenues decreased by USD 183m, or 50%, compared with a 51% decrease in the global LCM fee pool.

Global Markets revenues increased by USD 1,005m, or 21%, to USD 5,778m, partly due to the first nine months of 2021 including an USD 861m loss on the default of a US-based client of our prime brokerage business. Excluding that loss, revenues increased by USD 144m, or 3%, primarily driven by higher revenues in our Rates and Foreign Exchange businesses, partly offset by lower revenues in Cash Equities, Credit and Equity Derivatives.

Execution Services revenues decreased by USD 171m, or 12%, to USD 1,271m, mainly driven by Cash Equities due to lower exchange-traded volumes, particularly in Asia Pacific.

Derivatives & Solutions revenues increased by USD 324m, or 12%, to USD 3,124m, driven by Rates and Foreign Exchange, which benefited from elevated volatility due to inflationary concerns and the actions of central banks, partly offset by Credit and Equity Derivatives.

Financing revenues increased by USD 853m to USD 1,384m, predominantly due to the first nine months of 2021 including the aforementioned loss in our prime brokerage business. Excluding that loss, Financing revenues were broadly stable.

Global Markets Equities revenues increased by USD 613m, or 18%, to USD 4,087m, due to the first nine months of 2021 including the aforementioned loss in our prime brokerage business, partly offset by decreases in Cash Equities and Equity Derivatives in the same period of 2022. Global Markets Foreign Exchange, Rates and Credit revenues increased by USD 393m, or 30%, to USD 1,692m, driven by higher revenues in our Foreign Exchange and Rates businesses, partly offset by decreases in Credit revenues.

Net credit loss releases were USD 20m, compared with net releases of USD 19m.

Operating expenses decreased by USD 68m, or 1%, to USD 5,269m, with favorable foreign currency effects being almost entirely offset by increases across a number of expense lines.

Group Functions

Group Functions1
  As of or for the quarter ended % change from Year-to-date
USD m, except where indicated 30.9.22 30.6.22 30.9.21 2Q22 3Q21 30.9.22 30.9.21
 
Results
Total revenues (126) (284) (68) (56) 85 (505) (226)
Credit loss expense / (release) 0 2 0 (88) 3 0
Operating expenses 32 37 112 (14) (72) 86 217
Operating profit / (loss) before tax (158) (324) (180) (51) (12) (594) (443)
of which: Group Treasury (131) (239) (74) (45) 77 (531) (303)
of which: Non-core and Legacy Portfolio 52 1 (24) 98 (43)
of which: Group Services (79) (86) (82) (8) (3) (161) (96)
  1. Comparatives may differ as a result of adjustments following organizational changes, restatements due to the retrospective adoption of new accounting standards or changes in accounting policies, and events after the reporting period.
Results: 3Q22 vs 3Q21

Group Functions recorded a loss before tax of USD 158m, compared with a loss of USD 180m.

Group Treasury

The Group Treasury result was negative USD 131m, compared with negative USD 74m. The net effects from accounting asymmetries, including hedge accounting ineffectiveness, were negative USD 153m, compared with negative USD 56m. Accounting asymmetries are generally expected to mean revert to zero over time, though the length of time needed for full reversion can vary significantly, depending on market conditions. Income related to centralized Group Treasury risk management was positive USD 29m, compared with negative USD 6m. Operating expenses decreased by USD 6m, to USD 6m.

Non-core and Legacy Portfolio

The Non-core and Legacy Portfolio result was positive USD 52m, compared with negative USD 24m. This result was mainly due to income of USD 62m related to a legacy litigation settlement.

Group Services

The Group Services result was broadly unchanged.

Results: 9M22 vs 9M21

Group Functions recorded a loss before tax of USD 594m, compared with a loss of USD 443m.

The Group Treasury result was negative USD 531m, compared with negative USD 303m. The net effects from accounting asymmetries, including hedge accounting ineffectiveness, were negative USD 504m, compared with negative USD 239m. Income related to centralized Group Treasury risk management was negative USD 7m, compared with negative USD 32m in the first nine months of 2021. Operating expenses decreased by USD 13m, to USD 19m.

The Non-core and Legacy Portfolio result was positive USD 98m, compared with negative USD 43m. This result was mainly due to valuation gains of USD 67m on our USD 1.7bn portfolio of auction rate securities (ARS), compared with valuation gains of USD 46m in the same period of 2021. Our remaining exposures to ARS were all rated investment grade as of 30 September 2022. The first nine months of 2022 also included income of USD 62m related to a legacy litigation settlement.

The Group Services result was negative USD 161m, compared with negative USD 96m, mainly due to remeasurement losses of USD 46m on properties held for sale in the first nine months of 2022, compared with gains of USD 70m.

Risk, capital, liquidity and funding, and balance sheet

Management report

Risk management and control

This section provides information about key developments during the reporting period and should be read in conjunction with the “Risk management and control” section of our Annual Report 2021.

Credit risk
Overall banking products exposure

Overall banking products exposure decreased by USD 29bn to USD 660bn as of 30 September 2022, driven by a USD 24bn decrease in balances at central banks and an USD 11bn decrease in loans and advances to customers, primarily in Global Wealth Management and Personal & Corporate Banking, due to the US dollar appreciating and clients in Asia Pacific deleveraging. This was partly offset by a USD 9bn increase in other financial assets measured at amortized cost, primarily due to purchases of securities in our high-quality liquid asset (HQLA) portfolio.

Credit-impaired gross exposure decreased by USD 248m to USD 2,357m. Total net credit loss releases were USD 3m, reflecting USD 4m net credit loss expenses related to stage 1 and 2 positions and USD 7m net credit loss releases related to stage 3 positions.

In aggregate, exposure related to traded products increased by USD 3.2bn to USD 58.6bn during the third quarter of 2022, driven primarily by increased market volatility and interest rates.

Refer to the “Group performance” section and “Note 7 Expected credit loss measurement” in the “Consolidated financial statements” section of this report for more information about credit loss expense / release
Loan underwriting

In the Investment Bank, mandated loan underwriting commitments on a notional basis decreased by USD 2.2bn to USD 2.6bn as of 30 September 2022, driven by a lower level of origination activity in the loan underwriting business compared with the second quarter of 2022. USD 1.0bn of commitments had not yet been distributed as originally planned as of 30 September 2022.

Loan underwriting exposures are classified as held for trading, with fair values reflecting the market conditions at the end of the quarter. Credit hedges are in place to help protect against fair value movements in the portfolio.

Banking and traded products exposure in our business divisions and Group Functions
30.9.22
USD m

Global Wealth

Management

Personal &

Corporate

Banking

Asset

Management

Investment

Bank

Group

Functions

Total
Banking products1
Gross exposure 328,103 219,628 1,436 72,385 37,958 659,510
of which: loans and advances to customers (on-balance sheet) 215,986 144,566 (1) 12,107 1,138 373,796
of which: guarantees and loan commitments (off-balance sheet) 11,198 26,693 0 13,671 6,729 58,291
Traded products23
Gross exposure 10,797 695 0 47,096 58,588
of which: over-the-counter derivatives 8,403 672 0 20,285 29,359
of which: securities financing transactions 0 0 0 19,865 19,865
of which: exchange-traded derivatives 2,395 23 0 6,947 9,364
Other credit lines, gross4 10,885 21,365 0 5,169 96 37,515
 
Total credit-impaired exposure, gross (stage 3) 721 1,379 0 252 6 2,357
Total allowances and provisions for expected credit losses (stages 1 to 3) 224 668 0 156 7 1,056
of which: stage 1 70 126 0 52 4 252
of which: stage 2 49 155 0 50 0 254
of which: stage 3 105 386 0 55 3 549
 
30.6.22
USD m Global Wealth Management

Personal &

Corporate

Banking

Asset

Management

Investment

Bank

Group

Functions

Total
Banking products1
Gross exposure 337,929 225,420 1,533 73,478 50,560 688,920
of which: loans and advances to customers (on-balance sheet) 221,405 148,159 0 13,369 1,758 384,691
of which: guarantees and loan commitments (off-balance sheet) 10,628 27,915 0 13,736 7,980 60,259
Traded products23
Gross exposure 9,866 531 0 44,998 55,396
of which: over-the-counter derivatives 7,325 510 0 17,923 25,758
of which: securities financing transactions 0 0 0 19,020 19,020
of which: exchange-traded derivatives 2,541 21 0 8,056 10,618
Other credit lines, gross4 11,955 21,921 0 5,776 103 39,756
 
Total credit-impaired exposure, gross (stage 3) 869 1,473 0 257 6 2,605
Total allowances and provisions for expected credit losses (stages 1 to 3) 236 708 0 157 6 1,107
of which: stage 1 73 132 0 59 4 267
of which: stage 2 43 166 0 41 0 250
of which: stage 3 120 410 0 57 3 590
  1. IFRS 9 gross exposure including other financial assets at amortized cost, but excluding cash, receivables from securities financing transactions, cash collateral receivables on derivative instruments, financial assets at FVOCI, irrevocable committed prolongation of existing loans and unconditionally revocable committed credit lines, and forward starting reverse repurchase and securities borrowing agreements.
  2. Internal management view of credit risk, which differs in certain respects from IFRS.
  3. As counterparty risk for traded products is managed at counterparty level, no further split between exposures in the Investment Bank and Group Functions is provided.
  4. Unconditionally revocable committed credit lines.
Collateralization of Loans and advances to customers1
  UBS

of which:

Global Wealth Management

of which: Personal & Corporate Banking

of which:

Investment Bank

USD m, except where indicated 30.9.22 30.6.22 30.9.22 30.6.22 30.9.22 30.6.22 30.9.22 30.6.22
Secured by collateral 354,030 363,264 213,512 218,806 129,895 133,091 10,033 10,514
Residential real estate 162,742 166,409 59,548 59,830 103,194 106,579 0 0
Commercial / industrial real estate 23,132 22,323 4,406 3,902 18,384 17,991 343 430
Cash 35,757 38,147 32,843 34,948 2,905 2,993 9 206
Securities 112,385 116,359 104,229 107,131 2,024 1,975 5,541 6,401
Other collateral 20,014 20,026 12,486 12,995 3,389 3,554 4,139 3,477
Subject to guarantees 2,746 3,134 172 269 2,536 2,827 38 38
Uncollateralized and not subject to guarantees 17,020 18,293 2,302 2,330 12,135 12,241 2,036 2,818
Total loans and advances to customers, gross 373,796 384,691 215,986 221,405 144,566 148,159 12,107 13,369
Allowances (760) (793) (139) (142) (544) (573) (74) (75)
Total loans and advances to customers, net of allowances 373,036 383,898 215,847 221,263 144,023 147,586 12,033 13,294
Collateralized loans and advances to customers in % of total loans and advances of customers, gross (%) 94.7 94.4 98.9 98.8 89.9 89.8 82.9 78.6
  1. Collateral arrangements generally incorporate a range of collateral, including cash, securities, real estate and other collateral. UBS applies a risk-based approach that generally prioritizes collateral according to its liquidity profile.
Market risk

We continued to maintain generally low levels of management value-at-risk (VaR). Average management VaR (1‑day, 95% confidence level) decreased marginally to USD 11m from USD 12m at the end of the second quarter of 2022.

There was one new Group VaR negative backtesting exception in the third quarter of 2022, and the total number of negative backtesting exceptions within the most recent 250-business-day window increased to 2 from 1. The Swiss Financial Market Supervisory Authority (FINMA) VaR multiplier derived from backtesting exceptions for market risk risk-weighted assets was unchanged compared with the prior quarter, at 3.0.

Management value-at-risk (1-day, 95% confidence, 5 years of historical data) of our business divisions and

Group Functions by general market risk type1

Average by risk type
USD m Min. Max. Period end Average Equity

Interest

rates

Credit

spreads

Foreign

exchange

Commodities
Global Wealth Management 1 2 1 1 0 0 1 0 0
Personal & Corporate Banking 0 0 0 0 0 0 0 0 0
Asset Management 0 0 0 0 0 0 0 0 0
Investment Bank 7 16 12 10 6 9 4 2 4
Group Functions 4 5 4 4 1 4 3 0 0
Diversification effect23 (4) (5) (1) (3) (3) (1) 0
Total as of 30.9.22 7 17 12 11 6 10 5 3 4
Total as of 30.6.22 10 16 15 12 8 10 5 4 3
  1. Statistics at individual levels may not be summed to deduce the corresponding aggregate figures. The minima and maxima for each level may occur on different days, and, likewise, the VaR for each business line or risk type, being driven by the extreme loss tail of the corresponding distribution of simulated profits and losses for that business line or risk type, may well be driven by different days in the historical time series, rendering invalid the simple summation of figures to arrive at the aggregate total.
  2. The difference between the sum of the standalone VaR for the business divisions and Group Functions and the VaR for the Group as a whole.
  3. As the minima and maxima for different business divisions and Group Functions occur on different days, it is not meaningful to calculate a portfolio diversification effect.
Economic value of equity and net interest income sensitivity

The economic value of equity (EVE) sensitivity in the banking book to a +1-basis-point parallel shift in yield curves was negative USD 26.4m as of 30 September 2022, compared with negative USD 27.1m as of 30 June 2022, the change predominantly driven by rising market rates. EVE represents the present value of future cash flows related to the banking book irrespective of accounting treatment and, as per specific FINMA requirements, disregards the sensitivity of USD 3.7m from additional tier 1 (AT1) capital instruments that otherwise would be included under general Basel Committee on Banking Supervision (BCBS) guidance.

The majority of our interest rate risk in the banking book is a reflection of the net asset duration that we run to offset our modeled sensitivity of net USD 19.3m (30 June 2022: USD 19.9m) assigned to our equity, goodwill and real estate, with the aim of generating a stable net interest income contribution. Of this, USD 14.1m and USD 4.5m are attributable to the US dollar and the Swiss franc portfolios, respectively (30 June 2022: USD 14.3m and USD 4.7m, respectively).

In addition to the sensitivity mentioned above, we calculate the six interest rate shock scenarios prescribed by FINMA. The “Parallel up” scenario, assuming all positions were fair valued, was the most severe and would have resulted in a change in EVE of negative USD 4.9bn, or 8.3%, of our tier 1 capital (30 June 2022: negative USD 5.1bn, or 8.5%), which is well below the 15% threshold as per the BCBS supervisory outlier test for high levels of interest rate risk in the banking book.

The immediate effect on our tier 1 capital in the “Parallel up” scenario as of 30 September 2022 would have been only a decrease of USD 0.2bn, or 0.4% (30 June 2022: USD 0.1bn or 0.2%), reflecting the fact that the vast majority of our banking book is accrual accounted or subject to hedge accounting. The “Parallel up” scenario would subsequently have a positive effect on net interest income, assuming a constant balance sheet.

UBS also applies granular internal interest rate shock scenarios to its banking book positions to monitor the book’s specific risk profile.

Refer to “Interest rate risk in the banking book” in the “Market risk” section of our Annual Report 2021 for more information about the management of interest rate risk in the banking book Refer to “Sensitivity to interest rate movements” in the “Group performance” section of this report for more information about the effects of increases in interest rates on the net interest income of Global Wealth Management and Personal & Corporate Banking
Interest rate risk – banking book
USD m +1 bp Parallel up2 Parallel down2 Steepener3 Flattener4 Short-term up5 Short-term down6
CHF (3.1) (437.9) 501.3 (301.2) 211.8 18.8 (15.6)
EUR (0.8) (151.4) 185.8 (100.2) 76.3 26.1 (24.3)
GBP 0.1 14.6 (23.8) (18.7) 20.1 24.4 (24.5)
USD (22.4) (4,333.5) 4,433.5 (941.6) (70.7) (1,835.3) 1,993.1
Other (0.1) (36.1) 34.3 (6.3) (1.1) (16.8) 18.7
Effect on EVE1FINMA as of 30.9.22 (26.4) (4,944.3) 5,131.1 (1,368.1) 236.4 (1,782.9) 1,947.4
Additional tier 1 (AT1) capital instruments 3.7 697.7 (752.4) (44.6) 198.5 466.3 (484.5)
Effect on EVE1 – in line with BCBS as of 30.9.22 (22.7) (4,246.6) 4,378.6 (1,412.6) 434.9 (1,316.6) 1,462.9
Effect on EVE1FINMA as of 30.6.22 (27.1) (5,109.2) 5,196.4 (1,463.3) 287.7 (1,791.7) 1,976.2
Effect on EVE1 – in line with BCBS as of 30.6.22 (22.9) (4,315.8) 4,339.0 (1,500.0) 499.4 (1,273.8) 1,437.7
  1. Economic value of equity.
  2. Rates across all tenors move by ±150 bps for Swiss franc, ±200 bps for euro and US dollar, and ±250 bps for pound sterling.
  3. Short-term rates decrease and long-term rates increase.
  4. Short-term rates increase and long-term rates decrease.
  5. Short-term rates increase more than long-term rates.
  6. Short-term rates decrease more than long-term rates.
Country risk

We remain watchful of a range of geopolitical developments and political changes in a number of countries, as well as international tensions arising from the war in Ukraine. As described in the “Recent developments” section of this report, our direct exposure to Russia, Belarus and Ukraine is limited, and we continue to monitor potential second-order impacts, such as European energy security. We do have significant country risk exposure to major European economies, including Germany, the UK and France.

In the context of high inflation, central banks in most major economies have responded with interest rate hikes and tapering of quantitative easing, which increases the chances of recessions in those economies. Additionally, there are related concerns about energy security in a number of countries, global supply chain stresses and tight labor markets that are creating negative pressure on growth. China has experienced a slowing economy following the post-pandemic boom, as well as recent COVID-19-related lockdowns.

We continue to monitor potential trade policy disputes, as well as economic and political developments in addition to those mentioned above. A number of emerging markets are facing economic, political and market pressures, particularly in light of interest rate hikes, a stronger US dollar and energy prices, as well as continuing challenges related to the COVID-19 pandemic. Our exposure to emerging market countries is 5% of our total country exposure and is diversified.

Refer to the “Risk management and control” section of our Annual Report 2021 for more information Refer to the “Recent developments” section of this report for more information about our exposure and response to the war in Ukraine
Non-financial risk

Operational resilience continues to be a focus area for us, as well as for regulators across various jurisdictions. We have a global program to enhance our operational-resilience capabilities, which includes addressing constantly evolving regulatory requirements and recent market volatility, and considering the potential impacts of the developing energy crisis on our operations.

Increases in the sophistication of cyberattacks and fraud are noted worldwide, especially ransomware attacks. We believe that to date, our security controls, regular communications to help employees to stay alert to cyber threats while working remotely, and enhanced monitoring of cyber threats have been effective. No cybersecurity incidents had a material effect on our operations during the third quarter of 2022. UBS continues to be vigilant, particularly in view of the potential for cyber threats to intensify, both in volume and sophistication, as a result of the war in Ukraine.

Our response to the COVID-19 pandemic has relied upon our business continuity management and operational risk processes. They have enabled us to: maintain stable operations while complying with governmental measures to contain COVID-19; continue to serve our clients without material impact; and support the safety and well-being of our staff.

Hybrid working arrangements can lead to increased conduct risk, inherent risk of fraudulent activities, potential increases in the number of suspicious transactions and increased information security risks. We have implemented additional monitoring and supervision intended to mitigate these risks and continue to review the effectiveness of these measures. In addition, changes to the work environment, including permanent hybrid and the introduction of agile ways of working, may introduce new challenges for supervision and monitoring.

Achieving fair outcomes for our clients, upholding market integrity and cultivating the highest standards of employee conduct are of critical importance to the firm. We maintain a conduct risk framework across our activities, which is designed to align our standards and conduct with these objectives and to retain momentum on fostering a strong culture.

We are continuing our efforts regarding innovation and digitalization to create value for our clients. As part of the resulting transformation, we focus on timely changes to frameworks, including consideration of new or revised controls, working practices and oversight, with the aim of mitigating any new risks introduced, including those around data ethics.

Competition to find new business opportunities across the financial services industry, both for firms and for customers, is increasing, with the impact of inflation acting as an additional accelerant. Thus, suitability risk, product selection, cross-divisional service offerings, quality of advice and price transparency also remain areas of heightened focus for UBS and for the industry as a whole. Market volatility and major legislative change programs (such as the Swiss Financial Services Act (FIDLEG) in Switzerland, Regulation Best Interest (Reg BI) in the US and the revised Markets in Financial Instruments Directive (MiFID II) in the EU), along with new requirements for sustainable investments and climate alignment and reporting, all significantly impact the industry and require adjustments to control processes. We regularly monitor our suitability, product and conflicts-of-interest control frameworks to assess whether they are reasonably designed to facilitate adherence to applicable laws and regulatory expectations.

Cross-border risk remains an area of regulatory attention for global financial institutions, with a strong focus on fiscal transparency, as well as market access, particularly third-country market access into the European Economic Area (the EEA). There is also an ongoing high level of attention regarding the risk that tax authorities may, on the basis of new interpretations of existing law, seek to impose taxation based on the existence of a permanent establishment. We maintain a series of controls designed to address these risks.

Financial crime, including money laundering, terrorist financing, sanctions violations, fraud, bribery and corruption, continues to present a major risk, as technological innovation and geopolitical developments increase the complexity of doing business and heightened regulatory attention continues. An effective financial crime prevention program therefore remains essential for UBS. Money laundering and financial fraud techniques are becoming increasingly sophisticated, and geopolitical volatility makes the sanctions landscape more complex, as new or novel sanctions may be imposed that require complex implementation in a short time frame, not least the extensive and continuously evolving sanctions arising from Russia’s invasion of Ukraine. New risks continue to emerge, such as virtual currencies and related activities or investments.

The Office of the Comptroller of the Currency issued a Cease and Desist Order against the firm in May 2018 relating to our US branch know-your-client (KYC) and anti-money-laundering (AML) programs. In response, we initiated an extensive program for the purpose of ensuring sustainable remediation of US-relevant Bank Secrecy Act / AML issues across all our US legal entities. We introduced significant improvements to the framework between 2019 and 2021. We are continuing to implement these enhancements, as well as evolving them to respond to new risks.

We continued to focus on strategic enhancements to our global AML / KYC and sanctions programs to address evolving risk profiles and regulatory expectations, including the exploration of new technologies and more sophisticated monitoring.

Refer to “The war in Ukraine” in the “Recent developments” section of this report for more information

Capital management

The disclosures in this section are provided for UBS Group AG on a consolidated basis and focus on key developments during the reporting period and information in accordance with the Basel III framework, as applicable to Swiss systemically relevant banks (SRBs). They should be read in conjunction with “Capital management” in the “Capital, liquidity and funding, and balance sheet” section of our Annual Report 2021, which provides more information about our capital management objectives, planning and activities, as well as the Swiss SRB total loss-absorbing capacity framework.

UBS Group AG is a holding company and conducts substantially all of its operations through UBS AG and subsidiaries thereof. UBS Group AG and UBS AG have contributed a significant portion of their respective capital to, and provide substantial liquidity to, such subsidiaries. Many of these subsidiaries are subject to regulations requiring compliance with minimum capital, liquidity and similar requirements.

Refer to our 30 September 2022 Pillar 3 Report, available under “Pillar 3 disclosures” at ubs.com/​investors, for more information relating to additional regulatory disclosures for UBS Group AG on a consolidated basis, as well as our significant regulated subsidiaries and sub-groups (UBS AG standalone, UBS Switzerland AG standalone, UBS Europe SE consolidated and UBS Americas Holding LLC consolidated) Refer to our UBS AG third quarter 2022 report, available under “Quarterly reporting” at ubs.com/​investors, for more information about capital and other regulatory information for UBS AG consolidated in accordance with the Basel III framework, as applicable to Swiss SRBs
Swiss SRB going and gone concern requirements and information
As of 30.9.22 RWA LRD
USD m, except where indicated in % in %
Required going concern capital
Total going concern capital 14.581 45,300 5.001 49,489
Common equity tier 1 capital 10.28 31,944 3.502 34,643
of which: minimum capital 4.50 13,978 1.50 14,847
of which: buffer capital 5.50 17,084 2.00 19,796
of which: countercyclical buffer 0.28 882
Maximum additional tier 1 capital 4.30 13,356 1.50 14,847
of which: additional tier 1 capital 3.50 10,872 1.50 14,847
of which: additional tier 1 buffer capital 0.80 2,485
 
Eligible going concern capital
Total going concern capital 19.11 59,359 6.00 59,359
Common equity tier 1 capital 14.38 44,664 4.51 44,664
Total loss-absorbing additional tier 1 capital3 4.73 14,695 1.48 14,695
of which: high-trigger loss-absorbing additional tier 1 capital 4.35 13,504 1.36 13,504
of which: low-trigger loss-absorbing additional tier 1 capital 0.38 1,190 0.12 1,190
 
Required gone concern capital
Total gone concern loss-absorbing capacity4 10.35 32,139 3.75 37,117
of which: base requirement5 12.86 39,945 4.50 44,540
of which: additional requirement for market share and LRD 1.44 4,473 0.50 4,949
of which: applicable reduction on requirements (3.95) (12,279) (1.25) (12,372)
of which: rebate granted6 (3.56) (11,066) (1.25) (12,372)
of which: reduction for usage of low-trigger tier 2 capital instruments (0.39) (1,214) 0.00 0
 
Eligible gone concern capital
Total gone concern loss-absorbing capacity 14.61 45,385 4.59 45,385
Total tier 2 capital 0.95 2,959 0.30 2,959
of which: low-trigger loss-absorbing tier 2 capital 0.78 2,427 0.25 2,427
of which: non-Basel III-compliant tier 2 capital 0.17 531 0.05 531
TLAC-eligible senior unsecured debt 13.66 42,426 4.29 42,426
 
Total loss-absorbing capacity
Required total loss-absorbing capacity 24.93 77,439 8.75 86,606
Eligible total loss-absorbing capacity 33.72 104,744 10.58 104,744
 
Risk-weighted assets / leverage ratio denominator
Risk-weighted assets 310,615
Leverage ratio denominator 989,787
  1. Includes applicable add-ons of 1.44% for RWA and 0.50% for LRD.
  2. Our minimum CET1 leverage ratio requirement of 3.5% consists of a 1.5% base requirement, a 1.5% base buffer capital requirement, a 0.25% LRD add-on requirement and a 0.25% market share add-on requirement based on our Swiss credit business.
  3. Includes outstanding low-trigger loss-absorbing additional tier 1 (AT1) capital instruments, which are available under the Swiss SRB framework to meet the going concern requirements until their first call date. As of their first call date, these instruments are eligible to meet the gone concern requirements.
  4. A maximum of 25% of the gone concern requirements can be met with instruments that have a remaining maturity of between one and two years. Once at least 75% of the minimum gone concern requirement has been met with instruments that have a remaining maturity of greater than two years, all instruments that have a remaining maturity of between one and two years remain eligible to be included in the total gone concern capital.
  5. The gone concern requirement after the application of the rebate for resolvability measures and the reduction for the use of higher quality capital instruments is floored at 10% and 3.75% for the RWA- and LRD-based requirements, respectively. This means that the combined reduction may not exceed 4.3 percentage points for the RWA-based requirement of 14.3% and 1.25 percentage points for the LRD-based requirement of 5.0%.
  6. Based on the actions we completed up to December 2021 to improve resolvability, FINMA granted an increase in the rebate on the gone concern requirement from 55.0% to 65.0% of the maximum rebate, effective 1 July 2022, with an effective maximum rebate of 1.25 percentage points for the LRD-based requirements and – given the risk density of 35% underlying the regulatory requirements – an effective maximum rebate of 3.56 percentage points for the RWA-based requirements.

We are subject to the going and gone concern requirements of the Swiss Capital Adequacy Ordinance that include the too-big-to-fail provisions applicable to Swiss SRBs. The table on the previous page provides the risk-weighted asset (RWA)- and leverage ratio denominator (LRD)-based requirements and information as of 30 September 2022.

On 30 September 2022, the Swiss countercyclical capital buffer was reactivated at a maximum level of 2.5% on risk-weighted positions that are directly or indirectly backed by residential properties in Switzerland. This increased our common equity tier 1 (CET1) minimum capital requirement by 26 basis points. Overall, countercyclical capital buffers contributed 28 basis points to our CET1 minimum capital requirement as of 30 September 2022.

The applicable gone concern requirement floor as of 30 September 2022 was 10% for RWA and 3.75% for LRD purposes. This floor was increased by 1.4 percentage points for RWA and 0.75 percentage points for LRD in the first quarter of 2022.

Based on the actions we completed up to December 2021 to improve resolvability, FINMA granted an increase of the rebate on the gone concern requirement from 55.0% to 65.0% of the maximum rebate, effective 1 July 2022, with an effective maximum rebate of 1.25 percentage points for the LRD-based requirements and an effective maximum rebate of 3.56 percentage points for the RWA-based requirements. The aforementioned requirements are also applicable to UBS AG consolidated. UBS Switzerland AG and UBS AG are subject to going and gone concern requirements on a standalone basis.

Total loss-absorbing capacity

The table below provides Swiss SRB going and gone concern information based on the Swiss SRB framework and requirements that are discussed under “Capital management” in the “Capital, liquidity and funding, and balance sheet” section of our Annual Report 2021.

Swiss SRB going and gone concern information
USD m, except where indicated 30.9.22 30.6.22 31.12.21
 
Eligible going concern capital
Total going concern capital 59,359 59,907 60,488
Total tier 1 capital 59,359 59,907 60,488
Common equity tier 1 capital 44,664 44,798 45,281
Total loss-absorbing additional tier 1 capital 14,695 15,108 15,207
of which: high-trigger loss-absorbing additional tier 1 capital 13,504 13,889 12,783
of which: low-trigger loss-absorbing additional tier 1 capital 1,190 1,219 2,425
 
Eligible gone concern capital
Total gone concern loss-absorbing capacity 45,385 46,342 44,264
Total tier 2 capital 2,959 3,009 3,144
of which: low-trigger loss-absorbing tier 2 capital 2,427 2,471 2,596
of which: non-Basel III-compliant tier 2 capital 531 538 547
TLAC-eligible senior unsecured debt 42,426 43,333 41,120
 
Total loss-absorbing capacity
Total loss-absorbing capacity 104,744 106,248 104,752
 
Risk-weighted assets / leverage ratio denominator
Risk-weighted assets 310,615 315,685 302,209
Leverage ratio denominator 989,787 1,025,422 1,068,862
 
Capital and loss-absorbing capacity ratios (%)
Going concern capital ratio 19.1 19.0 20.0
of which: common equity tier 1 capital ratio 14.4 14.2 15.0
Gone concern loss-absorbing capacity ratio 14.6 14.7 14.6
Total loss-absorbing capacity ratio 33.7 33.7 34.7
 
Leverage ratios (%)
Going concern leverage ratio 6.0 5.8 5.7
of which: common equity tier 1 leverage ratio 4.51 4.37 4.24
Gone concern leverage ratio 4.6 4.5 4.1
Total loss-absorbing capacity leverage ratio 10.6 10.4 9.8
Total loss-absorbing capacity and movement

Our total loss-absorbing capacity (TLAC) decreased by USD 1.5bn to USD 104.7bn in the third quarter of 2022.

Going concern capital and movement

Our going concern capital decreased by USD 0.5bn to USD 59.4bn. Our common equity tier 1 (CET1) capital decreased by USD 0.1bn to USD 44.7bn, mainly as operating profit before tax of USD 2.3bn was more than offset by share repurchases of USD 1.0bn, negative effects from foreign currency translation of USD 0.6bn, dividend accruals of USD 0.4bn and current tax expenses of USD 0.4bn.

Our additional tier 1 (AT1) capital decreased by USD 0.4bn to USD 14.7bn, mainly reflecting interest rate risk hedge, foreign currency translation and other effects.

Gone concern loss-absorbing capacity and movement

Our total gone concern loss-absorbing capacity decreased by USD 1.0bn to USD 45.4bn, mainly due to two calls of TLAC-eligible unsecured debt denominated in US dollars amounting to USD 3.3bn and interest rate risk hedge, foreign currency translation and other effects, partly offset by eight new issuances of TLAC-eligible senior unsecured debt, denominated in US dollars, euro and yen, amounting to USD 5.3bn equivalent.

Refer to “Bondholder information” at ubs.com/​investors for more information about the eligibility of capital and senior unsecured debt instruments and about key features and terms and conditions of capital instruments
Loss-absorbing capacity and leverage ratios

Our CET1 capital ratio increased to 14.4% from 14.2%, mainly reflecting a USD 5.1bn decrease in RWA.

Our CET1 leverage ratio increased to 4.51% from 4.37%, primarily due to a USD 35.6bn decrease in the LRD.

Our gone concern loss-absorbing capacity ratio decreased to 14.6% from 14.7%, due to a decrease in gone concern loss-absorbing capacity of USD 1.0bn, partly offset by the aforementioned decrease in RWA.

Our gone concern leverage ratio increased to 4.6% from 4.5%, reflecting the aforementioned decrease in the LRD, partly offset by the aforementioned decrease in gone concern loss-absorbing capacity.

Swiss SRB total loss-absorbing capacity movement
USD m
 
Going concern capital Swiss SRB
Common equity tier 1 capital as of 30.6.22 44,798
Operating profit before tax 2,323
Current tax (expense) / benefit (368)
Share repurchase program (1,024)
Foreign currency translation effects, before tax (639)
Other1 (426)
Common equity tier 1 capital as of 30.9.22 44,664
Loss-absorbing additional tier 1 capital as of 30.6.22 15,108
Interest rate risk hedge, foreign currency translation and other effects (413)
Loss-absorbing additional tier 1 capital as of 30.9.22 14,695
Total going concern capital as of 30.6.22 59,907
Total going concern capital as of 30.9.22 59,359
 
Gone concern loss-absorbing capacity
Tier 2 capital as of 30.6.22 3,009
Interest rate risk hedge, foreign currency translation and other effects (50)
Tier 2 capital as of 30.9.22 2,959
TLAC-eligible senior unsecured debt as of 30.6.22 43,333
Issuance of TLAC-eligible senior unsecured debt 5,281
Call of TLAC-eligible senior unsecured debt (3,251)
Interest rate risk hedge, foreign currency translation and other effects (2,937)
TLAC-eligible senior unsecured debt as of 30.9.22 42,426
Total gone concern loss-absorbing capacity as of 30.6.22 46,342
Total gone concern loss-absorbing capacity as of 30.9.22 45,385
 
Total loss-absorbing capacity
Total loss-absorbing capacity as of 30.6.22 106,248
Total loss-absorbing capacity as of 30.9.22 104,744
  1. Includes dividend accruals for the current year (negative USD 0.4bn) and movements related to other items.
Reconciliation of IFRS equity to Swiss SRB common equity tier 1 capital
USD m 30.9.22 30.6.22 31.12.21
Total IFRS equity 56,087 57,184 61,002
Equity attributable to non-controlling interests (330) (339) (340)
Defined benefit plans, net of tax (568) (471) (270)
Deferred tax assets recognized for tax loss carry-forwards (4,163) (4,401) (4,565)
Deferred tax assets on temporary differences, excess over threshold (49)
Goodwill, net of tax1 (5,699) (5,776) (5,838)
Intangible assets, net of tax (150) (174) (180)
Compensation-related components (not recognized in net profit) (1,974) (1,912) (1,700)
Expected losses on advanced internal ratings-based portfolio less provisions (486) (501) (482)
Unrealized (gains) / losses from cash flow hedges, net of tax 4,346 2,713 (628)
Own credit related to (gains) / losses on financial liabilities measured at fair value that existed at the balance sheet date, net of tax (778) (392) 315
Own credit related to (gains) / losses on derivative financial instruments that existed at the balance sheet date (134) (111) (50)
Unrealized gains related to financial assets at fair value through OCI, net of tax 0 0 (68)
Prudential valuation adjustments (238) (211) (167)
Accruals for dividends to shareholders for 2021 (1,700)
Other2 (1,247) (809) 1
Total common equity tier 1 capital 44,664 44,798 45,281
  1. Includes goodwill related to significant investments in financial institutions of USD 19m as of 30 September 2022 (30 June 2022: USD 21m; 31 December 2021: USD 22m) presented on the balance sheet line Investments in associates.
  2. Includes dividend accruals for the current year and other items.
Additional information
Sensitivity to currency movements
Risk-weighted assets

We estimate that a 10% depreciation of the US dollar against other currencies would have increased our RWA by USD 13bn and our CET1 capital by USD 1.3bn as of 30 September 2022 (30 June 2022: USD 13bn and USD 1.3bn, respectively) and decreased our CET1 capital ratio 15 basis points (30 June 2022: 14 basis points). Conversely, we estimate that a 10% appreciation of the US dollar against other currencies would have decreased our RWA by USD 11bn and our CET1 capital by USD 1.2bn (30 June 2022: USD 12bn and USD 1.2bn, respectively) and increased our CET1 capital ratio 14 basis points (30 June 2022: 15 basis points).

Leverage ratio denominator

We estimate that a 10% depreciation of the US dollar against other currencies would have increased our LRD by USD 57bn as of 30 September 2022 (30 June 2022: USD 61bn) and decreased our Swiss SRB going concern leverage ratio 17 basis points (30 June 2022: 18 basis points). Conversely, we estimate that a 10% appreciation of the US dollar against other currencies would have decreased our LRD by USD 51bn (30 June 2022: USD 55bn) and increased our Swiss SRB going concern leverage ratio 17 basis points (30 June 2022: 18 basis points).

The aforementioned sensitivities do not consider foreign currency translation effects related to defined benefit plans other than those related to the currency translation of the net equity of foreign operations.

Refer to “Active management of sensitivity to foreign exchange movements” under “Capital management” in the “Capital, liquidity and funding, and balance sheet” section of our Annual Report 2021 for more information
Estimated effect on capital from litigation, regulatory and similar matters subject to provisions and contingent liabilities

We have estimated the loss in capital that we could incur as a result of the risks associated with the matters described in “Note 14 Provisions and contingent liabilities” in the “Consolidated financial statements” section of this report. We have employed for this purpose the advanced measurement approach (AMA) methodology that we use when determining the capital requirements associated with operational risks, based on a 99.9% confidence level over a 12-month horizon. The methodology takes into consideration UBS and industry experience for the AMA operational risk categories to which those matters correspond, as well as the external environment affecting risks of these types, in isolation from other areas. On this basis, we estimate the maximum loss in capital that we could incur over a 12-month period as a result of our risks associated with these operational risk categories at USD 4.7bn as of 30 September 2022. This estimate is not related to and does not take into account any provisions recognized for any of these matters and does not constitute a subjective assessment of our actual exposure in any of these matters.

Refer to “Non-financial risk” in the “Risk management and control” section of our Annual Report 2021 for more information Refer to “Note 14 Provisions and contingent liabilities” in the “Consolidated financial statements” section of this report for more information

Risk-weighted assets

During the third quarter of 2022, RWA decreased by USD 5.1bn to USD 310.6bn, primarily driven by decreases of USD 5.1bn from currency effects and USD 2.5bn from asset size and other movements, partly offset by increases of USD 1.9bn from model updates and USD 0.6bn from regulatory add-ons.

Movement in risk-weighted assets by key driver
USD bn RWA as of 30.6.22 Currency effects Methodology and policy changes Model updates / changes Regulatory add-ons Asset size and other1 RWA as of 30.9.22
Credit and counterparty credit risk2 196.0 (4.8) 1.8 0.9 193.8
Non-counterparty-related risk3 23.3 (0.3) 0.3 23.4
Market risk 15.5 0.2 0.6 (3.7) 12.6
Operational risk 80.9 0.0 80.9
Total 315.7 (5.1) 1.9 0.6 (2.5) 310.6
  1. Includes the Pillar 3 categories “Asset size,” “Credit quality of counterparties,” “Acquisitions and disposals” and “Other.” For more information, refer to our 30 September 2022 Pillar 3 Report, available under “Pillar 3 disclosures” at ubs.com/​​investors.
  2. Includes settlement risk, credit valuation adjustments, equity exposures in the banking book, investments in funds and securitization exposures in the banking book.
  3. Non-counterparty-related risk includes deferred tax assets recognized for temporary differences, property, equipment, software and other items.
Credit and counterparty credit risk

Credit and counterparty credit risk RWA were USD 193.8bn as of 30 September 2022. The decrease of USD 2.2bn included negative currency effects of USD 4.8bn.

Asset size and other movements resulted in a USD 0.9bn increase in RWA.

– Global Wealth Management RWA increased by USD 3.9bn, mainly due to higher loan balances measured under the standardized approach, which carry a higher risk-weighting, as well as higher loan and other commitments.

– Investment Bank RWA decreased by USD 2.2bn, mainly reflecting lower loans and loan commitments.

– Group Functions RWA decreased by USD 0.7bn, mainly reflecting a decrease in nostro accounts.

– Asset Management RWA decreased by USD 0.1bn.

– Personal & Corporate Banking RWA were unchanged.

Model updates resulted in an RWA increase of USD 1.8bn, mainly driven by an increase of USD 0.6bn from updates to probability-of-default (PD) and loss-given-default (LGD) models for certain Lombard clients, an increase of USD 0.6bn from an update to the PD model for owner-occupied residential properties, and various smaller model updates amounting to an increase of USD 0.6bn.

We expect that further methodology changes, model updates and regulatory add-ons will increase credit and counterparty credit risk RWA by around USD 3bn in the fourth quarter of 2022. The extent and timing of RWA changes may vary as methodology changes and model updates are completed and receive regulatory approval. In addition, changes in the composition of the relevant portfolios and other market factors will affect RWA.

Refer to the “Risk management and control” section of this report for more information Refer to our 30 September 2022 Pillar 3 Report, available under “Pillar 3 disclosures” at ubs.com/​investors, for more information Refer to “Credit risk models” in the “Risk management and control” section of our Annual Report 2021 for more information
Market risk

Market risk RWA decreased by USD 2.9bn to USD 12.6bn in the third quarter of 2022, mainly due to a USD 3.7bn decrease in asset size and other movements in the Investment Bank’s Global Markets business. This was partly offset by an increase of USD 0.6bn in regulatory add-ons that reflected updates from the monthly risks-not-in-VaR assessment and an increase of USD 0.2bn related to ongoing parameter updates of our value-at-risk (VaR) model. We are in discussions with the Swiss Financial Market Supervisory Authority (FINMA) regarding the integration of time decay into the regulatory VaR, which would replace the current add-on.

Refer to the “Risk management and control” section of this report for more information Refer to our 30 September 2022 Pillar 3 Report, available under “Pillar 3 disclosures” at ubs.com/​investors, for more information Refer to ”Market risk” in the “Risk management and control” section of our Annual Report 2021 for more information
Operational risk

Operational risk RWA were USD 80.9bn as of 30 September 2022, unchanged from 30 June 2022.

Refer to “Note 14 Provisions and contingent liabilities” in the “Consolidated financial statements” section of this report for more information about the French cross-border matter Refer to “Non-financial risk” in the “Risk management and control” section of our Annual Report 2021 for information about the advanced measurement approach (AMA) model
Risk-weighted assets by business division and Group Functions
USD bn

Global Wealth

Management

Personal &

Corporate

Banking

Asset

Manage-

ment

Investment

Bank

Group

Functions

Total

RWA

30.9.22
Credit and counterparty credit risk1 65.5 61.1 2.6 58.8 5.8 193.8
Non-counterparty-related risk2 5.7 1.8 0.6 3.5 11.7 23.4
Market risk 1.2 0.0 9.9 1.4 12.6
Operational risk 37.4 9.1 3.1 21.2 10.1 80.9
Total 109.9 72.0 6.3 93.4 29.0 310.6
 
30.6.22
Credit and counterparty credit risk1 61.8 62.5 2.8 62.0 6.9 196.0
Non-counterparty-related risk2 5.8 1.9 0.6 3.6 11.5 23.3
Market risk 1.0 0.0 13.1 1.4 15.5
Operational risk 37.4 9.1 3.1 21.2 10.1 80.9
Total 106.0 73.5 6.5 99.9 29.8 315.7
 
30.9.22 vs 30.6.22
Credit and counterparty credit risk1 3.8 (1.4) (0.1) (3.3) (1.2) (2.2)
Non-counterparty-related risk2 (0.1) 0.0 0.0 (0.1) 0.3 0.0
Market risk 0.2 0.0 (3.2) 0.0 (2.9)
Operational risk 0.0 0.0
Total 3.9 (1.4) (0.1) (6.5) (0.9) (5.1)
  1. Includes settlement risk, credit valuation adjustments, equity exposures in the banking book and securitization exposures in the banking book.
  2. Non-counterparty-related risk includes deferred tax assets recognized for temporary differences (30 September 2022: USD 11.0bn; 30 June 2022: USD 10.9bn), as well as property, equipment, software and other items (30 September 2022: USD 12.3bn; 30 June 2022: USD 12.4bn).

Leverage ratio denominator

During the third quarter of 2022, the LRD decreased by USD 35.6bn to USD 989.8bn, driven by currency effects of USD 25.8bn and a USD 9.9bn decrease due to asset size and other movements.

Movement in leverage ratio denominator by key driver
USD bn

LRD as of

30.6.22

Currency

effects

Asset size and

other

LRD as of

30.9.22

On-balance sheet exposures (excluding derivative exposures and SFTs)1 804.3 (20.0) (24.5) 759.8
Derivative exposures 104.1 (3.2) 4.2 105.2
Securities financing transactions 98.2 (2.0) 8.0 104.3
Off-balance sheet items 30.1 (0.7) 2.3 31.6
Deduction items (11.3) 0.1 0.2 (11.1)
Total 1,025.4 (25.8) (9.9) 989.8
  1. The exposures exclude derivative financial instruments, cash collateral receivables on derivative instruments, receivables from SFTs, and margin loans, as well as prime brokerage receivables and financial assets at fair value not held for trading, both related to SFTs. These exposures are presented separately under Derivative exposures and Securities financing transactions in this table.

The LRD movements described below exclude currency effects.

On-balance sheet exposures decreased by USD 24.5bn, mainly driven by lower central bank balances, as well as a decrease in trading portfolio assets in the Investment Bank, partly offset by purchases of high-quality liquid asset securities in Group Treasury.

Derivative exposures increased by USD 4.2bn, primarily driven by the Investment Bank, reflecting market-driven movements in interest rate and foreign exchange contracts, amid volatility in interest rates and exchange rates.

Securities financing transactions increased by USD 8.0bn, mainly driven by higher collateral sourcing to hedge client positions and brokerage receivables in the Investment Bank, partly offset by roll-offs of excess cash reinvestment trades in Group Treasury.

Off-balance sheet items increased by USD 2.3bn, mainly due to higher forward starting reverse repurchase agreements in Group Treasury.

Refer to the “Balance sheet and off-balance sheet” section of this report for more information about balance sheet movements
Leverage ratio denominator by business division and Group Functions
USD bn

Global Wealth

Management

Personal &

Corporate

Banking

Asset

Management

Investment

Bank

Group Functions Total
30.9.22
Total IFRS assets 384.1 217.3 16.3 425.8 68.3 1,111.8
Difference in scope of consolidation1 0.0 0.0 (12.3) (0.1) 0.0 (12.4)
Less: derivative exposures and SFTs2 (28.4) (12.2) (0.1) (268.6) (30.2) (339.5)
On-balance sheet exposures 355.7 205.0 3.9 157.1 38.1 759.8
Derivative exposures 7.4 1.4 0.0 91.6 4.8 105.2
Securities financing transactions 23.1 11.0 0.1 52.8 17.3 104.3
Off-balance sheet items 6.9 15.3 7.0 2.4 31.6
Items deducted from Swiss SRB tier 1 capital (5.2) (0.2) (1.2) (0.5) (3.9) (11.1)
Total 387.8 232.6 2.8 308.0 58.6 989.8
 
30.6.22
Total IFRS assets 397.1 222.4 18.6 388.3 86.8 1,113.2
Difference in scope of consolidation1 0.0 0.0 (14.5) (0.1) 0.1 (14.6)
Less: derivative exposures and SFTs2 (28.3) (12.1) (0.1) (216.1) (37.6) (294.3)
On-balance sheet exposures 368.8 210.3 4.0 172.0 49.2 804.3
Derivative exposures 6.8 1.1 0.0 88.8 7.5 104.1
Securities financing transactions 24.1 11.4 0.1 41.1 21.6 98.2
Off-balance sheet items 6.3 16.0 7.2 0.6 30.1
Items deducted from Swiss SRB tier 1 capital (5.2) (0.2) (1.3) (0.5) (4.2) (11.3)
Total 400.7 238.6 2.8 308.6 74.8 1,025.4
 
30.9.22 vs 30.6.22
Total IFRS assets (13.1) (5.2) (2.3) 37.5 (18.5) (1.4)
Difference in scope of consolidation1 0.0 0.0 2.2 0.0 0.0 2.2
Less: derivative exposures and SFTs2 (0.1) (0.1) 0.0 (52.5) 7.4 (45.2)
On-balance sheet exposures (13.1) (5.3) (0.1) (14.9) (11.1) (44.5)
Derivative exposures 0.7 0.3 0.0 2.8 (2.8) 1.0
Securities financing transactions (1.0) (0.4) 0.0 11.8 (4.3) 6.0
Off-balance sheet items 0.6 (0.6) (0.1) 1.8 1.6
Items deducted from Swiss SRB tier 1 capital 0.1 0.0 0.0 (0.1) 0.2 0.3
Total (12.8) (6.0) (0.1) (0.6) (16.2) (35.6)
  1. Represents the difference between the IFRS and the regulatory scope of consolidation, which is the applicable scope for the LRD calculation.
  2. The exposures consist of derivative financial instruments, cash collateral receivables on derivative instruments, receivables from SFTs, and margin loans, as well as prime brokerage receivables and financial assets at fair value not held for trading, both related to SFTs, all of which are in accordance with the regulatory scope of consolidation. These exposures are presented separately under Derivative exposures and Securities financing transactions in this table.

Equity attribution and return on attributed equity

Under our equity attribution framework, tangible equity is attributed based on a weighting of 50% each for average risk-weighted assets (RWA) and average leverage ratio denominator (LRD), which both include resource allocations from Group Functions to the business divisions (the BDs). Average RWA and LRD are converted to common equity tier 1 (CET1) capital equivalents using capital ratios of 12.5% and 3.75%, respectively. If the attributed tangible equity calculated under the weighted-driver approach is less than the CET1 capital equivalent of risk-based capital (RBC) for any BD, the CET1 capital equivalent of RBC is used as a floor for that BD.

In addition to tangible equity, we allocate equity to the BDs to support goodwill and intangible assets.

We also allocate to the BDs attributed equity related to certain CET1 deduction items, such as compensation-related components and expected losses on the advanced internal ratings-based portfolio, less general provisions.

We attribute all remaining Basel III capital deduction items to Group Functions. These items include deferred tax assets (DTAs) recognized for tax loss carry-forwards, DTAs on temporary differences in excess of the threshold, accruals for shareholder returns and unrealized gains from cash flow hedges.

Refer to the “Capital, liquidity and funding, and balance sheet” section of our Annual Report 2021 for more information about the equity attribution framework Refer to the “Balance sheet and off-balance sheet” section of this report for more information about movements in equity attributable to shareholders
Average attributed equity
  For the quarter ended Year-to-date
USD bn 30.9.22 30.6.22 30.9.21 30.9.22 30.9.21
Global Wealth Management 20.0 20.0 19.0 19.9 18.6
Personal & Corporate Banking 9.2 9.3 9.2 9.3 9.1
Asset Management 1.7 1.7 1.9 1.7 2.1
Investment Bank 12.8 13.3 12.7 13.1 12.9
Group Functions 12.7 13.5 16.8 13.9 16.2
of which: deferred tax assets1 5.1 5.3 5.8 5.2 6.1
of which: related to retained RWA and LRD2 2.9 2.9 3.2 2.9 3.2
of which: accruals for shareholder returns and others3 4.8 5.4 7.8 5.7 6.9
Average equity attributed to business divisions and Group Functions 56.3 57.8 59.5 58.0 58.9
  1. Includes average attributed equity related to the Basel III capital deduction items for deferred tax assets (deferred tax assets recognized for tax loss carry-forwards and deferred tax assets on temporary differences, excess over threshold), as well as retained RWA and LRD related to deferred tax assets.
  2. Excludes average attributed equity related to retained RWA and LRD related to deferred tax assets.
  3. Includes attributed equity related to dividend accruals, unrealized gains from cash flow hedges, and a balancing item for capital held in excess of the 12.5%-capital and 3.75%-leverage-ratio calibration thresholds for equity attribution.
Return on attributed equity1
  For the quarter ended Year-to-date
in % 30.9.22 30.6.22 30.9.21 30.9.22 30.9.21
Global Wealth Management 29.1 23.2 31.9 26.2 30.2
Personal & Corporate Banking 19.3 17.8 20.8 18.4 19.9
Asset Management 33.2 221.3 46.3 98.1 45.2
Investment Bank 14.0 12.3 26.4 18.2 19.9
  1. Return on attributed equity for Group Functions is not shown, as it is not meaningful.

Liquidity and funding management

Strategy, objectives and governance

This section provides liquidity and funding management information and should be read in conjunction with “Liquidity and funding management” in the “Capital, liquidity and funding, and balance sheet” section of our Annual Report 2021, which provides more information about the Group’s strategy, objectives and governance in connection with liquidity and funding management.

Liquidity coverage ratio

In the third quarter of 2022, the quarterly average liquidity coverage ratio (the LCR) of UBS Group increased 1.8 percentage points to 162.7%, remaining above the prudential requirement communicated by the Swiss Financial Market Supervisory Authority (FINMA).

The movement in the average LCR was driven by a reduction in net cash outflows of USD 7.3bn to USD 147.8bn, mainly due to lower outflows from customer deposits. This was largely offset by a decrease in high-quality liquid assets of USD 8.9bn to USD 240.4bn, mainly driven by debt maturities and decreases in customer deposits, partly offset by lower funding consumption from the business divisions.

Refer to our 30 September 2022 Pillar 3 Report, available under “Pillar 3 disclosures” at ubs.com/​investors, and to “Liquidity and funding management” in the “Capital, liquidity and funding, and balance sheet” section of our Annual Report 2021 for more information about the LCR
Liquidity coverage ratio
USD bn, except where indicated Average 3Q221 Average 2Q221
High-quality liquid assets 240.4 249.4
Net cash outflows 147.8 155.1
Liquidity coverage ratio (%)2 162.7 160.8
  1. Calculated based on an average of 66 data points in the third quarter of 2022 and 64 data points in the second quarter of 2022.
  2. Calculated after the application of haircuts and inflow and outflow rates, as well as, where applicable, caps on Level 2 assets and cash inflows.
Net stable funding ratio

As of 30 September 2022, the net stable funding ratio (the NSFR) of UBS Group decreased 0.6 percentage points to 120.4%, remaining above the prudential requirement communicated by FINMA.

The movement in the NSFR was driven by USD 18.0bn lower available stable funding, predominantly due to decreases in customer deposits and debt maturities. Required stable funding decreased by USD 12.8bn, mainly driven by lower trading assets and loans to customers, partly offset by higher derivative and margin balances.

Refer to our 30 September 2022 Pillar 3 Report, available under “Pillar 3 disclosures” at ubs.com/​investors, and to “Liquidity and funding management” in the “Capital, liquidity and funding, and balance sheet” section of our Annual Report 2021 for more information about the NSFR
Net stable funding ratio
USD bn, except where indicated 30.9.22 30.6.22
Available stable funding 533.9 551.9
Required stable funding 443.5 456.3
Net stable funding ratio (%) 120.4 120.9

Balance sheet and off-balance sheet

Strategy, objectives and governance

This section provides balance sheet and off-balance sheet information and should be read in conjunction with “Balance sheet and off-balance sheet” in the “Capital, liquidity and funding, and balance sheet” section of our Annual Report 2021, which provides more information about the Group’s balance sheet and off-balance sheet positions.

Balances disclosed in this report represent quarter-end positions, unless indicated otherwise. Intra-quarter balances fluctuate in the ordinary course of business and may differ from quarter-end positions.

Balance sheet assets (30 September 2022 vs 30 June 2022)

Total assets were broadly unchanged at USD 1,112bn as of 30 September 2022, as a decrease from currency effects of approximately USD 25bn was largely offset by other net movements.

Cash and balances at central banks decreased by USD 24bn, mainly driven by purchases of securities in our high-quality liquid asset (HQLA) portfolio, currency effects, net redemptions of short-term debt, and higher margin requirements, as well as lower customer deposits. Trading portfolio assets decreased by USD 15bn, primarily reflecting lower inventory levels held to hedge client positions in our Financing and Derivatives & Solutions businesses in the Investment Bank, as well as market-driven movements. Lending assets decreased by USD 13bn, predominantly reflecting currency effects of approximately USD 9bn. Non-financial assets and financial assets for unit-linked investment contracts decreased by USD 3bn, mainly reflecting market-driven decreases from unit-linked investment contracts in Asset Management and the completion of the sale of our domestic wealth management business in Spain and the sale of UBS Swiss Financial Advisers AG.

Refer to the “Recent developments” section of this report for more information

These decreases were partly offset by a USD 39bn increase in Derivatives and cash collateral receivables on derivative instruments, mainly in our Derivatives & Solutions and Financing businesses, primarily reflecting market-driven movements in foreign currency and interest rate contracts, amid volatility in exchange rates and interest rates. Other financial assets measured at amortized cost and fair value increased by USD 8bn, mainly driven by purchases of securities in our HQLA portfolio. Securities financing transactions at amortized cost increased by USD 4bn, predominantly reflecting higher collateral sourcing to hedge client positions in the Investment Bank, partly offset by roll-offs of excess cash reinvestment trades in Group Treasury. Brokerage receivables increased by USD 3bn, mainly in our Financing business.

Refer to the “Consolidated financial statements” section of this report for more information
Assets
  As of % change from
USD bn 30.9.22 30.6.22 30.6.22
Cash and balances at central banks 166.4 190.4 (13)
Lending1 387.6 400.5 (3)
Securities financing transactions at amortized cost 66.9 63.3 6
Trading portfolio2 84.6 99.5 (15)
Derivatives and cash collateral receivables on derivative instruments 243.4 204.3 19
Brokerage receivables 22.5 19.3 17
Other financial assets measured at amortized cost and fair value3 90.9 83.1 9
Non-financial assets and financial assets for unit-linked investment contracts 49.5 52.9 (6)
Total assets 1,111.8 1,113.2 0
  1. Consists of loans and advances to customers and banks.
  2. Consists of financial assets at fair value held for trading.
  3. Consists of financial assets at fair value not held for trading, financial assets measured at fair value through other comprehensive income and other financial assets measured at amortized cost, but excludes financial assets for unit-linked investment contracts.
Balance sheet liabilities (30 September 2022 vs 30 June 2022)

Total liabilities were broadly unchanged at USD 1,056bn as of 30 September 2022 as a decrease from currency effects of approximately USD 22bn was entirely offset by other net movements.

Customer deposits decreased by USD 16bn, mainly reflecting currency effects of approximately USD 12bn, as well as decreases in Global Wealth Management in the Americas, partly offset by increases in Asia Pacific. Short-term borrowings decreased by USD 8bn, mainly driven by net maturities of short-term debt in Group Treasury. Debt issued designated at fair value and long-term debt issued measured at amortized cost decreased by USD 8bn, mainly driven by currency effects and other market-driven movements, partly offset by net new issuances of debt issued designated at fair value. Non-financial liabilities and financial liabilities related to unit-linked investment contracts decreased by USD 3bn, driven by decreases in unit-linked investment contracts in line with the asset side and the completion of the aforementioned sale transactions.

These decreases were partly offset by a USD 39bn increase in Derivatives and cash collateral payables on derivative instruments, mainly in our Derivatives & Solutions and Financing businesses, primarily reflecting market-driven movements, in line with the asset side.

The “Liabilities by product and currency” table in this section provides more information about our funding sources.

Refer to “Bondholder information” at ubs.com/​investors for more information about capital and senior debt instruments Refer to the “Consolidated financial statements” section of this report for more information
Liabilities and equity
  As of % change from
USD bn 30.9.22 30.6.22 30.6.22
Short-term borrowings1 38.7 46.7 (17)
Securities financing transactions at amortized cost 4.5 6.0 (24)
Customer deposits 496.2 512.2 (3)
Debt issued designated at fair value and long-term debt issued measured at amortized cost2 154.6 162.6 (5)
Trading portfolio3 30.7 30.4 1
Derivatives and cash collateral payables on derivative instruments 236.6 197.4 20
Brokerage payables 48.1 49.8 (3)
Other financial liabilities measured at amortized cost and fair value4 22.5 24.0 (6)
Non-financial liabilities and financial liabilities related to unit-linked investment contracts 23.7 26.9 (12)
Total liabilities 1,055.7 1,056.0 0
Share capital 0.3 0.3 0
Share premium 13.4 13.2 1
Treasury shares (5.6) (4.4) 27
Retained earnings 48.8 46.6 5
Other comprehensive income5 (1.1) 1.2 (196)
Total equity attributable to shareholders 55.8 56.8 (2)
Equity attributable to non-controlling interests 0.3 0.3 (3)
Total equity 56.1 57.2 (2)
Total liabilities and equity 1,111.8 1,113.2 0
  1. Consists of short-term debt issued measured at amortized cost and amounts due to banks.
  2. The classification of debt issued measured at amortized cost into short-term and long-term is based on original contractual maturity and therefore long-term debt also includes debt with a remaining time to maturity of less than one year. This classification does not consider any early redemption features.
  3. Consists of financial liabilities at fair value held for trading.
  4. Consists of other financial liabilities measured at amortized cost and other financial liabilities designated at fair value, but excludes financial liabilities related to unit-linked investment contracts.
  5. Excludes other comprehensive income related to defined benefit plans and own credit, which is recorded directly in Retained earnings.
Equity (30 September 2022 vs 30 June 2022)

Equity attributable to shareholders decreased by USD 1,089m to USD 55,756m as of 30 September 2022.

The decrease of USD 1,089m was mainly driven by net treasury share activity that reduced equity by USD 1,214m. This was predominantly due to repurchases of USD 1,024m of shares under our 2022 share repurchase program and USD 207m of shares purchased from the market to hedge future share delivery obligations related to employee share-based compensation awards.

Total comprehensive income attributable to shareholders was negative USD 40m, reflecting net profit of USD 1,733m and negative other comprehensive income (OCI) of USD 1,773m. OCI mainly included negative cash flow hedge OCI of USD 1,664m, negative OCI related to foreign currency translation of USD 633m, positive OCI related to own credit on financial liabilities designated at fair value of USD 335m and positive defined benefit plan OCI of USD 177m.

Refer to the “Group performance” and “Consolidated financial statements” sections of this report for more information Refer to “Reconciliation of IFRS equity to Swiss SRB common equity tier 1 capital” in the “Capital management” section of this report for more information about the effects of OCI on common equity tier 1 capital Refer to the “Share information and earnings per share” section of this report for more information about our share repurchase programs
Liabilities by product and currency
USD bn As a percentage of total liabilities
  All currencies All currencies USD CHF EUR Other
  30.9.22 30.6.22 30.9.22 30.6.22 30.9.22 30.6.22 30.9.22 30.6.22 30.9.22 30.6.22 30.9.22 30.6.22
Short-term borrowings 38.7 46.7 3.7 4.4 1.7 2.3 0.4 0.4 0.6 0.6 0.9 1.0
of which: amounts due to banks 13.9 15.2 1.3 1.4 0.4 0.5 0.4 0.4 0.1 0.1 0.4 0.4
of which: short-term debt issued1 24.8 31.5 2.4 3.0 1.4 1.8 0.0 0.0 0.5 0.5 0.5 0.6
Securities financing transactions at amortized cost 4.5 6.0 0.4 0.6 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0
Customer deposits 496.2 512.2 47.0 48.5 21.3 22.5 16.8 17.0 4.8 4.8 4.1 4.2
of which: demand deposits 190.4 211.2 18.0 20.0 5.4 6.8 6.1 6.1 4.0 4.1 2.5 3.0
of which: retail savings / deposits2 215.8 234.3 20.4 22.2 9.4 11.0 10.5 10.7 0.5 0.5 0.0 0.0
of which: time deposits 90.0 66.7 8.5 6.3 6.4 4.7 0.2 0.2 0.3 0.2 1.6 1.2
Debt issued designated at fair value and long-term debt issued measured at amortized cost3 154.6 162.6 14.6 15.4 9.1 9.4 1.5 1.6 2.7 3.0 1.3 1.4
Trading portfolio4 30.7 30.4 2.9 2.9 1.3 1.1 0.1 0.1 0.7 0.7 0.9 0.9
Derivatives and cash collateral payables on derivative instruments 236.6 197.4 22.4 18.7 19.0 15.7 0.4 0.4 1.7 1.4 1.3 1.2
Brokerage payables 48.1 49.8 4.6 4.7 3.3 3.5 0.0 0.0 0.4 0.3 0.9 0.9
Other financial liabilities measured at amortized cost and fair value5 22.5 24.0 2.1 2.3 1.1 1.3 0.2 0.2 0.5 0.5 0.3 0.3
Non-financial liabilities and financial liabilities related to unit-linked investment contracts 23.7 26.9 2.2 2.5 0.5 0.5 0.1 0.1 0.3 0.3 1.4 1.6
Total liabilities 1,055.7 1,056.0 100.0 100.0 57.7 56.8 19.5 19.9 11.7 11.7 11.1 11.5
  1. Short-term debt issued consists of certificates of deposit, commercial paper, acceptances and promissory notes, and other money market paper.
  2. Includes sweep deposit balances in the Americas which are generally not fully callable on demand.
  3. The classification of debt issued measured at amortized cost into short-term and long-term is based on original contractual maturity and therefore long-term debt also includes debt with a remaining time to maturity of less than one year. This classification does not consider any early redemption features.
  4. Consists of financial liabilities at fair value held for trading.
  5. Consists of other financial liabilities measured at amortized cost and other financial liabilities designated at fair value, but excludes financial liabilities related to unit-linked investment contracts.
Off-balance sheet (30 September 2022 vs 30 June 2022)

Guarantees decreased by USD 2bn, mainly in Group Treasury, relating to guarantees issued to corporate clients. Loan commitments were broadly unchanged as of 30 September 2022 compared with 30 June 2022. Committed unconditionally revocable credit lines decreased by USD 2bn, driven by credit lines provided to clients in Global Wealth Management and in the Global Banking business in the Investment Bank, as well as by currency effects. Forward starting reverse repurchase agreements increased by USD 4bn and Forward starting repurchase agreements decreased by USD 1bn, both in Group Treasury, reflecting fluctuations in the levels of business division activity in short-dated securities financing transactions.

Off-balance sheet
  As of % change from
USD bn 30.9.22 30.6.22 30.6.22
Guarantees12 19.1 20.9 (8)
Loan commitments13 37.5 37.7 (1)
Committed unconditionally revocable credit lines 37.5 39.8 (6)
Forward starting reverse repurchase agreements3 8.2 4.0 105
Forward starting repurchase agreements3 1.8 2.9 (36)
  1. Guarantees and loan commitments are shown net of sub-participations.
  2. Includes guarantees measured at fair value through profit or loss.
  3. Derivative loan commitments, as well as forward starting repurchase and reverse repurchase agreements, measured at fair value through profit or loss are not included. Refer to “Note 9 Derivative instruments” in the “Consolidated financial statements” section of this report for more information.

Share information and earnings per share

UBS Group AG shares are listed on the SIX Swiss Exchange (SIX). They are also listed on the New York Stock Exchange (the NYSE) as global registered shares. Each share has a nominal value of CHF 0.10. Shares issued were unchanged in the third quarter of 2022 compared with the second quarter of 2022.

We held 342m shares as of 30 September 2022, of which 220m shares had been acquired under our 2021 and 2022 share repurchase programs for cancellation purposes. The remaining 122m shares are primarily held to hedge our share delivery obligations related to employee share-based compensation and participation plans.

Treasury shares held increased by 75m shares in the third quarter of 2022. This mainly reflected repurchases of 64.9m shares (acquisition cost of CHF 998m, or USD 1,033m) under our 2022 share repurchase program and 12.5m shares purchased from the market to hedge future share delivery obligations related to employee share-based compensation awards.

From 1 January 2022 to 30 September 2022, we repurchased 245m shares for a total acquisition cost of CHF 4,090m (USD 4,303m) under the 2021 and 2022 share repurchase programs. We expect repurchases in aggregate in 2022 under our 2021 and 2022 share repurchase programs to be approximately USD 5.5bn.

Refer to the “Equity, CET1 capital and returns” table in the “Group performance” section of this report for more information about equity attributable to shareholders and tangible equity attributable to shareholders
  As of or for the quarter ended As of or year-to-date
  30.9.22 30.6.22 30.9.21 30.9.22 30.9.21
 
Basic and diluted earnings (USD m)
Net profit / (loss) attributable to shareholders for basic EPS 1,733 2,108 2,279 5,977 6,109
Less: (profit) / loss on own equity derivative contracts (1) (5) 0 (4) (2)
Net profit / (loss) attributable to shareholders for diluted EPS 1,732 2,103 2,279 5,973 6,108
 
Weighted average shares outstanding
Weighted average shares outstanding for basic EPS1 3,217,212,461 3,304,598,259 3,463,572,205 3,300,688,319 3,501,490,976
Effect of dilutive potential shares resulting from notional employee shares, in-the-money options and warrants outstanding2 132,630,871 128,725,327 141,509,280 136,632,556 143,658,122
Weighted average shares outstanding for diluted EPS 3,349,843,332 3,433,323,586 3,605,081,485 3,437,320,875 3,645,149,098
 
Earnings per share (USD)
Basic 0.54 0.64 0.66 1.81 1.74
Diluted 0.52 0.61 0.63 1.74 1.68
 
Shares outstanding and potentially dilutive instruments
Shares issued 3,524,635,722 3,524,635,722 3,702,422,995 3,524,635,722 3,702,422,995
Treasury shares3 342,282,123 267,270,042 256,853,565 342,282,123 256,853,565
of which: related to the 2021 share repurchase program 62,548,000 62,548,000 119,201,773 62,548,000 119,201,773
of which: related to the 2022 share repurchase program 157,608,950 92,749,500 157,608,950
Shares outstanding 3,182,353,599 3,257,365,680 3,445,569,430 3,182,353,599 3,445,569,430
Potentially dilutive instruments4 7,284,942 5,366,916 14,796,870 6,281,940 13,846,870
 
Other key figures
Total book value per share (USD) 17.52 17.45 17.48 17.52 17.48
Tangible book value per share (USD) 15.57 15.51 15.62 15.57 15.62
Share price (USD)5 14.67 16.11 16.09 14.67 16.09
Market capitalization (USD m) 46,674 52,475 55,423 46,674 55,423
  1. The weighted average shares outstanding for basic EPS are calculated by taking the number of shares at the beginning of the period, adjusted by the number of shares acquired or issued during the period, multiplied by a time-weighted factor for the period outstanding. As a result, balances are affected by the timing of acquisitions and issuances during the period.
  2. The weighted average number of shares for notional employee awards with performance conditions reflects all potentially dilutive shares that are expected to vest under the terms of the awards.
  3. Based on a settlement date view.
  4. Reflects potential shares that could dilute basic earnings per share in the future, but were not dilutive for any of the periods presented. It mainly includes equity derivative contracts and equity-based awards subject to absolute and relative performance conditions.
  5. Represents the share price as listed on the SIX Swiss Exchange, translated to US dollars using the closing exchange rate as of the respective date.
Ticker symbols UBS Group AG Security identification codes
Trading exchange SIX / NYSE Bloomberg Reuters ISIN CH0244767585
SIX Swiss Exchange UBSG UBSG SW UBSG.S Valoren 24 476 758
New York Stock Exchange UBS UBS UN UBS.N CUSIP CINS H42097 10 7

Consolidated financial statements

Unaudited

UBS Group AG interim consolidated financial statements (unaudited)

Income statement
  For the quarter ended Year-to-date
USD m Note 30.9.22 30.6.22 30.9.21 30.9.22 30.9.21

Interest income from financial instruments measured at amortized cost and fair value through

other comprehensive income

3 3,078 2,380 2,178 7,602 6,381
Interest expense from financial instruments measured at amortized cost 3 (1,758) (1,070) (822) (3,610) (2,491)
Net interest income from financial instruments measured at fair value through profit or loss 3 277 355 338 1,040 1,044
Net interest income 3 1,596 1,665 1,693 5,032 4,934
Other net income from financial instruments measured at fair value through profit or loss 1,796 1,619 1,697 5,641 4,485
Fee and commission income 4 4,957 5,224 6,119 16,018 18,330
Fee and commission expense 4 (476) (450) (510) (1,410) (1,472)
Net fee and commission income 4 4,481 4,774 5,610 14,608 16,858
Other income 363 859 115 1,254 412
Total revenues 8,236 8,917 9,115 26,534 26,689
 
Credit loss expense / (release) 7 (3) 7 (14) 22 (121)
 
Personnel expenses 5 4,216 4,422 4,598 13,559 14,170
General and administrative expenses 6 1,192 1,370 1,148 3,769 3,340
Depreciation, amortization and impairment of non-financial assets 508 503 518 1,517 1,544
Operating expenses 5,916 6,295 6,264 18,845 19,054
Operating profit / (loss) before tax 2,323 2,615 2,865 7,667 7,755
Tax expense / (benefit) 580 497 576 1,662 1,629
Net profit / (loss) 1,742 2,118 2,289 6,005 6,127
Net profit / (loss) attributable to non-controlling interests 9 10 9 28 18
Net profit / (loss) attributable to shareholders 1,733 2,108 2,279 5,977 6,109
 
Earnings per share (USD)
Basic 0.54 0.64 0.66 1.81 1.74
Diluted 0.52 0.61 0.63 1.74 1.68
Statement of comprehensive income
  For the quarter ended Year-to-date
USD m 30.9.22 30.6.22 30.9.21 30.9.22 30.9.21
 
Comprehensive income attributable to shareholders1
Net profit / (loss) 1,733 2,108 2,279 5,977 6,109
Other comprehensive income that may be reclassified to the income statement
Foreign currency translation
Foreign currency translation movements related to net assets of foreign operations, before tax (1,135) (1,030) (392) (2,647) (1,391)
Effective portion of changes in fair value of hedging instruments designated as net investment hedges, before tax 475 443 175 1,135 681
Foreign currency translation differences on foreign operations reclassified to the income statement 24 8 7 32 (2)
Effective portion of changes in fair value of hedging instruments designated as net investment hedges reclassified to the income statement (3) (4) 0 (7) 7
Income tax relating to foreign currency translations, including the impact of net investment hedges 6 5 53 14 59
Subtotal foreign currency translation, net of tax (633) (577) (156) (1,473) (646)
Financial assets measured at fair value through other comprehensive income
Net unrealized gains / (losses), before tax (3) (3) (44) (445) (154)
Net realized gains / (losses) reclassified to the income statement from equity 0 0 0 0 (9)
Reclassification of financial assets to Other financial assets measured at amortized cost2 449 449
Income tax relating to net unrealized gains / (losses) 0 (116) 11 (3) 42
Subtotal financial assets measured at fair value through other comprehensive income, net of tax (3) 330 (33) 0 (121)
Cash flow hedges of interest rate risk
Effective portion of changes in fair value of derivative instruments designated as cash flow hedges, before tax (2,053) (1,298) (112) (5,816) (742)
Net (gains) / losses reclassified to the income statement from equity 16 (149) (282) (370) (804)
Income tax relating to cash flow hedges 373 276 77 1,168 292
Subtotal cash flow hedges, net of tax (1,664) (1,171) (316) (5,018) (1,254)
Cost of hedging
Cost of hedging, before tax 17 21 5 114 (18)
Income tax relating to cost of hedging (3) 0 0 (3) 0
Subtotal cost of hedging, net of tax 14 21 5 111 (18)
Total other comprehensive income that may be reclassified to the income statement, net of tax (2,286) (1,396) (500) (6,380) (2,037)
 
Other comprehensive income that will not be reclassified to the income statement
Defined benefit plans
Gains / (losses) on defined benefit plans, before tax 136 122 10 299 (146)
Income tax relating to defined benefit plans 42 (7) (9) 33 18
Subtotal defined benefit plans, net of tax 177 115 2 332 (128)
Own credit on financial liabilities designated at fair value
Gains / (losses) from own credit on financial liabilities designated at fair value, before tax 452 296 (98) 1,171 (8)
Income tax relating to own credit on financial liabilities designated at fair value (116) (26) 0 (142) 0
Subtotal own credit on financial liabilities designated at fair value, net of tax 335 271 (98) 1,029 (8)
Total other comprehensive income that will not be reclassified to the income statement, net of tax 513 385 (96) 1,361 (136)
 
Total other comprehensive income (1,773) (1,011) (596) (5,018) (2,174)
Total comprehensive income attributable to shareholders (40) 1,097 1,683 959 3,935
 
Comprehensive income attributable to non-controlling interests
Net profit / (loss) 9 10 9 28 18
Total other comprehensive income that will not be reclassified to the income statement, net of tax (17) (28) (14) (27) (12)
Total comprehensive income attributable to non-controlling interests (8) (17) (5) 1 6
 
Total comprehensive income
Net profit / (loss) 1,742 2,118 2,289 6,005 6,127
Other comprehensive income (1,791) (1,039) (610) (5,045) (2,186)
of which: other comprehensive income that may be reclassified to the income statement (2,286) (1,396) (500) (6,380) (2,037)
of which: other comprehensive income that will not be reclassified to the income statement 496 357 (110) 1,334 (149)
Total comprehensive income (48) 1,079 1,678 960 3,941
  1. Refer to the “Group performance” section of this report for more information.
  2. Effective 1 April 2022, a portfolio of assets previously classified as Financial assets measured at fair value through other comprehensive income was reclassified to Other financial assets measured at amortized cost. Refer to Note 1 for more information.
Balance sheet
USD m Note 30.9.22 30.6.22 31.12.21
 
Assets
Cash and balances at central banks 166,406 190,353 192,817
Loans and advances to banks 14,518 16,596 15,480
Receivables from securities financing transactions 66,926 63,291 75,012
Cash collateral receivables on derivative instruments 9 48,206 43,763 30,514
Loans and advances to customers 7 373,036 383,898 397,761
Other financial assets measured at amortized cost 10 47,019 37,528 26,209
Total financial assets measured at amortized cost 716,112 735,428 737,794
Financial assets at fair value held for trading 8 84,584 99,507 130,821
of which: assets pledged as collateral that may be sold or repledged by counterparties 26,810 33,830 43,397
Derivative financial instruments 8, 9 195,206 160,524 118,142
Brokerage receivables 8 22,510 19,289 21,839
Financial assets at fair value not held for trading 8 53,795 57,637 60,080
Total financial assets measured at fair value through profit or loss 356,096 336,957 330,882
Financial assets measured at fair value through other comprehensive income 8 2,243 2,251 8,844
Investments in associates 1,032 1,094 1,243
Property, equipment and software 11,829 12,049 12,888
Goodwill and intangible assets 6,210 6,312 6,378
Deferred tax assets 9,299 9,119 8,876
Other non-financial assets 10 8,932 9,984 10,277
Total assets 1,111,753 1,113,193 1,117,182
Liabilities
Amounts due to banks 13,870 15,202 13,101
Payables from securities financing transactions 4,540 5,956 5,533
Cash collateral payables on derivative instruments 9 44,321 40,468 31,798
Customer deposits 496,209 512,216 542,007
Debt issued measured at amortized cost 12 110,038 121,896 139,155
Other financial liabilities measured at amortized cost 10 9,397 9,930 9,001
Total financial liabilities measured at amortized cost 678,375 705,669 740,595
Financial liabilities at fair value held for trading 8 30,741 30,450 31,688
Derivative financial instruments 8, 9 192,297 156,888 121,309
Brokerage payables designated at fair value 8 48,093 49,798 44,045
Debt issued designated at fair value 8, 11 69,374 72,264 73,799
Other financial liabilities designated at fair value 8, 10 25,437 28,566 30,074
Total financial liabilities measured at fair value through profit or loss 365,943 337,966 300,916
Provisions 14 3,281 3,465 3,518
Other non-financial liabilities 10 8,068 8,910 11,151
Total liabilities 1,055,666 1,056,010 1,056,180
 
Equity
Share capital 304 304 322
Share premium 13,359 13,202 15,928
Treasury shares (5,617) (4,412) (4,675)
Retained earnings 48,813 46,598 43,851
Other comprehensive income recognized directly in equity, net of tax (1,103) 1,152 5,236
Equity attributable to shareholders 55,756 56,845 60,662
Equity attributable to non-controlling interests 330 339 340
Total equity 56,087 57,184 61,002
Total liabilities and equity 1,111,753 1,113,193 1,117,182
Statement of changes in equity
USD m Share capital and share premium

Treasury

shares

Retained

earnings

OCI recognized

directly in equity,

net of tax1

of which:

foreign currency translation

of which:

cash flow hedges

Total equity

attributable to

shareholders

Balance as of 1 January 20222 16,250 (4,675) 43,851 5,236 4,653 628 60,662
Acquisition of treasury shares (4,944)3 (4,944)
Delivery of treasury shares under share-based compensation plans (761) 857 96
Other disposal of treasury shares (2) 1243 123
Cancellation of treasury shares related to the 2021 share repurchase program4 (1,520) 3,022 (1,502) 0
Share-based compensation expensed in the income statement 544 544
Tax (expense) / benefit 12 12
Dividends (834)5 (834)5 (1,668)
Equity classified as obligation to purchase own shares (31) (31)
Translation effects recognized directly in retained earnings (44) 44 44 0
Share of changes in retained earnings of associates and joint ventures 0 0
New consolidations / (deconsolidations) and other increases / (decreases) 4 3 (3) 4
Total comprehensive income for the period 7,338 (6,380) (1,473) (5,018) 959
of which: net profit / (loss) 5,977 5,977
of which: OCI, net of tax 1,361 (6,380) (1,473) (5,018) (5,018)
Balance as of 30 September 20222 13,663 (5,617) 48,813 (1,103) 3,180 (4,346) 55,756
Non-controlling interests as of 30 September 2022 330
Total equity as of 30 September 2022 56,087
 
Balance as of 1 January 20212 17,091 (4,068) 38,776 7,647 5,188 2,321 59,445
Acquisition of treasury shares (2,663)3 (2,663)
Delivery of treasury shares under share-based compensation plans (673) 768 96
Other disposal of treasury shares 5 723 77
Cancellation of treasury shares related to the 2018–2021 share repurchase program (252) 2,044 (1,792) 0
Share-based compensation expensed in the income statement 501 501
Tax (expense) / benefit (56) (56)
Dividends (651)5 (651)5 (1,301)
Translation effects recognized directly in retained earnings 23 (23) (23) 0
Share of changes in retained earnings of associates and joint ventures 1 1
New consolidations / (deconsolidations) and other increases / (decreases) 185 185
Total comprehensive income for the period 5,973 (2,037) (646) (1,254) 3,935
of which: net profit / (loss) 6,109 6,109
of which: OCI, net of tax (136) (2,037) (646) (1,254) (2,174)
Balance as of 30 September 20212 16,150 (3,847) 42,330 5,586 4,543 1,044 60,219
Non-controlling interests as of 30 September 2021 333
Total equity as of 30 September 2021 60,552
  1. Excludes other comprehensive income related to defined benefit plans and own credit that is recorded directly in Retained earnings.
  2. Excludes non-controlling interests.
  3. Includes treasury shares acquired and disposed of by the Investment Bank in its capacity as a market maker with regard to UBS shares and related derivatives, and to hedge certain issued structured debt instruments. These acquisitions and disposals are reported based on the sum of the net monthly movements.
  4. Reflects the cancellation of 177,787,273 shares purchased under UBS’s 2021 share repurchase program as approved by shareholders at the 2022 Annual General Meeting. Swiss tax law requires Switzerland-domiciled companies with shares listed on a Swiss stock exchange to reduce capital contribution reserves by at least 50% of the total capital reduction amount exceeding the nominal value upon cancellation of the shares.
  5. Reflects the payment of an ordinary cash dividend of USD 0.50 per dividend-bearing share in April 2022 (2021: USD 0.37 per dividend-bearing share paid in April 2021). Swiss tax law requires Switzerland-domiciled companies with shares listed on a Swiss stock exchange to pay no more than 50% of dividends from capital contribution reserves, with the remainder required to be paid from retained earnings.
Statement of cash flows
  Year-to-date
USD m 30.9.22 30.9.21
 
Cash flow from / (used in) operating activities
Net profit / (loss) 6,005 6,127
Non-cash items included in net profit and other adjustments:
Depreciation, amortization and impairment of non-financial assets 1,517 1,544
Credit loss expense / (release) 22 (121)
Share of net (profit) / loss of associates and joint ventures and impairment related to associates (31) (72)
Deferred tax expense / (benefit) 563 429
Net loss / (gain) from investing activities (889) (322)
Net loss / (gain) from financing activities (22,611) (217)
Other net adjustments 14,766 5,407
Net change in operating assets and liabilities:
Loans and advances to banks and amounts due to banks 1,808 2,626
Securities financing transactions at amortized cost 5,347 (1,926)
Cash collateral on derivative instruments (5,313) (3,171)
Loans and advances to customers and customer deposits (15,899) (15,193)
Financial assets and liabilities at fair value held for trading and derivative financial instruments 22,996 (3,787)
Brokerage receivables and payables 3,243 10,715
Financial assets at fair value not held for trading and other financial assets and liabilities 4,448 18,106
Provisions and other non-financial assets and liabilities 313 1,909
Income taxes paid, net of refunds (1,284) (760)
Net cash flow from / (used in) operating activities 15,000 21,292
 
Cash flow from / (used in) investing activities
Purchase of subsidiaries, associates and intangible assets 0 (1)
Disposal of subsidiaries, associates and intangible assets 1,6821 564
Purchase of property, equipment and software (1,181) (1,354)
Disposal of property, equipment and software 9 268
Purchase of financial assets measured at fair value through other comprehensive income (3,958) (3,118)
Disposal and redemption of financial assets measured at fair value through other comprehensive income 3,234 2,798
Net (purchase) / redemption of debt securities measured at amortized cost (8,228) 223
Net cash flow from / (used in) investing activities (8,443) (622)
  1. Includes cash proceeds from the sales of: UBS’s shareholding in its Japanese real estate joint venture, Mitsubishi Corp.-UBS Realty Inc.; UBS’s wholly owned subsidiary UBS Swiss Financial Advisers AG; and UBS’s domestic wealth management business in Spain. Refer to the “Recent developments” section of this report for more information.
  2. Consists of balances with an original maturity of three months or less. USD 3,855m and USD 3,823m (mainly reflected in Loans and advances to banks) were restricted as of 30 September 2022 and 30 September 2021, respectively. Refer to “Note 23 Restricted and transferred financial assets” in the “Consolidated financial statements” section of the Annual Report 2021 for more information.
Cash flow from / (used in) financing activities
Net short-term debt issued / (repaid) (16,249) (7,717)
Net movements in treasury shares and own equity derivative activity (4,745) (2,511)
Distributions paid on UBS shares (1,668) (1,301)
Issuance of debt designated at fair value and long-term debt measured at amortized cost 68,389 80,801
Repayment of debt designated at fair value and long-term debt measured at amortized cost (54,184) (65,458)
Net cash flows from other financing activities (481) (145)
Net cash flow from / (used in) financing activities (8,939) 3,668
 
Total cash flow
Cash and cash equivalents at the beginning of the period 207,875 173,531
Net cash flow from / (used in) operating, investing and financing activities (2,382) 24,338
Effects of exchange rate differences on cash and cash equivalents (15,788) (6,896)
Cash and cash equivalents at the end of the period2 189,707 190,973
 
Additional information
Net cash flow from / (used in) operating activities includes:
Interest received in cash 10,189 8,285
Interest paid in cash 5,028 3,901
Dividends on equity investments, investment funds and associates received in cash 1,556 1,969
  1. Includes cash proceeds from the sales of: UBS’s shareholding in its Japanese real estate joint venture, Mitsubishi Corp.-UBS Realty Inc.; UBS’s wholly owned subsidiary UBS Swiss Financial Advisers AG; and UBS’s domestic wealth management business in Spain. Refer to the “Recent developments” section of this report for more information.
  2. Consists of balances with an original maturity of three months or less. USD 3,855m and USD 3,823m (mainly reflected in Loans and advances to banks) were restricted as of 30 September 2022 and 30 September 2021, respectively. Refer to “Note 23 Restricted and transferred financial assets” in the “Consolidated financial statements” section of the Annual Report 2021 for more information.

Notes to the UBS Group AG interim consolidated financial statements (unaudited)

Note 1 Basis of accounting
Basis of preparation

The consolidated financial statements (the financial statements) of UBS Group AG and its subsidiaries (together, “UBS” or the “Group”) are prepared in accordance with International Financial Reporting Standards (IFRS), as issued by the International Accounting Standards Board (the IASB), and are presented in US dollars (USD). These interim financial statements are prepared in accordance with IAS 34, Interim Financial Reporting.

In preparing these interim financial statements, the same accounting policies and methods of computation have been applied as in the UBS Group AG consolidated annual financial statements for the period ended 31 December 2021, except for the changes described in this Note. These interim financial statements are unaudited and should be read in conjunction with UBS Group AG’s audited consolidated financial statements in the Annual Report 2021 and the “Management report” sections of this report, including the disclosures in the “Global Wealth Management” and “Asset Management” sections of this report regarding the sales of UBS’s domestic wealth management business in Spain and UBS Swiss Financial Advisers AG in the third quarter of 2022, as well as the sale of UBS’s shareholding in Mitsubishi Corp.-UBS Realty Inc. in the second quarter of 2022. In the opinion of management, all necessary adjustments have been made for a fair presentation of the Group’s financial position, results of operations and cash flows.

Preparation of these interim financial statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, income, expenses and disclosures of contingent assets and liabilities. These estimates and assumptions are based on the best available information. Actual results in the future could differ from such estimates and differences may be material to the financial statements. Revisions to estimates, based on regular reviews, are recognized in the period in which they occur. For more information about areas of estimation uncertainty that are considered to require critical judgment, refer to “Note 1a Material accounting policies” in the “Consolidated financial statements” section of the Annual Report 2021.

Changes to the presentation of the financial statements

Effective from the second quarter of 2022, UBS has made several changes to simplify the presentation of the income statement alongside other primary financial statements and disclosure notes and to align them with management information. In particular, Total operating income has been renamed Total revenues and excludes Credit loss expense / (release), which is now separately presented below Total revenues.

Reclassification of a portfolio from Financial assets measured at fair value through other comprehensive income to Other financial assets measured at amortized cost

Effective from 1 April 2022, UBS has reclassified a portfolio of financial assets from Financial assets measured at fair value through other comprehensive income (FVOCI) with a fair value of USD 6.9bn (the Portfolio) to Other financial assets measured at amortized cost in line with the principles in IFRS 9, Financial Instruments, which require a reclassification when an entity changes its business model for managing financial assets.

The Portfolio’s cumulative fair value losses of USD 449m pre-tax and USD 333m post-tax, previously recognized in Other comprehensive income, have been removed from equity and adjusted against the value of the assets at the reclassification date, so that the Portfolio is measured as if the assets had always been classified at amortized cost, with a value as of 1 April 2022 of USD 7.4bn.

The reclassification had no effect on the income statement.

The reclassified Portfolio is made up of high-quality liquid assets, primarily US government treasuries and US government agency mortgage-backed securities, held and separately managed by UBS Bank USA (BUSA).

The accounting reclassification has arisen as a direct result of the transformation of UBS’s Global Wealth Management Americas business that has significantly impacted BUSA. This includes initiatives approved by the Group Executive Board to significantly grow and extend the business, as disclosed on 1 February 2022 during UBS’s fourth quarter 2021 earnings presentation. BUSA’s deposit base has grown by more than 100% in the last two years, generating substantial cash balances, with a number of new products being launched, including new deposit types that are longer in duration, additional lending and a broader range of customer segments targeted.

Following the commencement of these activities and the announcement made in the first quarter of 2022, the Portfolio is no longer held in a business model to collect the contractual cash flows and sell the assets, but is instead solely held to collect the contractual cash flows until the assets mature, requiring a reclassification of the Portfolio in line with IFRS 9 with effect from 1 April 2022.

The fair value of the Portfolio as of 30 September 2022 was USD 5.8bn (30 June 2022: USD 6.4bn). A pre-tax fair value loss of USD 515m would have been recognized in Other comprehensive income during the third quarter of 2022 (second quarter of 2022: USD 264m) if the Portfolio had not been reclassified.

Currency translation rates

The following table shows the rates of the main currencies used to translate the financial information of UBS’s operations with a functional currency other than the US dollar into US dollars.

Closing exchange rate Average rate1
  As of For the quarter ended Year-to-date
  30.9.22 30.6.22 31.12.21 30.9.21 30.9.22 30.6.22 30.9.21 30.9.22 30.9.21
1 CHF 1.01 1.05 1.10 1.07 1.03 1.04 1.09 1.05 1.09
1 EUR 0.98 1.05 1.14 1.16 0.99 1.06 1.17 1.05 1.19
1 GBP 1.12 1.22 1.35 1.35 1.16 1.25 1.37 1.24 1.38
100 JPY 0.69 0.74 0.87 0.90 0.72 0.76 0.90 0.78 0.91
  1. Monthly income statement items of operations with a functional currency other than the US dollar are translated into US dollars using month-end rates. Disclosed average rates for a quarter represent an average of three month-end rates, weighted according to the income and expense volumes of all operations of the Group with the same functional currency for each month. Weighted average rates for individual business divisions may deviate from the weighted average rates for the Group.
Note 2 Segment reporting
USD m Global Wealth Management

Personal &

Corporate

Banking

Asset

Management

Investment Bank Group Functions UBS
 
For the nine months ended 30 September 20221
Net interest income 3,775 1,559 (12) (2) (288) 5,032
Non-interest income 10,592 1,613 2,478 7,036 (218) 21,502
Total revenues 14,367 3,172 2,466 7,034 (505) 26,534
Credit loss expense / (release) (3) 42 0 (20) 3 22
Operating expenses 10,450 1,847 1,193 5,269 86 18,845
Operating profit / (loss) before tax 3,919 1,283 1,273 1,785 (594) 7,667
Tax expense / (benefit) 1,662
Net profit / (loss) 6,005
 
As of 30 September 20221
Total assets 384,054 217,268 16,346 425,806 68,279 1,111,753
 
For the nine months ended 30 September 20211
Net interest income 3,130 1,577 (11) 318 (81) 4,934
Non-interest income 11,467 1,609 1,907 6,917 (145) 21,754
Total revenues 14,598 3,187 1,896 7,235 (226) 26,689
Credit loss expense / (release) (27) (76) 0 (19) 0 (121)
Operating expenses 10,405 1,897 1,199 5,337 217 19,054
Operating profit / (loss) before tax 4,220 1,366 696 1,917 (443) 7,755
Tax expense / (benefit) 1,629
Net profit / (loss) 6,127
 
As of 31 December 20211
Total assets2 395,235 225,370 25,639 346,431 124,507 1,117,182
  1. Refer to “Note 2 Segment reporting” in the “Consolidated financial statements” section of the Annual Report 2021 for more information about the Group’s reporting segments.
  2. In the first quarter of 2022, UBS refined the methodology applied to allocate balance sheet resources from Group Functions to the business divisions, with prospective effect. If the new methodology had been applied as of 31 December 2021, balance sheet assets allocated to business divisions would have been USD 17bn higher, of which USD 14bn would have related to the Investment Bank.
Note 3 Net interest income
  For the quarter ended Year-to-date
USD m 30.9.22 30.6.22 30.9.21 30.9.22 30.9.21
Interest income from loans and deposits1 2,520 1,886 1,645 6,066 4,841
Interest income from securities financing transactions2 415 209 132 742 393
Interest income from other financial instruments measured at amortized cost 148 118 71 338 213
Interest income from debt instruments measured at fair value through other comprehensive income 12 6 33 60 84
Interest income from derivative instruments designated as cash flow hedges (17) 160 297 396 849
Total interest income from financial instruments measured at amortized cost and fair value through other comprehensive income 3,078 2,380 2,178 7,602 6,381
Interest expense on loans and deposits3 698 262 128 1,099 401
Interest expense on securities financing transactions4 282 288 299 794 850
Interest expense on debt issued 756 498 370 1,649 1,163
Interest expense on lease liabilities 22 22 25 67 78
Total interest expense from financial instruments measured at amortized cost 1,758 1,070 822 3,610 2,491
Total net interest income from financial instruments measured at amortized cost and fair value through other comprehensive income 1,319 1,310 1,356 3,992 3,890
Net interest income from financial instruments measured at fair value through profit or loss 277 355 338 1,040 1,044
Total net interest income 1,596 1,665 1,693 5,032 4,934
  1. Consists of interest income from cash and balances at central banks, loans and advances to banks and customers, and cash collateral receivables on derivative instruments, as well as negative interest on amounts due to banks, customer deposits and cash collateral payables on derivative instruments.
  2. Includes interest income on receivables from securities financing transactions and negative interest, including fees, on payables from securities financing transactions.
  3. Consists of interest expense on amounts due to banks, cash collateral payables on derivative instruments, and customer deposits, as well as negative interest on cash and balances at central banks, loans and advances to banks, and cash collateral receivables on derivative instruments.
  4. Includes interest expense on payables from securities financing transactions and negative interest, including fees, on receivables from securities financing transactions.
Note 4 Net fee and commission income
  For the quarter ended Year-to-date
USD m 30.9.22 30.6.22 30.9.21 30.9.22 30.9.21
Underwriting fees 175 111 348 458 1,128
M&A and corporate finance fees 152 220 315 608 883
Brokerage fees 779 869 1,016 2,726 3,411
Investment fund fees 1,173 1,233 1,428 3,794 4,269
Portfolio management and related services 2,178 2,298 2,517 6,938 7,227
Other 500 492 495 1,494 1,412
Total fee and commission income1 4,957 5,224 6,119 16,018 18,330
of which: recurring 3,453 3,593 3,952 10,905 11,395
of which: transaction-based 1,490 1,621 2,133 5,069 6,764
of which: performance-based 14 10 34 43 171
Fee and commission expense 476 450 510 1,410 1,472
Net fee and commission income 4,481 4,774 5,610 14,608 16,858
  1. Reflects third-party fee and commission income for the third quarter of 2022 of USD 3,106m for Global Wealth Management (second quarter of 2022: USD 3,281m; third quarter of 2021: USD 3,663m), USD 398m for Personal & Corporate Banking (second quarter of 2022: USD 421m; third quarter of 2021: USD 429m), USD 682m for Asset Management (second quarter of 2022: USD 720m; third quarter of 2021: USD 815m), USD 769m for the Investment Bank (second quarter of 2022: USD 801m; third quarter of 2021: USD 1,209m) and USD 2m for Group Functions (second quarter of 2022: USD 1m; third quarter of 2021: USD 3m).
Note 5 Personnel expenses
  For the quarter ended Year-to-date
USD m 30.9.22 30.6.22 30.9.21 30.9.22 30.9.21
Salaries and variable compensation 2,473 2,664 2,659 8,085 8,475
Financial advisor compensation1 1,093 1,122 1,239 3,436 3,592
Contractors 80 80 91 243 288
Social security 230 218 259 734 767
Post-employment benefit plans 177 199 205 625 644
Other personnel expenses 163 139 144 437 404
Total personnel expenses 4,216 4,422 4,598 13,559 14,170
  1. Financial advisor compensation consists of formulaic compensation based directly on compensable revenues generated by financial advisors and supplemental compensation calculated on the basis of financial advisor productivity, firm tenure, new assets and other variables. It also includes expenses related to compensation commitments with financial advisors entered into at the time of recruitment that are subject to vesting requirements.
Note 6 General and administrative expenses
  For the quarter ended Year-to-date
USD m 30.9.22 30.6.22 30.9.21 30.9.22 30.9.21
Outsourcing costs 217 227 225 671 632
IT expenses 277 286 255 853 777
Consulting, legal and audit fees 141 144 124 413 354
Real estate and logistics costs 141 152 162 439 464
Market data services 104 101 102 311 309
Marketing and communication 64 61 53 165 148
Travel and entertainment 44 46 18 110 39
Litigation, regulatory and similar matters1 21 221 12 298 84
Other 185 133 197 510 534
Total general and administrative expenses 1,192 1,370 1,148 3,769 3,340
  1. Reflects the net increase in provisions for litigation, regulatory and similar matters recognized in the income statement. Refer to Note 14b for more information.
Note 7 Expected credit loss measurement
a) Credit loss expense / release

Total net credit loss releases in the third quarter of 2022 were USD 3m, reflecting USD 4m net credit loss expenses related to stage 1 and 2 positions and USD 7m net credit loss releases primarily related to stage 3 positions in Personal & Corporate Banking.

Stage 1 and 2 net expenses of USD 4m included scenario-update-related expenses of USD 13m, mainly from the update of interest rate forecasts, partly offset by the net effect of changes to models and portfolio quality and size.

b) Changes to ECL models, scenarios, scenario weights and post-model adjustments
Scenarios and scenario weights

The expected credit loss (ECL) scenarios, along with their related macroeconomic factors and market data, were reviewed in light of the economic and political conditions prevailing in the third quarter of 2022 through a series of governance meetings, with input and feedback from UBS Risk and Finance experts across the business divisions and regions. UBS decided to apply the same scenarios and weights in the third quarter of 2022 as in the second quarter of 2022.

The baseline scenario assumptions on a calendar-year basis are included in the table on the next page. Such baseline information includes interest rate increases by central banks in September 2022, as well as other updated macro-economic data.

The global crisis scenario and the asset price inflation scenario were updated with current macroeconomic factors, but remain materially unchanged compared with the second quarter of 2022. Shocks in equity prices in the global crisis scenario have been made slightly less severe in the third quarter of 2022 than in the second quarter to reflect the decline seen in the first half of 2022.

As a response to inflationary developments and the war in Ukraine, in the first quarter of 2022 UBS replaced the mild global interest rate steepening scenario applied at year-end 2021 with the severe global interest rate steepening scenario. In the second quarter of 2022, a new severe Russia–Ukraine conflict scenario was developed. It has similar dynamics to the severe global interest rate steepening scenario, but includes a deepening energy crisis and disruptions in the delivery of Russian energy. These factors have resulted in surging commodity prices and accelerated inflation in major economies, compared with the severe global interest rate steepening scenario. Eurozone economic activity in particular is impacted in this scenario, due to the region’s reliance on its supply of energy from Russia. Equity price shocks in the severe Russia–Ukraine conflict scenario have been made slightly less severe in the third quarter of 2022 than in the second quarter, to reflect the decline seen in the first half of 2022.

Refer to the table on the next page for scenarios and weights applied.

Post-model adjustments

Total stage 1 and 2 allowances and provisions amounted to USD 507m as of 30 September 2022 and included post-model adjustments (PMA) of USD 151m (30 June 2022: USD 155m; 31 December 2021: USD 224m).

The PMA represent uncertainty and risk related to substantially heightened geopolitical tensions and the continued COVID-19 pandemic, which cannot be fully and reliably modeled, due to a lack of sufficiently supportable data.

The PMA were reduced during the second and first quarters of 2022 as the application of different and more adverse scenarios and scenario assumptions in UBS’s models addressed some of the uncertainties that had been reflected in the PMA in prior periods.

Comparison of shock factors
  Baseline
Key parameters 2021 2022 2023
Real GDP growth (annual percentage change)
US 5.5 1.7 0.6
Eurozone 5.1 2.9 0.8
Switzerland 3.1 2.1 0.6
Unemployment rate (%, annual average)
US 5.4 3.6 3.7
Eurozone 7.7 6.7 6.9
Switzerland 3.0 2.2 2.1
Fixed income: 10-year government bonds (%, Q4)
USD 1.5 3.8 3.7
EUR (0.2) 2.2 2.2
CHF (0.1) 1.3 1.4
Real estate (annual percentage change, Q4)
US 16.1 10.1 1.7
Eurozone 7.9 3.3 0.5
Switzerland 6.0 5.0 0.0
 
 
Economic scenarios and weights applied
  Assigned weights in %
ECL scenario 30.9.22 30.6.22 31.12.21
Upside 0.0 0.0 5.0
Baseline 55.0 55.0 55.0
Mild global interest rate steepening 10.0
Severe Russia–Ukraine conflict scenario 25.0 25.0
Global crisis 20.0 20.0 30.0
c) ECL-relevant balance sheet and off-balance sheet positions including ECL allowances and provisions

The following tables provide information about financial instruments and certain non-financial instruments that are subject to ECL requirements. For amortized-cost instruments, the carrying amount represents the maximum exposure to credit risk, taking into account the allowance for credit losses. Financial assets measured at fair value through other comprehensive income (FVOCI) are also subject to ECL; however, unlike amortized-cost instruments, the allowance for credit losses for FVOCI instruments does not reduce the carrying amount of these financial assets. Instead, the carrying amount of financial assets measured at FVOCI represents the maximum exposure to credit risk.

In addition to recognized financial assets, certain off-balance sheet financial instruments and other credit lines are also subject to ECL. The maximum exposure to credit risk for off-balance sheet financial instruments is calculated based on the maximum contractual amounts.

USD m 30.9.22
  Carrying amount1 ECL allowances
Financial instruments measured at amortized cost Total Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3
Cash and balances at central banks 166,406 166,350 56 0 (15) 0 (15) 0
Loans and advances to banks 14,518 14,457 61 0 (6) (5) (1) 0
Receivables from securities financing transactions 66,926 66,926 0 0 (2) (2) 0 0
Cash collateral receivables on derivative instruments 48,206 48,206 0 0 0 0 0 0
Loans and advances to customers 373,036 356,609 14,973 1,455 (760) (124) (170) (466)
of which: Private clients with mortgages 148,347 140,274 7,430 643 (129) (26) (78) (25)
of which: Real estate financing 42,647 38,981 3,658 8 (55) (17) (38) 0
of which: Large corporate clients 11,775 10,035 1,458 282 (119) (20) (18) (81)
of which: SME clients 13,032 11,504 1,179 349 (241) (24) (22) (195)
of which: Lombard 134,535 134,455 0 79 (34) (8) 0 (26)
of which: Credit cards 1,737 1,352 358 27 (36) (10) (10) (17)
of which: Commodity trade finance 3,383 3,368 0 15 (92) (5) 0 (86)
Other financial assets measured at amortized cost 47,019 46,455 404 160 (92) (18) (7) (67)
of which: Loans to financial advisors 2,505 2,191 187 128 (69) (10) (3) (56)
Total financial assets measured at amortized cost 716,112 699,003 15,494 1,614 (874) (148) (192) (533)
Financial assets measured at fair value through other comprehensive income 2,243 2,243 0 0 0 0 0 0
Total on-balance sheet financial assets in scope of ECL requirements 718,354 701,246 15,494 1,614 (874) (148) (192) (533)
 
  Total exposure ECL provisions
Off-balance sheet (in scope of ECL) Total Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3
Guarantees 20,835 19,652 1,054 128 (36) (12) (8) (16)
of which: Large corporate clients 3,537 2,714 748 75 (12) (2) (3) (7)
of which: SME clients 1,201 1,015 134 52 (7) (1) (1) (5)
of which: Financial intermediaries and hedge funds 10,950 10,882 68 0 (11) (8) (4) 0
of which: Lombard 2,273 2,272 0 1 (1) 0 0 (1)
of which: Commodity trade finance 2,062 2,061 0 0 (1) (1) 0 0
Irrevocable loan commitments 37,456 34,996 2,378 82 (102) (60) (42) 0
of which: Large corporate clients 22,121 20,283 1,779 58 (85) (51) (34) 0
Forward starting reverse repurchase and securities borrowing agreements 8,161 8,161 0 0 0 0 0 0
Committed unconditionally revocable credit lines 37,515 35,553 1,918 43 (42) (30) (12) 0
of which: Real estate financing 8,223 8,099 124 0 (5) (5) 0 0
of which: Large corporate clients 3,889 3,448 436 5 (8) (2) (6) 0
of which: SME clients 4,446 4,111 306 29 (17) (14) (3) 0
of which: Lombard 6,884 6,879 0 5 0 0 0 0
of which: Credit cards 8,976 8,537 435 3 (6) (4) (2) 0
of which: Commodity trade finance 282 282 0 0 0 0 0 0
Irrevocable committed prolongation of existing loans 3,732 3,725 4 4 (2) (2) 0 0
Total off-balance sheet financial instruments and other credit lines 107,699 102,088 5,355 257 (182) (104) (62) (16)
Total allowances and provisions (1,056) (252) (254) (549)
  1. The carrying amount of financial assets measured at amortized cost represents the total gross exposure net of the respective ECL allowances.
USD m 30.6.22
  Carrying amount1 ECL allowances
Financial instruments measured at amortized cost Total Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3
Cash and balances at central banks 190,353 190,296 57 0 (13) 0 (13) 0
Loans and advances to banks 16,596 16,479 117 0 (8) (7) (1) 0
Receivables from securities financing transactions 63,291 63,291 0 0 (2) (2) 0 0
Cash collateral receivables on derivative instruments 43,763 43,763 0 0 0 0 0 0
Loans and advances to customers 383,898 366,452 15,759 1,686 (793) (128) (163) (501)
of which: Private clients with mortgages 150,884 142,050 8,064 770 (126) (27) (72) (27)
of which: Real estate financing 43,291 39,358 3,925 7 (59) (17) (42) 0
of which: Large corporate clients 12,208 10,791 1,088 329 (141) (27) (17) (98)
of which: SME clients 13,309 11,744 1,167 397 (249) (22) (22) (205)
of which: Lombard 140,333 140,251 0 82 (37) (7) 0 (29)
of which: Credit cards 1,760 1,384 349 27 (36) (10) (9) (17)
of which: Commodity trade finance 3,699 3,686 0 12 (94) (5) 0 (89)
Other financial assets measured at amortized cost2 37,528 36,977 391 160 (99) (18) (7) (74)
of which: Loans to financial advisors 2,447 2,171 144 132 (78) (11) (2) (64)
Total financial assets measured at amortized cost 735,428 717,257 16,325 1,846 (915) (155) (184) (575)
Financial assets measured at fair value through other comprehensive income2 2,251 2,251 0 0 0 0 0 0
Total on-balance sheet financial assets in scope of ECL requirements 737,678 719,507 16,325 1,846 (915) (155) (184) (575)
 
  Total exposure ECL provisions
Off-balance sheet (in scope of ECL) Total Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3
Guarantees 22,556 21,381 1,028 146 (40) (16) (9) (15)
of which: Large corporate clients 3,539 2,710 734 95 (10) (3) (3) (4)
of which: SME clients 1,213 1,034 128 51 (9) (1) (1) (7)
of which: Financial intermediaries and hedge funds 12,113 12,021 92 0 (16) (11) (5) 0
of which: Lombard 2,332 2,332 0 0 (1) 0 0 (1)
of which: Commodity trade finance 2,388 2,387 0 0 (1) (1) 0 0
Irrevocable loan commitments 37,703 35,308 2,359 37 (113) (67) (46) 0
of which: Large corporate clients 22,649 21,001 1,642 6 (94) (60) (34) 0
Forward starting reverse repurchase and securities borrowing agreements 3,985 3,985 0 0 0 0 0 0
Committed unconditionally revocable credit lines 39,756 37,407 2,306 42 (37) (27) (10) 0
of which: Real estate financing 9,123 8,931 193 0 (5) (5) 0 0
of which: Large corporate clients 4,354 3,662 687 5 (6) (1) (5) 0
of which: SME clients 4,660 4,240 392 29 (16) (13) (3) 0
of which: Lombard 7,697 7,693 0 4 0 0 0 0
of which: Credit cards 9,162 8,725 433 3 (6) (4) (2) 0
of which: Commodity trade finance 172 172 0 0 0 0 0 0
Irrevocable committed prolongation of existing loans 5,156 5,136 18 2 (2) (2) 0 0
Total off-balance sheet financial instruments and other credit lines 109,156 103,217 5,712 228 (192) (112) (66) (15)
Total allowances and provisions (1,107) (267) (250) (590)
  1. The carrying amount of financial assets measured at amortized cost represents the total gross exposure net of the respective ECL allowances.
  2. Effective 1 April 2022, a portfolio of assets previously classified as Financial assets measured at fair value through other comprehensive income was reclassified to Other financial assets measured at amortized cost. Refer to Note 1 for more information.
USD m 31.12.21
  Carrying amount1 ECL allowances
Financial instruments measured at amortized cost Total Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3
Cash and balances at central banks 192,817 192,817 0 0 0 0 0 0
Loans and advances to banks 15,480 15,453 26 1 (8) (7) (1) 0
Receivables from securities financing transactions 75,012 75,012 0 0 (2) (2) 0 0
Cash collateral receivables on derivative instruments 30,514 30,514 0 0 0 0 0 0
Loans and advances to customers 397,761 380,564 15,620 1,577 (850) (126) (152) (572)
of which: Private clients with mortgages 152,479 143,505 8,262 711 (132) (28) (71) (33)
of which: Real estate financing 43,945 40,463 3,472 9 (60) (19) (40) 0
of which: Large corporate clients 13,990 12,643 1,037 310 (170) (22) (16) (133)
of which: SME clients 14,004 12,076 1,492 436 (259) (19) (15) (225)
of which: Lombard 149,283 149,255 0 27 (33) (6) 0 (28)
of which: Credit cards 1,716 1,345 342 29 (36) (10) (9) (17)
of which: Commodity trade finance 3,813 3,799 7 7 (114) (6) 0 (108)
Other financial assets measured at amortized cost 26,209 25,718 302 189 (109) (27) (7) (76)
of which: Loans to financial advisors 2,453 2,184 106 163 (86) (19) (3) (63)
Total financial assets measured at amortized cost 737,794 720,079 15,948 1,767 (969) (161) (160) (647)
Financial assets measured at fair value through other comprehensive income 8,844 8,844 0 0 0 0 0 0
Total on-balance sheet financial assets in scope of ECL requirements 746,638 728,923 15,948 1,767 (969) (161) (160) (647)
 
  Total exposure ECL provisions
Off-balance sheet (in scope of ECL) Total Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3
Guarantees 20,972 19,695 1,127 150 (41) (18) (8) (15)
of which: Large corporate clients 3,464 2,567 793 104 (6) (3) (3) 0
of which: SME clients 1,353 1,143 164 46 (8) (1) (1) (7)
of which: Financial intermediaries and hedge funds 9,575 9,491 84 0 (17) (13) (4) 0
of which: Lombard 2,454 2,454 0 0 (1) 0 0 (1)
of which: Commodity trade finance 3,137 3,137 0 0 (1) (1) 0 0
Irrevocable loan commitments 39,478 37,097 2,335 46 (114) (72) (42) 0
of which: Large corporate clients 23,922 21,811 2,102 9 (100) (66) (34) 0
Forward starting reverse repurchase and securities borrowing agreements 1,444 1,444 0 0 0 0 0 0
Committed unconditionally revocable credit lines 40,778 38,207 2,508 63 (38) (28) (10) 0
of which: Real estate financing 7,328 7,046 281 0 (5) (4) (1) 0
of which: Large corporate clients 5,358 4,599 736 23 (7) (4) (3) 0
of which: SME clients 5,160 4,736 389 35 (15) (11) (3) 0
of which: Lombard 8,670 8,670 0 0 0 0 0 0
of which: Credit cards 9,466 9,000 462 4 (6) (5) (2) 0
of which: Commodity trade finance 117 117 0 0 0 0 0 0
Irrevocable committed prolongation of existing loans 5,611 5,527 36 48 (3) (3) 0 0
Total off-balance sheet financial instruments and other credit lines 108,284 101,971 6,006 307 (196) (121) (60) (15)
Total allowances and provisions (1,165) (282) (220) (662)
  1. The carrying amount of financial assets measured at amortized cost represents the total gross exposure net of the respective ECL allowances.

The table below provides information about the ECL gross exposure and the ECL coverage ratio for UBS’s core loan portfolios (i.e., Loans and advances to customersand Loans to financial advisors) and relevant off-balance sheet exposures. Cash and balances at central banks, Loans and advances to banks, Receivables from securities financing transactions, Cash collateral receivables on derivative instruments and Financial assets measured at fair value through other comprehensive income are not included in the table below, due to their lower sensitivity to ECL.

ECL coverage ratios are calculated by dividing ECL allowances and provisions by the gross carrying amount of the related exposures.

Coverage ratios for core loan portfolio 30.9.22
  Gross carrying amount (USD m) ECL coverage (bps)
On-balance sheet Total Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 1&2 Stage 3
Private clients with mortgages 148,476 140,301 7,508 668 9 2 104 7 370
Real estate financing 42,702 38,998 3,695 8 13 4 102 13 429
Total real estate lending 191,178 179,299 11,203 676 10 2 104 8 370
Large corporate clients 11,893 10,055 1,476 363 100 20 123 33 2,234
SME clients 13,273 11,527 1,202 544 181 21 187 36 3,578
Total corporate lending 25,166 21,582 2,678 906 143 20 151 35 3,041
Lombard 134,569 134,463 0 106 3 1 0 1 2,495
Credit cards 1,774 1,362 367 44 205 74 263 114 3,783
Commodity trade finance 3,475 3,374 0 101 264 16 0 16 8,556
Other loans and advances to customers 17,635 16,653 895 88 31 9 42 10 4,112
Loans to financial advisors 2,573 2,201 190 183 266 45 148 53 3,040
Total other lending 160,026 158,052 1,451 522 18 3 112 4 4,239
Total1 376,370 358,933 15,333 2,104 22 4 113 8 2,480
 
  Gross exposure (USD m) ECL coverage (bps)
Off-balance sheet Total Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 1&2 Stage 3
Private clients with mortgages 5,456 5,253 201 1 4 3 17 4 410
Real estate financing 9,059 8,880 179 0 8 7 53 8 0
Total real estate lending 14,515 14,133 381 1 7 6 34 7 410
Large corporate clients 29,740 26,639 2,963 138 36 21 145 33 506
SME clients 6,708 6,097 503 108 48 28 204 42 432
Total corporate lending 36,449 32,736 3,466 246 38 22 154 35 474
Lombard 12,392 12,386 0 6 1 0 0 0 0
Credit cards 8,976 8,537 435 3 7 5 37 7 0
Commodity trade finance 2,343 2,343 0 0 3 3 0 3 0
Financial intermediaries and hedge funds 16,001 15,595 407 0 8 6 97 8 0
Other off-balance sheet commitments 8,861 8,196 666 0 15 10 30 12 0
Total other lending 48,574 47,057 1,508 9 7 5 50 6 0
Total2 99,538 93,927 5,355 257 18 11 116 17 607
Total on- and off-balance sheet3 475,908 452,859 20,687 2,361 21 5 114 10 2,276
  1. Includes Loans and advances to customers of USD 373,797m and Loans to financial advisors of USD 2,573m, which are presented on the balance sheet line Other financial assets measured at amortized cost.
  2. Excludes Forward starting reverse repurchase and securities borrowing agreements.
  3. Includes on-balance-sheet exposure, gross and off-balance-sheet exposure (notional) and the related ECL coverage ratio (bps)
Coverage ratios for core loan portfolio 30.6.22
  Gross carrying amount (USD m) ECL coverage (bps)
On-balance sheet Total Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 1&2 Stage 3
Private clients with mortgages 151,010 142,077 8,136 798 8 2 88 7 342
Real estate financing 43,350 39,375 3,967 8 14 4 106 14 505
Total real estate lending 194,360 181,452 12,103 805 10 2 94 8 344
Large corporate clients 12,349 10,818 1,105 427 114 25 153 37 2,286
SME clients 13,558 11,766 1,190 602 184 19 187 34 3,400
Total corporate lending 25,907 22,584 2,294 1,029 151 22 170 35 2,938
Lombard 140,370 140,259 0 111 3 1 0 1 2,641
Credit cards 1,796 1,394 359 43 201 72 263 111 3,805
Commodity trade finance 3,793 3,692 0 101 248 15 0 15 8,768
Other loans and advances to customers 18,466 17,201 1,167 98 28 8 7 8 3,796
Loans to financial advisors 2,525 2,182 147 196 307 50 163 57 3,278
Total other lending 166,949 164,728 1,672 549 18 3 76 4 4,293
Total1 387,216 368,763 16,069 2,383 22 4 103 8 2,373
 
  Gross exposure (USD m) ECL coverage (bps)
Off-balance sheet Total Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 1&2 Stage 3
Private clients with mortgages 6,860 6,658 199 3 4 3 9 3 786
Real estate financing 10,336 10,126 210 0 11 6 232 11 0
Total real estate lending 17,196 16,784 409 3 8 5 123 8 786
Large corporate clients 30,750 27,581 3,062 107 36 23 136 35 368
SME clients 7,301 6,603 589 109 45 23 178 36 649
Total corporate lending 38,051 34,184 3,651 216 37 23 143 35 510
Lombard 12,931 12,927 0 4 1 0 0 0 0
Credit cards 9,162 8,725 433 3 7 5 36 7 0
Commodity trade finance 2,615 2,615 0 0 4 4 0 4 0
Financial intermediaries and hedge funds 16,668 16,151 517 0 11 7 129 11 0
Other off-balance sheet commitments 8,548 7,845 701 2 11 8 5 8 0
Total other lending 49,924 48,264 1,651 9 7 5 52 7 0
Total2 105,171 99,232 5,712 228 18 11 115 17 644
Total on- and off-balance sheet3 492,387 467,995 21,781 2,611 22 5 106 10 2,222
  1. Includes Loans and advances to customers of USD 384,691m and Loans to financial advisors of USD 2,525m, which are presented on the balance sheet line Other financial assets measured at amortized cost.
  2. Excludes Forward starting reverse repurchase and securities borrowing agreements.
  3. Includes on-balance-sheet exposure, gross and off-balance-sheet exposure (notional) and the related ECL coverage ratio (bps)
Coverage ratios for core loan portfolio 31.12.21
  Gross carrying amount (USD m) ECL coverage (bps)
On-balance sheet Total Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 1&2 Stage 3
Private clients with mortgages 152,610 143,533 8,333 744 9 2 85 6 446
Real estate financing 44,004 40,483 3,512 10 14 5 114 14 231
Total real estate lending 196,615 184,016 11,845 754 10 3 94 8 443
Large corporate clients 14,161 12,665 1,053 443 120 18 148 28 2,997
SME clients 14,263 12,095 1,507 661 182 16 103 25 3,402
Total corporate lending 28,424 24,760 2,560 1,104 151 17 121 26 3,240
Lombard 149,316 149,261 0 55 2 0 0 0 5,026
Credit cards 1,752 1,355 351 46 204 72 255 109 3,735
Commodity trade finance 3,927 3,805 7 115 290 15 3 15 9,388
Other loans and advances to customers 18,578 17,493 1,010 75 25 9 15 10 3,730
Loans to financial advisors 2,539 2,203 109 226 338 88 303 99 2,791
Total other lending 176,111 174,117 1,477 517 18 3 93 4 4,718
Total1 401,150 382,893 15,882 2,374 23 4 98 8 2,673
 
  Gross exposure (USD m) ECL coverage (bps)
Off-balance sheet Total Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 1&2 Stage 3
Private clients with mortgages 9,123 8,798 276 49 3 3 9 3 15
Real estate financing 8,766 8,481 285 0 9 7 88 9 0
Total real estate lending 17,889 17,278 562 49 6 5 49 6 15
Large corporate clients 32,748 28,981 3,630 136 34 25 110 35 1
SME clients 8,077 7,276 688 114 38 19 151 30 585
Total corporate lending 40,826 36,258 4,318 250 35 24 117 34 266
Lombard 14,438 14,438 0 0 1 0 0 0 0
Credit cards 9,466 9,000 462 4 7 5 34 7 0
Commodity trade finance 3,262 3,262 0 0 4 4 0 4 0
Financial intermediaries and hedge funds 12,153 11,784 369 0 15 12 120 15 0
Other off-balance sheet commitments 8,806 8,507 296 4 15 6 30 7 0
Total other lending 48,126 46,991 1,127 8 9 5 61 7 0
Total2 106,840 100,527 6,006 307 18 12 100 17 486
Total on- and off-balance sheet3 507,990 483,420 21,888 2,681 22 6 99 10 2,423
  1. Includes Loans and advances to customers of USD 398,611m and Loans to financial advisors of USD 2,539m, which are presented on the balance sheet line Other financial assets measured at amortized cost.
  2. Excludes Forward starting reverse repurchase and securities borrowing agreements.
  3. Includes on-balance-sheet exposure, gross and off-balance-sheet exposure (notional) and the related ECL coverage ratio (bps)
Note 8 Fair value measurement
a) Fair value hierarchy

The fair value hierarchy classification of financial and non-financial assets and liabilities measured at fair value is summarized in the table below.

During the first nine months of 2022, assets and liabilities that were transferred from Level 2 to Level 1, or from Level 1 to Level 2, and were held for the entire reporting period were not material.

Determination of fair values from quoted market prices or valuation techniques1
  30.9.22 30.6.22 31.12.21
USD m Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total
 
Financial assets measured at fair value on a recurring basis
 
Financial assets at fair value held for trading 71,450 11,867 1,267 84,584 85,270 12,314 1,923 99,507 113,697 14,825 2,299 130,821
of which: Equity instruments 59,111 938 114 60,163 70,284 982 85 71,351 97,958 1,090 149 99,197
of which: Government bills / bonds 6,580 1,235 9 7,824 8,633 1,409 9 10,052 7,135 1,351 10 8,496
of which: Investment fund units 5,067 1,231 68 6,365 5,728 1,040 18 6,786 7,843 1,364 21 9,229
of which: Corporate and municipal bonds 688 7,070 481 8,239 619 7,056 673 8,349 708 7,604 556 8,868
of which: Loans 0 1,073 472 1,545 0 1,553 1,010 2,563 0 3,099 1,443 4,542
of which: Asset-backed securities 4 320 123 447 5 274 128 407 53 317 120 489
 
Derivative financial instruments 2,120 191,419 1,667 195,206 1,185 157,586 1,753 160,524 522 116,479 1,140 118,142
of which: Foreign exchange 1,496 114,350 2 115,847 527 82,845 3 83,375 255 53,043 7 53,305
of which: Interest rate 0 40,826 488 41,314 0 37,930 351 38,281 0 32,747 494 33,241
of which: Equity / index 0 32,742 710 33,452 0 33,266 680 33,946 0 27,861 384 28,245
of which: Credit derivatives 0 1,351 391 1,743 0 1,446 640 2,087 0 1,179 236 1,414
of which: Commodities 0 1,975 73 2,048 0 1,936 76 2,013 0 1,590 16 1,606
 
Brokerage receivables 0 22,510 0 22,510 0 19,289 0 19,289 0 21,839 0 21,839
 
Financial assets at fair value not held for trading 17,385 32,529 3,881 53,795 20,844 32,623 4,171 57,637 27,278 28,622 4,180 60,080
of which: Financial assets for unit-linked investment contracts 12,166 0 7 12,173 14,341 0 8 14,348 21,110 187 6 21,303
of which: Corporate and municipal bonds 65 12,715 221 13,000 131 14,361 249 14,741 123 13,937 306 14,366
of which: Government bills / bonds 4,811 6,266 0 11,077 5,954 4,607 0 10,561 5,624 3,236 0 8,860
of which: Loans 0 3,338 654 3,992 0 3,301 976 4,277 0 4,982 892 5,874
of which: Securities financing transactions 0 9,686 114 9,799 0 9,881 108 9,989 0 5,704 100 5,804
of which: Auction rate securities 0 0 1,651 1,651 0 0 1,644 1,644 0 0 1,585 1,585
of which: Investment fund units 272 524 117 913 317 471 112 901 338 574 117 1,028
of which: Equity instruments 72 0 751 823 101 0 721 822 83 2 681 765
 
Financial assets measured at fair value through other comprehensive income on a recurring basis
 
Financial assets measured at fair value through other comprehensive income 55 2,188 0 2,243 55 2,196 0 2,251 2,704 6,140 0 8,844
of which: Asset-backed securities2 0 0 0 0 0 0 0 0 0 4,849 0 4,849
of which: Government bills / bonds2 0 25 0 25 0 18 0 18 2,658 27 0 2,686
of which: Corporate and municipal bonds 55 2,162 0 2,217 55 2,178 0 2,233 45 1,265 0 1,310
 
Non-financial assets measured at fair value on a recurring basis
 
Precious metals and other physical commodities 4,133 0 0 4,133 4,377 0 0 4,377 5,258 0 0 5,258
 
Non-financial assets measured at fair value on a non-recurring basis
 
Other non-financial assets3 0 0 96 96 0 0 105 105 0 0 26 26
Total assets measured at fair value 95,143 260,513 6,911 362,567 111,730 224,008 7,951 343,689 149,459 187,905 7,645 345,010
 
Financial liabilities measured at fair value on a recurring basis
 
Financial liabilities at fair value held for trading 25,449 5,199 93 30,741 24,393 5,932 125 30,450 25,413 6,170 105 31,688
of which: Equity instruments 16,695 366 69 17,130 16,323 440 89 16,852 18,328 513 83 18,924
of which: Corporate and municipal bonds 33 4,008 22 4,062 39 4,159 33 4,231 30 4,219 17 4,266
of which: Government bills / bonds 7,358 714 0 8,073 6,979 1,049 0 8,028 5,883 826 0 6,709
of which: Investment fund units 1,363 85 1 1,449 1,051 261 2 1,314 1,172 555 6 1,733
 
Derivative financial instruments 2,311 188,329 1,658 192,297 1,293 153,884 1,711 156,888 509 118,558 2,242 121,309
of which: Foreign exchange 1,615 112,929 25 114,569 486 81,982 26 82,494 258 53,800 21 54,078
of which: Interest rate 0 38,698 108 38,806 0 34,585 96 34,681 0 28,398 278 28,675
of which: Equity / index 0 33,078 1,150 34,228 0 33,561 1,076 34,638 0 33,438 1,511 34,949
of which: Credit derivatives 0 1,260 285 1,544 0 1,448 373 1,820 0 1,412 341 1,753
of which: Commodities 0 2,186 57 2,243 0 2,107 76 2,183 0 1,503 63 1,566
 
Financial liabilities designated at fair value on a recurring basis
 
Brokerage payables designated at fair value 0 48,093 0 48,093 0 49,798 0 49,798 0 44,045 0 44,045
 
Debt issued designated at fair value 0 59,513 9,862 69,374 0 60,270 11,994 72,264 0 59,606 14,194 73,799
 
Other financial liabilities designated at fair value 0 24,738 699 25,437 0 27,684 881 28,566 0 29,258 816 30,074
of which: Financial liabilities related to unit-linked investment contracts 0 12,321 0 12,321 0 14,503 0 14,503 0 21,466 0 21,466
of which: Securities financing transactions 0 11,376 0 11,376 0 12,024 2 12,026 0 6,375 2 6,377
of which: Over-the-counter debt instruments 0 1,041 699 1,740 0 1,157 879 2,036 0 1,334 794 2,128
Total liabilities measured at fair value 27,760 325,872 12,311 365,943 25,686 297,569 14,711 337,966 25,922 257,637 17,357 300,916
  1. Bifurcated embedded derivatives are presented on the same balance sheet lines as their host contracts and are not included in this table. The fair value of these derivatives was not material for any of the periods presented.
  2. Effective 1 April 2022, a portfolio of assets previously classified as Financial assets measured at fair value through other comprehensive income was reclassified to Other financial assets measured at amortized cost. Refer to Note 1 for more information.
  3. Other non-financial assets primarily consist of properties and other non-current assets held for sale, which are measured at the lower of their net carrying amount or fair value less costs to sell.
b) Valuation adjustments

The table below summarizes the changes in deferred day-1 profit or loss reserves during the relevant period.

Deferred day-1 profit or loss is generally released into Other net income from financial instruments measured at fair value through profit or losswhen the pricing of equivalent products or the underlying parameters become observable or when the transaction is closed out.

Deferred day-1 profit or loss reserves
  For the quarter ended Year-to-date
USD m 30.9.22 30.6.22 30.9.21 30.9.22 30.9.21
Reserve balance at the beginning of the period 451 425 405 418 269
Profit / (loss) deferred on new transactions 84 86 102 245 380
(Profit) / loss recognized in the income statement (108) (58) (78) (235) (220)
Foreign currency translation (1) (1) (1) (2) (1)
Reserve balance at the end of the period 426 451 429 426 429

The table below summarizes other valuation adjustment reserves recognized on the balance sheet.

Other valuation adjustment reserves on the balance sheet
  As of
Life-to-date gain / (loss), USD m 30.9.22 30.6.22 31.12.21
Own credit adjustments on financial liabilities designated at fair value 848 406 (315)
of which: debt issued designated at fair value 731 308 (347)
of which: other financial liabilities designated at fair value 117 98 32
 
Credit valuation adjustments1 (40) (36) (44)
Funding valuation adjustments (50) (8) (49)
Debit valuation adjustments 6 5 2
 
Other valuation adjustments (824) (869) (913)
of which: liquidity (293) (326) (341)
of which: model uncertainty (531) (543) (571)
  1. Amount does not include reserves against defaulted counterparties.
c) Level 3 instruments: valuation techniques and inputs

The table below presents material Level 3 assets and liabilities, together with the valuation techniques used to measure fair value, as well as the inputs used in a given valuation technique that are considered significant as of 30 September 2022 and unobservable, and a range of values for those unobservable inputs.

The range of values represents the highest- and lowest-level inputs used in the valuation techniques. Therefore the range does not reflect the level of uncertainty regarding a particular input or an assessment of the reasonableness of the Group’s estimates and assumptions, but rather the different underlying characteristics of the relevant assets and liabilities held by the Group.

The significant unobservable inputs disclosed in the table below are consistent with those included in “Note 21 Fair value measurement” in the “Consolidated financial statements” section of the Annual Report 2021.

Valuation techniques and inputs used in the fair value measurement of Level 3 assets and liabilities
Fair value Significant unobservable input(s)1 Range of inputs
Assets Liabilities Valuation technique(s) 30.9.22 31.12.21
USD bn 30.9.22 31.12.21 30.9.22 31.12.21 low high weighted average2 low high weighted average2 unit1
Financial assets and liabilities at fair value held for trading and Financial assets at fair value not held for trading
Corporate and municipal bonds 0.7 0.9 0.0 0.0 Relative value to market comparable Bond price equivalent 9 107 84 16 143 98 points
  Discounted expected cash flows Discount margin 447 447 434 434 basis points
Traded loans, loans measured at fair value, loan commitments and guarantees 1.5 2.8 0.0 0.0 Relative value to market comparable Loan price equivalent 20 100 97 0 101 99 points
  Discounted expected cash flows Credit spread 200 350 287 175 800 436 basis points
  Market comparable and securitization model Credit spread 125 1,343 301 28 1,544 241 basis points
Auction rate securities 1.7 1.6 Discounted expected cash flows Credit spread 115 192 152 115 197 153 basis points
Investment fund units3 0.2 0.1 0.0 0.0 Relative value to market comparable Net asset value
Equity instruments3 0.9 0.8 0.1 0.1 Relative value to market comparable Price
Debt issued designated at fair value4 9.9 14.2
Other financial liabilities designated at fair value 0.7 0.8 Discounted expected cash flows Funding spread 25 175 24 175 basis points
Derivative financial instruments
Interest rate 0.5 0.5 0.1 0.3 Option model Volatility of interest rates 74 153 65 81 basis points
Credit derivatives 0.4 0.2 0.3 0.3 Discounted expected cash flows Credit spreads 10 410 1 583 basis points
  Bond price equivalent 3 232 2 136 points
Equity / index 0.7 0.4 1.2 1.5 Option model Equity dividend yields 0 20 0 11 %
  Volatility of equity stocks, equity and other indices 2 118 4 98 %
  Equity-to-FX correlation (29) 84 (29) 76 %
  Equity-to-equity correlation (25) 100 (25) 100 %
  1. The ranges of significant unobservable inputs are represented in points, percentages and basis points. Points are a percentage of par (e.g., 100 points would be 100% of par).
  2. Weighted averages are provided for most non-derivative financial instruments and were calculated by weighting inputs based on the fair values of the respective instruments. Weighted averages are not provided for inputs related to Other financial liabilities designated at fair value and Derivative financial instruments, as this would not be meaningful.
  3. The range of inputs is not disclosed, as there is a dispersion of values given the diverse nature of the investments.
  4. Debt issued designated at fair value primarily consists of UBS structured notes, which include variable maturity notes with various equity and foreign exchange underlying risks, rates-linked and credit-linked notes, all of which have embedded derivative parameters that are considered to be unobservable. The equivalent derivative instrument parameters are presented in the respective derivative financial instruments lines in this table.
d) Level 3 instruments: sensitivity to changes in unobservable input assumptions

The table below summarizes those financial assets and liabilities classified as Level 3 for which a change in one or more of the unobservable inputs to reflect reasonably possible alternative assumptions would change fair value significantly, and the estimated effect thereof.

The sensitivity data shown below presents an estimation of valuation uncertainty based on reasonably possible alternative values for Level 3 inputs at the balance sheet date and does not represent the estimated effect of stress scenarios. Typically, these financial assets and liabilities are sensitive to a combination of inputs from Levels 1–3. Although well-defined interdependencies may exist between Level 1 / 2 parameters and Level 3 parameters (e.g., between interest rates, which are generally Level 1 or Level 2, and prepayments, which are generally Level 3), these have not been incorporated in the table. Furthermore, direct interrelationships between the Level 3 parameters are not a significant element of the valuation uncertainty.

Sensitivity of fair value measurements to changes in unobservable input assumptions1
  30.9.22 30.6.22 31.12.21
USD m

Favorable

changes

Unfavorable

changes

Favorable

changes

Unfavorable

changes

Favorable

changes

Unfavorable

changes

Traded loans, loans measured at fair value, loan commitments and guarantees 22 (19) 25 (32) 19 (13)
Securities financing transactions 41 (43) 53 (55) 41 (53)
Auction rate securities 552 (55)2 79 (79) 66 (66)
Asset-backed securities 31 (24) 25 (19) 20 (20)
Equity instruments 181 (161) 177 (152) 173 (146)
Interest rate derivatives, net 162 (23)2 41 (54) 29 (19)
Credit derivatives, net 3 (5) 7 (6) 5 (8)
Foreign exchange derivatives, net 10 (5) 11 (7) 19 (11)
Equity / index derivatives, net 326 (314) 382 (374) 368 (335)
Other 362 (80)2 71 (98) 50 (73)
Total 721 (728) 869 (877) 790 (744)
  1. Sensitivity of issued and over-the-counter debt instruments is reported with the equivalent derivative or securities financing instrument.
  2. Includes refinements applied in estimating valuation uncertainty across various parameters.
e) Level 3 instruments: movements during the period

The table on the following page presents additional information about material Level 3 assets and liabilities measured at fair value on a recurring basis. Level 3 assets and liabilities may be hedged with instruments classified as Level 1 or Level 2 in the fair value hierarchy and, as a result, realized and unrealized gains and losses included in the table may not include the effect of related hedging activity. Furthermore, the realized and unrealized gains and losses presented in the table are not limited solely to those arising from Level 3 inputs, as valuations are generally derived from both observable and unobservable parameters.

Assets and liabilities transferred into or out of Level 3 are presented as if those assets or liabilities had been transferred at the beginning of the year.

Movements of Level 3 instruments
USD bn

Balance at the beginning

of the period

Net gains / losses included in compre-

hensive income1

of which: related to instruments held at the end of the period Purchases Sales Issuances Settlements

Transfers

into

Level 3

Transfers

out of

Level 3

Foreign

currency

translation

Balance at the end

of the period

 
For the nine months ended 30 September 20222
 
Financial assets at fair value held for trading 2.3 (0.2) (0.2) 0.3 (1.4) 0.3 0.0 0.3 (0.3) (0.0) 1.3
of which: Investment fund units 0.0 0.0 0.0 0.0 (0.0) 0.0 0.0 0.1 (0.0) (0.0) 0.1
of which: Corporate and municipal bonds 0.6 (0.0) (0.0) 0.2 (0.2) 0.0 0.0 0.0 (0.0) (0.0) 0.5
of which: Loans 1.4 (0.1) (0.1) 0.0 (1.1) 0.3 0.0 0.0 (0.2) (0.0) 0.5
 
Derivative financial instruments – assets 1.1 0.8 0.5 0.0 0.0 0.6 (0.7) 0.1 (0.1) (0.1) 1.7
of which: Interest rate 0.5 0.2 0.2 0.0 0.0 0.0 (0.1) 0.1 (0.1) (0.1) 0.5
of which: Equity / index 0.4 0.4 0.3 0.0 0.0 0.2 (0.3) 0.0 (0.0) (0.0) 0.7
of which: Credit derivatives 0.2 0.1 (0.1) 0.0 0.0 0.2 (0.2) 0.0 0.0 0.0 0.4
 
Financial assets at fair value not held for trading 4.2 0.1 0.1 0.6 (0.8) 0.1 (0.0) 0.1 (0.3) (0.1) 3.9
of which: Loans 0.9 (0.0) (0.1) 0.4 (0.4) 0.1 0.0 0.0 (0.3) (0.0) 0.7
of which: Auction rate securities 1.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7
of which: Equity instruments 0.7 0.0 0.0 0.1 (0.1) 0.0 0.0 0.1 0.0 (0.0) 0.8
 
Derivative financial instruments – liabilities 2.2 (0.8) (0.6) 0.0 0.0 1.3 (0.8) 0.1 (0.2) (0.2) 1.7
of which: Interest rate 0.3 (0.2) (0.1) 0.0 0.0 0.1 (0.0) 0.0 0.0 (0.1) 0.1
of which: Equity / index 1.5 (0.5) (0.5) 0.0 0.0 1.0 (0.7) 0.0 (0.2) (0.1) 1.2
of which: Credit derivatives 0.3 (0.1) (0.1) 0.0 0.0 0.1 (0.0) 0.1 (0.0) (0.0) 0.3
 
Debt issued designated at fair value 14.2 (2.7) (2.3) 0.0 0.0 4.4 (3.0) 0.5 (3.0) (0.5) 9.9
 
Other financial liabilities designated at fair value 0.8 0.0 0.0 0.0 0.0 0.2 (0.3) 0.0 (0.0) (0.1) 0.7
  1. Net gains /​ losses included in comprehensive income are recognized in Net interest income and Other net income from financial instruments measured at fair value through profit or loss in the Income statement, and also in Gains /​ (losses) from own credit on financial liabilities designated at fair value, before tax in the Statement of comprehensive income.
  2. Total Level 3 assets as of 30 September 2022 were USD 6.9bn (31 December 2021: USD 7.6bn). Total Level 3 liabilities as of 30 September 2022 were USD 12.3bn (31 December 2021: USD 17.4bn).
For the nine months ended 30 September 2021
Financial assets at fair value held for trading 2.3 0.0 (0.0) 0.3 (1.0) 0.2 0.0 0.2 (0.2) (0.0) 1.8
of which: Investment fund units 0.0 (0.0) (0.0) 0.0 (0.0) 0.0 0.0 0.0 (0.0) (0.0) 0.0
of which: Corporate and municipal bonds 0.8 0.0 0.0 0.2 (0.2) 0.0 0.0 0.0 (0.1) (0.0) 0.8
of which: Loans 1.1 0.0 0.0 0.0 (0.6) 0.2 0.0 0.0 (0.2) 0.0 0.7
 
Derivative financial instruments – assets 1.8 (0.2) (0.2) 0.0 0.0 0.5 (0.5) 0.1 (0.1) (0.0) 1.4
of which: Interest rate 0.5 (0.1) (0.1) 0.0 0.0 0.0 (0.1) 0.0 (0.0) (0.0) 0.3
of which: Equity / index 0.9 0.0 0.0 0.0 0.0 0.3 (0.4) 0.0 (0.1) (0.0) 0.7
of which: Credit derivatives 0.3 (0.1) (0.1) 0.0 0.0 0.1 (0.0) 0.1 (0.0) 0.0 0.3
 
Financial assets at fair value not held for trading 3.9 0.1 0.1 0.8 (0.4) 0.0 0.0 0.1 (0.3) (0.0) 4.3
of which: Loans 0.9 0.0 0.0 0.4 (0.2) 0.0 0.0 0.0 (0.3) (0.0) 0.9
of which: Auction rate securities 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6
of which: Equity instruments 0.5 0.1 0.1 0.1 (0.1) 0.0 0.0 0.0 (0.0) (0.0) 0.6
 
Derivative financial instruments – liabilities 3.5 0.2 (0.0) 0.0 0.0 0.8 (1.6) 0.0 (0.3) (0.0) 2.5
of which: Interest rate 0.5 (0.0) (0.0) 0.0 0.0 0.1 (0.1) 0.0 (0.0) (0.0) 0.5
of which: Equity / index 2.3 0.4 0.1 0.0 0.0 0.6 (1.4) 0.0 (0.2) (0.0) 1.6
of which: Credit derivatives 0.5 (0.2) (0.2) 0.0 0.0 0.1 (0.0) 0.0 (0.1) (0.0) 0.3
 
Debt issued designated at fair value 11.0 0.2 0.2 0.0 0.0 8.6 (3.4) 0.2 (0.9) (0.2) 15.5
 
Other financial liabilities designated at fair value 0.7 0.0 0.0 0.0 0.0 0.3 (0.3) 0.0 (0.0) (0.0) 0.7
  1. Net gains /​ losses included in comprehensive income are recognized in Net interest income and Other net income from financial instruments measured at fair value through profit or loss in the Income statement, and also in Gains /​ (losses) from own credit on financial liabilities designated at fair value, before tax in the Statement of comprehensive income.
  2. Total Level 3 assets as of 30 September 2022 were USD 6.9bn (31 December 2021: USD 7.6bn). Total Level 3 liabilities as of 30 September 2022 were USD 12.3bn (31 December 2021: USD 17.4bn).
f) Financial instruments not measured at fair value

The table below reflects the estimated fair values of financial instruments not measured at fair value. Valuation principles applied when determining fair value estimates for financial instruments not measured at fair value are consistent with those described in “Note 21 Fair value measurement” in the “Consolidated financial statements” section of the Annual Report 2021.

Financial instruments not measured at fair value
  30.9.22 30.6.22 31.12.21
USD bn Carrying amount Fair value Carrying amount Fair value Carrying amount Fair value
Assets
Cash and balances at central banks 166.4 166.4 190.4 190.4 192.8 192.8
Loans and advances to banks 14.5 14.5 16.6 16.6 15.5 15.5
Receivables from securities financing transactions 66.9 66.9 63.3 63.3 75.0 75.0
Cash collateral receivables on derivative instruments 48.2 48.2 43.8 43.8 30.5 30.5
Loans and advances to customers 373.0 361.3 383.9 373.6 397.8 396.9
Other financial assets measured at amortized cost1 47.0 44.5 37.5 36.0 26.2 26.5
Liabilities
Amounts due to banks 13.9 13.9 15.2 15.2 13.1 13.1
Payables from securities financing transactions 4.5 4.5 6.0 6.0 5.5 5.5
Cash collateral payables on derivative instruments 44.3 44.3 40.5 40.5 31.8 31.8
Customer deposits 496.2 495.9 512.2 512.1 542.0 542.0
Debt issued measured at amortized cost 110.0 108.0 121.9 120.0 139.2 141.1
Other financial liabilities measured at amortized cost2 6.3 6.3 6.7 6.7 5.4 5.4
  1. Effective 1 April 2022, a portfolio of assets previously classified as Financial assets measured at fair value through other comprehensive income was reclassified to Other financial assets measured at amortized cost. Refer to Note 1 for more information.
  2. Excludes lease liabilities.
Note 9 Derivative instruments
a) Derivative instruments
As of 30.9.22, USD bn

Derivative

financial

assets

Notional values

related to derivative

financial assets1

Derivative

financial

liabilities

Notional values

related to derivative

financial liabilities1

Other

notional

values2

Derivative financial instruments
Interest rate 41.3 974 38.8 967 10,300
Credit derivatives 1.7 48 1.5 48 0
Foreign exchange 115.8 3,299 114.6 3,108 45
Equity / index 33.5 367 34.2 418 68
Commodities 2.0 73 2.2 65 17
Loan commitments measured at FVTPL 0.0 1 0.1 5
Unsettled purchases of non-derivative financial instruments3 0.4 28 0.5 22
Unsettled sales of non-derivative financial instruments3 0.4 28 0.4 18
Total derivative financial instruments, based on IFRS netting4 195.2 4,819 192.3 4,652 10,430
Further netting potential not recognized on the balance sheet5 (177.7) (176.1)
of which: netting of recognized financial liabilities / assets (142.8) (142.8)
of which: netting with collateral received / pledged (35.0) (33.3)
Total derivative financial instruments, after consideration of further netting potential 17.5 16.2
 
As of 30.6.22, USD bn
Derivative financial instruments
Interest rate 38.3 1,083 34.7 1,049 9,799
Credit derivatives 2.1 48 1.8 47 0
Foreign exchange 83.4 3,252 82.5 3,092 33
Equity / index 33.9 388 34.6 457 69
Commodities 2.0 78 2.2 70 16
Loan commitments measured at FVTPL 0.0 1 0.0 7
Unsettled purchases of non-derivative financial instruments3 0.3 29 0.5 22
Unsettled sales of non-derivative financial instruments3 0.5 30 0.5 24
Total derivative financial instruments, based on IFRS netting4 160.5 4,910 156.9 4,769 9,916
Further netting potential not recognized on the balance sheet5 (146.5) (141.0)
of which: netting of recognized financial liabilities / assets (116.0) (116.0)
of which: netting with collateral received / pledged (30.5) (24.9)
Total derivative financial instruments, after consideration of further netting potential 14.0 15.9
 
As of 31.12.21, USD bn
Derivative financial instruments
Interest rate 33.2 991 28.7 943 8,675
Credit derivatives 1.4 45 1.8 46 0
Foreign exchange 53.3 3,031 54.1 2,939 1
Equity / index 28.2 457 34.9 604 80
Commodities 1.6 58 1.6 56 15
Loan commitments measured at FVTPL 0.0 1 0.0 8
Unsettled purchases of non-derivative financial instruments3 0.1 13 0.2 11
Unsettled sales of non-derivative financial instruments3 0.2 18 0.1 9
Total derivative financial instruments, based on IFRS netting4 118.1 4,614 121.3 4,617 8,771
Further netting potential not recognized on the balance sheet5 (107.4) (107.0)
of which: netting of recognized financial liabilities / assets (88.9) (88.9)
of which: netting with collateral received / pledged (18.5) (18.1)
Total derivative financial instruments, after consideration of further netting potential 10.7 14.3
  1. In cases where derivative financial instruments are presented on a net basis on the balance sheet, the respective notional values of the netted derivative financial instruments are still presented on a gross basis. Notional amounts of client-cleared ETD and OTC transactions through central clearing counterparties are not disclosed, as they have a significantly different risk profile.
  2. Other notional values relate to derivatives that are cleared through either a central counterparty or an exchange. The fair value of these derivatives is presented on the balance sheet net of the corresponding cash margin under Cash collateral receivables on derivative instruments and Cash collateral payables on derivative instruments and was not material for any of the periods presented.
  3. Changes in the fair value of purchased and sold non-derivative financial instruments between trade date and settlement date are recognized as derivative financial instruments.
  4. Financial assets and liabilities are presented net on the balance sheet if UBS has the unconditional and legally enforceable right to offset the recognized amounts, both in the normal course of business and in the event of default, bankruptcy or insolvency of UBS or its counterparties, and intends either to settle on a net basis or to realize the asset and settle the liability simultaneously.
  5. Reflects the netting potential in accordance with enforceable master netting and similar arrangements where not all criteria for a net presentation on the balance sheet have been met. Refer to “Note 22 Offsetting financial assets and financial liabilities” in the “Consolidated financial statements” section of the Annual Report 2021 for more information.
b) Cash collateral on derivative instruments
USD bn

Receivables

30.9.22

Payables

30.9.22

Receivables

30.6.22

Payables

30.6.22

Receivables

31.12.21

Payables

31.12.21

Cash collateral on derivative instruments, based on IFRS netting1 48.2 44.3 43.8 40.5 30.5 31.8
Further netting potential not recognized on the balance sheet2 (30.2) (25.6) (23.2) (22.6) (18.4) (16.4)
of which: netting of recognized financial liabilities / assets (28.2) (23.6) (20.4) (19.9) (15.2) (13.1)
of which: netting with collateral received / pledged (2.1) (2.1) (2.8) (2.8) (3.3) (3.3)
Cash collateral on derivative instruments, after consideration of further netting potential 18.0 18.7 20.6 17.9 12.1 15.4
  1. Financial assets and liabilities are presented net on the balance sheet if UBS has the unconditional and legally enforceable right to offset the recognized amounts, both in the normal course of business and in the event of default, bankruptcy or insolvency of UBS or its counterparties, and intends either to settle on a net basis or to realize the asset and settle the liability simultaneously.
  2. Reflects the netting potential in accordance with enforceable master netting and similar arrangements where not all criteria for a net presentation on the balance sheet have been met. Refer to “Note 22 Offsetting financial assets and financial liabilities” in the “Consolidated financial statements” section of the Annual Report 2021 for more information.
Note 10 Other assets and liabilities
a) Other financial assets measured at amortized cost
USD m 30.9.22 30.6.22 31.12.21
Debt securities1 39,259 29,812 18,858
Loans to financial advisors 2,505 2,447 2,453
Fee- and commission-related receivables 1,879 1,970 1,972
Finance lease receivables 1,271 1,283 1,356
Settlement and clearing accounts 611 501 455
Accrued interest income 851 681 520
Other 644 833 594
Total other financial assets measured at amortized cost 47,019 37,528 26,209
  1. Effective 1 April 2022, a portfolio of assets previously classified as Financial assets measured at fair value through other comprehensive income was reclassified to Other financial assets measured at amortized cost. Refer to Note 1 for more information.
b) Other non-financial assets
USD m 30.9.22 30.6.22 31.12.21
Precious metals and other physical commodities 4,133 4,377 5,258
Deposits and collateral provided in connection with litigation, regulatory and similar matters1 2,018 2,150 1,526
Prepaid expenses 1,069 1,037 1,108
VAT and other tax receivables 495 440 638
Properties and other non-current assets held for sale 321 340 32
Assets of disposal groups held for sale2 823 1,093
Other 897 817 621
Total other non-financial assets 8,932 9,984 10,277
  1. Refer to Note 14 for more information.
  2. In the third quarter of 2022, UBS completed the sale of its domestic wealth management business in Spain and the sale of UBS Swiss Financial Advisers AG. Refer to the “Recent developments” section of this report for more information.
c) Other financial liabilities measured at amortized cost
USD m 30.9.22 30.6.22 31.12.21
Other accrued expenses 1,785 1,711 1,876
Accrued interest expenses 1,142 1,195 1,094
Settlement and clearing accounts 1,543 1,882 1,304
Lease liabilities 3,116 3,252 3,558
Other 1,810 1,891 1,167
Total other financial liabilities measured at amortized cost 9,397 9,930 9,001
d) Other financial liabilities designated at fair value
USD m 30.9.22 30.6.22 31.12.21
Financial liabilities related to unit-linked investment contracts 12,321 14,503 21,466
Securities financing transactions 11,376 12,026 6,377
Over-the-counter debt instruments 1,740 2,036 2,128
Other 103
Total other financial liabilities designated at fair value 25,437 28,566 30,074
e) Other non-financial liabilities
USD m 30.9.22 30.6.22 31.12.21
Compensation-related liabilities 6,013 5,421 7,257
of which: net defined benefit liability 430 480 633
Deferred tax liabilities 297 207 300
Current tax liabilities 935 973 1,398
VAT and other tax payables 534 643 590
Deferred income 260 245 240
Liabilities of disposal groups held for sale1 1,351 1,298
Other 29 70 68
Total other non-financial liabilities 8,068 8,910 11,151
  1. In the third quarter of 2022, UBS completed the sale of its domestic wealth management business in Spain and the sale of UBS Swiss Financial Advisers AG. Refer to the “Recent developments” section of this report for more information.
Note 11 Debt issued designated at fair value
USD m 30.9.22 30.6.22 31.12.21
Equity-linked1 37,785 39,629 47,059
Rates-linked 16,559 16,916 16,369
Credit-linked 2,330 2,147 1,723
Fixed-rate 5,887 5,411 2,868
Commodity-linked 4,350 4,640 2,911
Other 2,462 3,523 2,868
of which: debt that contributes to total loss-absorbing capacity 1,960 1,864 2,136
Total debt issued designated at fair value 69,374 72,264 73,799
  1. Includes investment fund unit-linked instruments issued.
Note 12 Debt issued measured at amortized cost
USD m 30.9.22 30.6.22 31.12.21
Short-term debt1 24,849 31,525 43,098
Senior unsecured debt that contributes to total loss-absorbing capacity (TLAC) 40,466 41,469 38,984
Senior unsecured debt other than TLAC 20,275 21,421 27,590
Covered bonds 1,389
Subordinated debt 15,881 18,304 18,640
of which: high-trigger loss-absorbing additional tier 1 capital instruments 11,732 12,076 11,052
of which: low-trigger loss-absorbing additional tier 1 capital instruments 1,190 1,219 2,425
of which: low-trigger loss-absorbing tier 2 capital instruments 2,427 2,471 2,596
of which: non-Basel III-compliant tier 2 capital instruments 531 538 547
Debt issued through the Swiss central mortgage institutions 8,567 9,177 9,454
Long-term debt2 85,189 90,371 96,057
Total debt issued measured at amortized cost3 110,038 121,896 139,155
  1. Debt with an original contractual maturity of less than one year, mainly consisting of certificates of deposit and commercial paper.
  2. Debt with an original contractual maturity greater than or equal to one year. The classification of debt issued into short-term and long-term does not consider any early redemption features.
  3. Net of bifurcated embedded derivatives, the fair value of which was not material for any of the periods presented.
Note 13 Interest rate benchmark reform

During 2022, UBS has continued to manage the transition to alternative reference rates (ARRs). The transition of non-USD interbank offered rates (IBORs) is substantially complete, with efforts now focused on managing the transition of the remaining USD London Interbank Offered Rate (LIBOR) exposures.

On 15 March 2022, the US enacted federal legislation, the Adjustable Interest Rate (LIBOR) Act, which is substantially based on, and supersedes, the New York State LIBOR legislation. The Adjustable Interest Rate (LIBOR) Act provides a legislative solution for USD LIBOR legacy products governed by any US state law should such products fail to transition prior to the USD LIBOR cessation date of 30 June 2023.

In January 2022, UBS completed the transition of USD LIBOR-linked balances related to brokerage accounts. Substantially all US securities-based lending that was outstanding as of 31 December 2021 has been transitioned to the Secured Overnight Financing Rate (SOFR) and UBS continues to make good progress on the transition of the remaining USD LIBOR non-derivative assets and liabilities.

In August 2022, to facilitate the transition of derivatives linked to the USD LIBOR Swap Rate, UBS adhered to the June 2022 Benchmark Module of the ISDA 2021 Fallbacks Protocol on the USD LIBOR Swap Rate. The transition of USD LIBOR-cleared derivatives is planned to commence in the second quarter of 2023.

Note 14 Provisions and contingent liabilities
a) Provisions

The table below presents an overview of total provisions.

USD m 30.9.22 30.6.22 31.12.21
Provisions other than provisions for expected credit losses 3,099 3,272 3,322
Provisions for expected credit losses1 182 192 196
Total provisions 3,281 3,465 3,518
  1. Refer to Note 7c for more information.

The following table presents additional information for provisions other than provisions for expected credit losses.

USD m Litigation, regulatory and similar matters1 Restructuring2 Other3 Total
Balance as of 31 December 2021 2,798 172 352 3,322
Balance as of 30 June 2022 2,799 142 331 3,272
Increase in provisions recognized in the income statement 25 31 10 65
Release of provisions recognized in the income statement (4) (6) (5) (16)
Provisions used in conformity with designated purpose (52) (53) (11) (116)
Foreign currency translation / unwind of discount (90) (5) (13) (107)
Balance as of 30 September 2022 2,678 109 313 3,099
  1. Consists of provisions for losses resulting from legal, liability and compliance risks.
  2. Consists of personnel-related restructuring provisions of USD 75m as of 30 September 2022 (30 June 2022: USD 102m; 31 December 2021: USD 125m) and provisions for onerous contracts of USD 34m as of 30 September 2022 (30 June 2022: USD 40m; 31 December 2021: USD 47m).
  3. Mainly includes provisions related to real estate, employee benefits and operational risks.

Restructuring provisions relate to personnel-related provisions and onerous contracts. Personnel-related restructuring provisions are generally used within a short period of time. The level of personnel-related provisions can change when natural staff attrition reduces the number of people affected by a restructuring event, and therefore results in lower estimated costs. Onerous contracts for property are recognized when UBS is committed to pay for non‑lease components, such as utilities, service charges, taxes and maintenance, when a property is vacated or not fully recovered from sub-tenants.

Information about provisions and contingent liabilities in respect of litigation, regulatory and similar matters, as a class, is included in Note 14b. There are no material contingent liabilities associated with the other classes of provisions.

b) Litigation, regulatory and similar matters

The Group operates in a legal and regulatory environment that exposes it to significant litigation and similar risks arising from disputes and regulatory proceedings. As a result, UBS (which for purposes of this Note may refer to UBS Group AG and/or one or more of its subsidiaries, as applicable) is involved in various disputes and legal proceedings, including litigation, arbitration, and regulatory and criminal investigations.

Such matters are subject to many uncertainties, and the outcome and the timing of resolution are often difficult to predict, particularly in the earlier stages of a case. There are also situations where the Group may enter into a settlement agreement. This may occur in order to avoid the expense, management distraction or reputational implications of continuing to contest liability, even for those matters for which the Group believes it should be exonerated. The uncertainties inherent in all such matters affect the amount and timing of any potential outflows for both matters with respect to which provisions have been established and other contingent liabilities. The Group makes provisions for such matters brought against it when, in the opinion of management after seeking legal advice, it is more likely than not that the Group has a present legal or constructive obligation as a result of past events, it is probable that an outflow of resources will be required, and the amount can be reliably estimated. Where these factors are otherwise satisfied, a provision may be established for claims that have not yet been asserted against the Group, but are nevertheless expected to be, based on the Group’s experience with similar asserted claims. If any of those conditions is not met, such matters result in contingent liabilities. If the amount of an obligation cannot be reliably estimated, a liability exists that is not recognized even if an outflow of resources is probable. Accordingly, no provision is established even if the potential outflow of resources with respect to such matters could be significant. Developments relating to a matter that occur after the relevant reporting period, but prior to the issuance of financial statements, which affect management’s assessment of the provision for such matter (because, for example, the developments provide evidence of conditions that existed at the end of the reporting period), are adjusting events after the reporting period under IAS 10 and must be recognized in the financial statements for the reporting period.

Specific litigation, regulatory and other matters are described below, including all such matters that management considers to be material and others that management believes to be of significance due to potential financial, reputational and other effects. The amount of damages claimed, the size of a transaction or other information is provided where available and appropriate in order to assist users in considering the magnitude of potential exposures.

In the case of certain matters below, we state that we have established a provision, and for the other matters, we make no such statement. When we make this statement and we expect disclosure of the amount of a provision to prejudice seriously our position with other parties in the matter because it would reveal what UBS believes to be the probable and reliably estimable outflow, we do not disclose that amount. In some cases we are subject to confidentiality obligations that preclude such disclosure. With respect to the matters for which we do not state whether we have established a provision, either: (a) we have not established a provision, in which case the matter is treated as a contingent liability under the applicable accounting standard; or (b) we have established a provision but expect disclosure of that fact to prejudice seriously our position with other parties in the matter because it would reveal the fact that UBS believes an outflow of resources to be probable and reliably estimable.

With respect to certain litigation, regulatory and similar matters for which we have established provisions, we are able to estimate the expected timing of outflows. However, the aggregate amount of the expected outflows for those matters for which we are able to estimate expected timing is immaterial relative to our current and expected levels of liquidity over the relevant time periods.

The aggregate amount provisioned for litigation, regulatory and similar matters as a class is disclosed in the “Provisions” table in Note 14a above. It is not practicable to provide an aggregate estimate of liability for our litigation, regulatory and similar matters as a class of contingent liabilities. Doing so would require UBS to provide speculative legal assessments as to claims and proceedings that involve unique fact patterns or novel legal theories, that have not yet been initiated or are at early stages of adjudication, or as to which alleged damages have not been quantified by the claimants. Although UBS therefore cannot provide a numerical estimate of the future losses that could arise from litigation, regulatory and similar matters, UBS believes that the aggregate amount of possible future losses from this class that are more than remote substantially exceeds the level of current provisions.

Litigation, regulatory and similar matters may also result in non-monetary penalties and consequences. A guilty plea to, or conviction of, a crime could have material consequences for UBS. Resolution of regulatory proceedings may require UBS to obtain waivers of regulatory disqualifications to maintain certain operations, may entitle regulatory authorities to limit, suspend or terminate licenses and regulatory authorizations, and may permit financial market utilities to limit, suspend or terminate UBS’s participation in such utilities. Failure to obtain such waivers, or any limitation, suspension or termination of licenses, authorizations or participations, could have material consequences for UBS.

The risk of loss associated with litigation, regulatory and similar matters is a component of operational risk for purposes of determining capital requirements. Information concerning our capital requirements and the calculation of operational risk for this purpose is included in the “Capital management” section of this report.

Provisions for litigation, regulatory and similar matters by business division and in Group Functions1
USD m

Global Wealth

Manage-

ment

Personal & Corporate Banking

Asset

Manage-

ment

Investment Bank Group Functions Total
Balance as of 31 December 2021 1,338 181 8 310 962 2,798
Balance as of 30 June 2022 1,289 168 8 387 946 2,799
Increase in provisions recognized in the income statement 22 0 0 3 0 25
Release of provisions recognized in the income statement (4) 0 0 0 0 (4)
Provisions used in conformity with designated purpose (44) 0 0 0 (8) (52)
Foreign currency translation / unwind of discount (68) (10) 0 (11) (1) (90)
Balance as of 30 September 2022 1,195 158 8 378 937 2,678
  1. Provisions, if any, for the matters described in items 3 and 4 of this Note are recorded in Global Wealth Management, and provisions, if any, for the matters described in item 2 are recorded in Group Functions. Provisions, if any, for the matters described in items 1 and 6 of this Note are allocated between Global Wealth Management and Personal & Corporate Banking, provisions, if any, for the matters described in item 5 are allocated between the Investment Bank and Group Functions, and provisions, if any, for the matters described in item 7 are allocated between Global Wealth Management and the Investment Bank.
1. Inquiries regarding cross-border wealth management businesses

Tax and regulatory authorities in a number of countries have made inquiries, served requests for information or examined employees located in their respective jurisdictions relating to the cross-border wealth management services provided by UBS and other financial institutions. It is possible that the implementation of automatic tax information exchange and other measures relating to cross-border provision of financial services could give rise to further inquiries in the future. UBS has received disclosure orders from the Swiss Federal Tax Administration (FTA) to transfer information based on requests for international administrative assistance in tax matters. The requests concern a number of UBS account numbers pertaining to current and former clients and are based on data from 2006 and 2008. UBS has taken steps to inform affected clients about the administrative assistance proceedings and their procedural rights, including the right to appeal. The requests are based on data received from the German authorities, who seized certain data related to UBS clients booked in Switzerland during their investigations and have apparently shared this data with other European countries. UBS expects additional countries to file similar requests.

Since 2013, UBS (France) S.A., UBS AG and certain former employees have been under investigation in France in relation to UBS’s cross-border business with French clients. In connection with this investigation, the investigating judges ordered UBS AG to provide bail (“caution”) of EUR 1.1bn.

On 20 February 2019, the court of first instance returned a verdict finding UBS AG guilty of unlawful solicitation of clients on French territory and aggravated laundering of the proceeds of tax fraud, and UBS (France) S.A. guilty of aiding and abetting unlawful solicitation and of laundering the proceeds of tax fraud. The court imposed fines aggregating EUR 3.7bn on UBS AG and UBS (France) S.A. and awarded EUR 800m of civil damages to the French state. A trial in the French Court of Appeal took place in March 2021. On 13 December 2021, the Court of Appeal found UBS AG guilty of unlawful solicitation and aggravated laundering of the proceeds of tax fraud. The court ordered a fine of EUR 3.75m, the confiscation of EUR 1bn, and awarded civil damages to the French state of EUR 800m. The court also found UBS (France) SA guilty of the aiding and abetting of unlawful solicitation and ordered it to pay a fine of EUR 1.875m. UBS AG has filed an appeal with the French Supreme Court to preserve its rights. The notice of appeal enables UBS AG to thoroughly assess the verdict of the Court of Appeal and to determine next steps in the best interest of its stakeholders. The fine and confiscation imposed by the Court of Appeal are suspended during the appeal. The civil damages award has been paid to the French state (EUR 99m of which was deducted from the bail), subject to the result of UBS’s appeal.

Our balance sheet at 30 September 2022 reflected provisions with respect to this matter in an amount of EUR 1.1bn (USD 1.1bn). The wide range of possible outcomes in this case contributes to a high degree of estimation uncertainty and the provision reflects our best estimate of possible financial implications, although actual penalties and civil damages could exceed (or may be less than) the provision amount.

Our balance sheet at 30 September 2022 reflected provisions with respect to matters described in this item 1 in an amount that UBS believes to be appropriate under the applicable accounting standard. As in the case of other matters for which we have established provisions, the future outflow of resources in respect of such matters cannot be determined with certainty based on currently available information and accordingly may ultimately prove to be substantially greater (or may be less) than the provision that we have recognized.

2. Claims related to sales of residential mortgage-backed securities and mortgages

From 2002 through 2007, prior to the crisis in the US residential loan market, UBS was a substantial issuer and underwriter of US residential mortgage-backed securities (RMBS) and was a purchaser and seller of US residential mortgages.

In November 2018, the DOJ filed a civil complaint in the District Court for the Eastern District of New York. The complaint seeks unspecified civil monetary penalties under the Financial Institutions Reform, Recovery and Enforcement Act of 1989 related to UBS’s issuance, underwriting and sale of 40 RMBS transactions in 2006 and 2007. UBS moved to dismiss the civil complaint on 6 February 2019. On 10 December 2019, the district court denied UBS’s motion to dismiss.

Our balance sheet at 30 September 2022 reflected a provision with respect to matters described in this item 2 in an amount that UBS believes to be appropriate under the applicable accounting standard. As in the case of other matters for which we have established provisions, the future outflow of resources in respect of this matter cannot be determined with certainty based on currently available information and accordingly may ultimately prove to be substantially greater (or may be less) than the provision that we have recognized.

3. Madoff

In relation to the Bernard L. Madoff Investment Securities LLC (BMIS) investment fraud, UBS AG, UBS (Luxembourg) S.A. (now UBS Europe SE, Luxembourg branch) and certain other UBS subsidiaries have been subject to inquiries by a number of regulators, including the Swiss Financial Market Supervisory Authority (FINMA) and the Luxembourg Commission de Surveillance du Secteur Financier. Those inquiries concerned two third-party funds established under Luxembourg law, substantially all assets of which were with BMIS, as well as certain funds established in offshore jurisdictions with either direct or indirect exposure to BMIS. These funds faced severe losses, and the Luxembourg funds are in liquidation. The documentation establishing both funds identifies UBS entities in various roles, including custodian, administrator, manager, distributor and promoter, and indicates that UBS employees serve as board members.

In 2009 and 2010, the liquidators of the two Luxembourg funds filed claims against UBS entities, non-UBS entities and certain individuals, including current and former UBS employees, seeking amounts totaling approximately EUR 2.1bn, which includes amounts that the funds may be held liable to pay the trustee for the liquidation of BMIS (BMIS Trustee).

A large number of alleged beneficiaries have filed claims against UBS entities (and non-UBS entities) for purported losses relating to the Madoff fraud. The majority of these cases have been filed in Luxembourg, where decisions that the claims in eight test cases were inadmissible have been affirmed by the Luxembourg Court of Appeal, and the Luxembourg Supreme Court has dismissed a further appeal in one of the test cases.

In the US, the BMIS Trustee filed claims against UBS entities, among others, in relation to the two Luxembourg funds and one of the offshore funds. The total amount claimed against all defendants in these actions was not less than USD 2bn. In 2014, the US Supreme Court rejected the BMIS Trustee’s motion for leave to appeal decisions dismissing all claims except those for the recovery of approximately USD 125m of payments alleged to be fraudulent conveyances and preference payments. In 2016, the bankruptcy court dismissed these claims against the UBS entities. In February 2019, the Court of Appeals reversed the dismissal of the BMIS Trustee’s remaining claims, and the US Supreme Court subsequently denied a petition seeking review of the Court of Appeals’ decision. The case has been remanded to the Bankruptcy Court for further proceedings.

4. Puerto Rico

Declines since 2013 in the market prices of Puerto Rico municipal bonds and of closed-end funds (funds) that are sole-managed and co-managed by UBS Trust Company of Puerto Rico and distributed by UBS Financial Services Incorporated of Puerto Rico (UBS PR) led to multiple regulatory inquiries, which in 2014 and 2015, led to settlements with the Office of the Commissioner of Financial Institutions for the Commonwealth of Puerto Rico, the US Securities and Exchange Commission (SEC) and the Financial Industry Regulatory Authority.

Since then, UBS clients in Puerto Rico who own the funds or Puerto Rico municipal bonds and/or who used their UBS account assets as collateral for UBS non-purpose loans filed customer complaints and arbitration demands seeking aggregate damages of USD 3.4bn, of which USD 3.3bn have been resolved through settlements, arbitration or withdrawal of claims. Allegations include fraud, misrepresentation and unsuitability of the funds and of the loans.

A shareholder derivative action was filed in 2014 against various UBS entities and current and certain former directors of the funds, alleging hundreds of millions of US dollars in losses in the funds. In 2021, the parties reached an agreement to settle this matter for USD 15m, subject to court approval.

In 2011, a purported derivative action was filed on behalf of the Employee Retirement System of the Commonwealth of Puerto Rico (System) against over 40 defendants, including UBS PR, which was named in connection with its underwriting and consulting services. Plaintiffs alleged that defendants violated their purported fiduciary duties and contractual obligations in connection with the issuance and underwriting of USD 3bn of bonds by the System in 2008 and sought damages of over USD 800m. In 2016, the court granted the System’s request to join the action as a plaintiff. In 2017, the court denied defendants’ motion to dismiss the complaint. In 2020, the court denied plaintiffs’ motion for summary judgment. In 2022, UBS filed a motion to dismiss in the bankruptcy proceeding.

Beginning in 2015, certain agencies and public corporations of the Commonwealth of Puerto Rico (Commonwealth) defaulted on certain interest payments on Puerto Rico bonds. In 2016, US federal legislation created an oversight board with power to oversee Puerto Rico’s finances and to restructure its debt. The oversight board has imposed a stay on the exercise of certain creditors’ rights. In 2017, the oversight board placed certain of the bonds into a bankruptcy-like proceeding under the supervision of a Federal District Judge.

In May 2019, the oversight board filed complaints in Puerto Rico federal district court bringing claims against financial, legal and accounting firms that had participated in Puerto Rico municipal bond offerings, including UBS, seeking a return of underwriting and swap fees paid in connection with those offerings. UBS estimates that it received approximately USD 125m in fees in the relevant offerings.

In August 2019, and February and November 2020, four US insurance companies that insured issues of Puerto Rico municipal bonds sued UBS and several other underwriters of Puerto Rico municipal bonds in three separate cases. The actions collectively seek recovery of an aggregate of USD 955m in damages from the defendants. The plaintiffs in these cases claim that defendants failed to reasonably investigate financial statements in the offering materials for the insured Puerto Rico bonds issued between 2002 and 2007, which plaintiffs argue they relied upon in agreeing to insure the bonds notwithstanding that they had no contractual relationship with the underwriters. Defendants’ motions to dismiss have been granted in all three cases; those decisions are being appealed by the plaintiffs.

Our balance sheet at 30 September 2022 reflected provisions with respect to matters described in this item 4 in amounts that UBS believes to be appropriate under the applicable accounting standard. As in the case of other matters for which we have established provisions, the future outflow of resources in respect of such matters cannot be determined with certainty based on currently available information and accordingly may ultimately prove to be substantially greater (or may be less) than the provisions that we have recognized.

5. Foreign exchange, LIBOR and benchmark rates, and other trading practices

Foreign exchange-related regulatory matters: Beginning in 2013, numerous authorities commenced investigations concerning possible manipulation of foreign exchange markets and precious metals prices. As a result of these investigations, UBS entered into resolutions with Swiss, US and United Kingdom regulators and the European Commission. UBS was granted conditional immunity by the Antitrust Division of the DOJ and by authorities in other jurisdictions in connection with potential competition law violations relating to foreign exchange and precious metals businesses.

Foreign exchange-related civil litigation: Putative class actions have been filed since 2013 in US federal courts and in other jurisdictions against UBS and other banks on behalf of putative classes of persons who engaged in foreign currency transactions with any of the defendant banks. UBS has resolved US federal court class actions relating to foreign currency transactions with the defendant banks and persons who transacted in foreign exchange futures contracts and options on such futures under a settlement agreement that provides for UBS to pay an aggregate of USD 141m and provide cooperation to the settlement classes. Certain class members have excluded themselves from that settlement and have filed individual actions in US and English courts against UBS and other banks, alleging violations of US and European competition laws and unjust enrichment.

In 2015, a putative class action was filed in federal court against UBS and numerous other banks on behalf of persons and businesses in the US who directly purchased foreign currency from the defendants and alleged co-conspirators for their own end use. In March 2017, the court granted UBS’s (and the other banks’) motions to dismiss the complaint. The plaintiffs filed an amended complaint in August 2017. In March 2018, the court denied the defendants’ motions to dismiss the amended complaint. In March 2022, the court denied plaintiffs’ motion for class certification.

LIBOR and other benchmark-related regulatory matters: Numerous government agencies conducted investigations regarding potential improper attempts by UBS, among others, to manipulate LIBOR and other benchmark rates at certain times. UBS reached settlements or otherwise concluded investigations relating to benchmark interest rates with the investigating authorities. UBS was granted conditional leniency or conditional immunity from authorities in certain jurisdictions, including the Antitrust Division of the DOJ and the Swiss Competition Commission (WEKO), in connection with potential antitrust or competition law violations related to certain rates. However, UBS has not reached a final settlement with WEKO, as the Secretariat of WEKO has asserted that UBS does not qualify for full immunity.

LIBOR and other benchmark-related civil litigation: A number of putative class actions and other actions are pending in the federal courts in New York against UBS and numerous other banks on behalf of parties who transacted in certain interest rate benchmark-based derivatives. Also pending in the US and in other jurisdictions are a number of other actions asserting losses related to various products whose interest rates were linked to LIBOR and other benchmarks, including adjustable rate mortgages, preferred and debt securities, bonds pledged as collateral, loans, depository accounts, investments and other interest-bearing instruments. The complaints allege manipulation, through various means, of certain benchmark interest rates, including USD LIBOR, Euroyen TIBOR, Yen LIBOR, EURIBOR, CHF LIBOR, GBP LIBOR, SGD SIBOR and SOR and Australian BBSW, and seek unspecified compensatory and other damages under varying legal theories.

USD LIBOR class and individual actions in the US: In 2013 and 2015, the district court in the USD LIBOR actions dismissed, in whole or in part, certain plaintiffs’ antitrust claims, federal racketeering claims, CEA claims, and state common law claims, and again dismissed the antitrust claims in 2016 following an appeal. In December 2021, the Second Circuit affirmed the district court’s dismissal in part and reversed in part and remanded to the district court for further proceedings. The Second Circuit, among other things, held that there was personal jurisdiction over UBS and other foreign defendants based on allegations that at least one alleged co-conspirator undertook an overt act in the United States. Separately, in 2018, the Second Circuit reversed in part the district court’s 2015 decision dismissing certain individual plaintiffs’ claims and certain of these actions are now proceeding. In 2018, the district court denied plaintiffs’ motions for class certification in the USD class actions for claims pending against UBS, and plaintiffs sought permission to appeal that ruling to the Second Circuit. In July 2018, the Second Circuit denied the petition to appeal of the class of USD lenders and in November 2018 denied the petition of the USD exchange class. In January 2019, a putative class action was filed in the District Court for the Southern District of New York against UBS and numerous other banks on behalf of US residents who, since 1 February 2014, directly transacted with a defendant bank in USD LIBOR instruments. The complaint asserts antitrust claims. The defendants moved to dismiss the complaint in August 2019. In March 2020 the court granted defendants’ motion to dismiss the complaint in its entirety. Plaintiffs have appealed the dismissal. In March 2022, the Second Circuit dismissed the appeal because appellants, who had been substituted in to replace the original plaintiffs who had withdrawn, lacked standing to pursue the appeal. In August 2020, an individual action was filed in the Northern District of California against UBS and numerous other banks alleging that the defendants conspired to fix the interest rate used as the basis for loans to consumers by jointly setting the USD LIBOR rate and monopolized the market for LIBOR-based consumer loans and credit cards. Defendants moved to dismiss the complaint in September 2021. In September 2022, the court granted defendants’ motion to dismiss the complaint in its entirety, while allowing plaintiffs the opportunity to file an amended complaint. Plaintiffs filed an amended complaint in October 2022.

Other benchmark class actions in the US:

Yen LIBOR / Euroyen TIBORIn 2014, 2015 and 2017, the court in one of the Yen LIBOR / Euroyen TIBOR lawsuits dismissed certain of the plaintiffs’ claims, including the plaintiffs’ federal antitrust and racketeering claims. In August 2020, the court granted defendants’ motion for judgment on the pleadings and dismissed the lone remaining claim in the action as impermissibly extraterritorial. In October 2022, the appeals court affirmed the dismissal on multiple grounds. In 2017, the court dismissed the other Yen LIBOR / Euroyen TIBOR action in its entirety on standing grounds. In April 2020, the appeals court reversed the dismissal and in August 2020 plaintiffs in that action filed an amended complaint focused on Yen LIBOR. The court granted in part and denied in part defendants’ motion to dismiss the amended complaint in September 2021. In August 2022, the court granted UBS’s motion for reconsideration and dismissed the case against UBS.

CHF LIBOR – In 2017, the court dismissed the CHF LIBOR action on standing grounds and failure to state a claim. Plaintiffs filed an amended complaint, and the court granted a renewed motion to dismiss in September 2019. Plaintiffs appealed. In September 2021, the Second Circuit granted the parties’ joint motion to vacate the dismissal and remand the case for further proceedings.

EURIBOR – In 2017, the court in the EURIBOR lawsuit dismissed the case as to UBS and certain other foreign defendants for lack of personal jurisdiction. Plaintiffs have appealed.

SIBOR / SOR ­– In October 2018, the court in the SIBOR / SOR action dismissed all but one of plaintiffs’ claims against UBS. Plaintiffs filed an amended complaint, and the court granted a renewed motion to dismiss in July 2019. Plaintiffs appealed. In March 2021, the Second Circuit reversed the dismissal. Plaintiffs filed an amended complaint in October 2021, which defendants have moved to dismiss. In March 2022, plaintiffs reached a settlement in principle with the remaining defendants, including UBS. The court granted preliminary approval of the settlement in June 2022.

BBSW – In November 2018, the court dismissed the BBSW lawsuit as to UBS and certain other foreign defendants for lack of personal jurisdiction. Plaintiffs filed an amended complaint in April 2019, which UBS and other defendants moved to dismiss. In February 2020, the court granted in part and denied in part defendants’ motions to dismiss the amended complaint. In August 2020, UBS and other BBSW defendants joined a motion for judgment on the pleadings, which the court denied in May 2021. In February 2022, plaintiffs reached a settlement in principle with the remaining defendants, including UBS. The court granted preliminary approval of the settlement in May 2022.

GBP LIBOR – The court dismissed the GBP LIBOR action in August 2019. Plaintiffs have appealed.

Government bonds: Putative class actions have been filed since 2015 in US federal courts against UBS and other banks on behalf of persons who participated in markets for US Treasury securities since 2007. A consolidated complaint was filed in 2017 in the US District Court for the Southern District of New York alleging that the banks colluded with respect to, and manipulated prices of, US Treasury securities sold at auction and in the secondary market and asserting claims under the antitrust laws and for unjust enrichment. Defendants’ motions to dismiss the consolidated complaint were granted in March 2021. Plaintiffs filed an amended complaint, which defendants moved to dismiss in June 2021. In March 2022, the court granted defendants’ motion to dismiss that complaint. Plaintiffs have appealed the dismissal. Similar class actions have been filed concerning European government bonds and other government bonds.

In May 2021, the European Commission issued a decision finding that UBS and six other banks breached European Union antitrust rules in 2007–2011 relating to European government bonds. The European Commission fined UBS EUR 172m. UBS is appealing the amount of the fine.

With respect to additional matters and jurisdictions not encompassed by the settlements and orders referred to above, our balance sheet at 30 September 2022 reflected a provision in an amount that UBS believes to be appropriate under the applicable accounting standard. As in the case of other matters for which we have established provisions, the future outflow of resources in respect of such matters cannot be determined with certainty based on currently available information and accordingly may ultimately prove to be substantially greater (or may be less) than the provision that we have recognized.

6. Swiss retrocessions

The Federal Supreme Court of Switzerland ruled in 2012, in a test case against UBS, that distribution fees paid to a firm for distributing third-party and intra-group investment funds and structured products must be disclosed and surrendered to clients who have entered into a discretionary mandate agreement with the firm, absent a valid waiver. FINMA issued a supervisory note to all Swiss banks in response to the Supreme Court decision. UBS has met the FINMA requirements and has notified all potentially affected clients.

The Supreme Court decision has resulted, and continues to result, in a number of client requests for UBS to disclose and potentially surrender retrocessions. Client requests are assessed on a case-by-case basis. Considerations taken into account when assessing these cases include, among other things, the existence of a discretionary mandate and whether or not the client documentation contained a valid waiver with respect to distribution fees.

Our balance sheet at 30 September 2022 reflected a provision with respect to matters described in this item 6 in an amount that UBS believes to be appropriate under the applicable accounting standard. The ultimate exposure will depend on client requests and the resolution thereof, factors that are difficult to predict and assess. Hence, as in the case of other matters for which we have established provisions, the future outflow of resources in respect of such matters cannot be determined with certainty based on currently available information and accordingly may ultimately prove to be substantially greater (or may be less) than the provision that we have recognized.

7. Communications recordkeeping

The SEC and CFTC conducted investigations of UBS and other financial institutions regarding compliance with records preservation requirements relating to business communications sent over unapproved electronic messaging channels. UBS cooperated with the investigations, and, in September 2022, UBS agreed to pay civil monetary penalties of USD 125m to the SEC and USD 75m to the CFTC to resolve these matters.

UBS AG interim consolidated financial information (unaudited)

This section contains a comparison of selected financial and capital information between UBS Group AG consolidated and UBS AG consolidated. Refer to the UBS AG third quarter 2022 report, which will be available as of 28 October 2022 under “Quarterly reporting” at ubs.com/​investors, for the interim consolidated financial statements of UBS AG.

Comparison between UBS Group AG consolidated and UBS AG consolidated

The accounting policies applied under International Financial Reporting Standards (IFRS) to both the UBS Group AG and the UBS AG consolidated financial statements are identical. However, there are certain scope and presentation differences as noted below.

Assets, liabilities, revenues, operating expenses and tax expenses / (benefits) relating to UBS Group AG and its directly held subsidiaries, including UBS Business Solutions AG, are reflected in the consolidated financial statements of UBS Group AG but not of UBS AG. UBS AG’s assets, liabilities, revenues and operating expenses related to transactions with UBS Group AG and its directly held subsidiaries, including UBS Business Solutions AG and other shared services subsidiaries, are not subject to elimination in the UBS AG consolidated financial statements, but are eliminated in the UBS Group AG consolidated financial statements.

Differences in net profit between UBS Group AG consolidated and UBS AG consolidated mainly arise as UBS Business Solutions AG and other shared services subsidiaries of UBS Group AG charge other legal entities within the UBS AG consolidation scope for services provided, including a markup on costs incurred. In addition, and to a lesser extent, differences arise as a result of certain compensation-related matters, including pensions.

The equity of UBS Group AG consolidated was USD 1.1bn higher than the equity of UBS AG consolidated as of 30 September 2022. This difference was mainly driven by higher dividends paid by UBS AG to UBS Group AG compared with the dividend distributions of UBS Group AG, as well as higher retained earnings in the UBS Group AG consolidated financial statements, largely related to the aforementioned markup charged by shared services subsidiaries of UBS Group AG to other legal entities in the UBS AG scope of consolidation. In addition, UBS Group AG is the grantor of the majority of the compensation plans of the Group and recognizes share premium for equity-settled awards granted. These effects were partly offset by treasury shares acquired as part of our share repurchase programs and those held to hedge share delivery obligations associated with Group compensation plans, as well as additional share premium recognized at the UBS AG consolidated level related to the establishment of UBS Group AG and UBS Business Solutions AG, a wholly owned subsidiary of UBS Group AG.

The going concern capital of UBS Group AG consolidated was USD 3.6bn higher than the going concern capital of UBS AG consolidated as of 30 September 2022, reflecting higher common equity tier 1 (CET1) capital of USD 2.6bn and going concern loss-absorbing additional tier 1 (AT1) capital of USD 1.0bn.

The CET1 capital of UBS Group AG consolidated was USD 2.6bn higher than that of UBS AG consolidated as of 30 September 2022. The higher CET1 capital of UBS Group AG consolidated was primarily due to lower UBS Group AG accruals for dividends to shareholders and higher UBS Group AG consolidated IFRS equity of USD 1.1bn. The aforementioned factors were partly offset by compensation-related regulatory capital accruals at the UBS Group AG level.

The going concern loss-absorbing AT1 capital of UBS Group AG consolidated was USD 1.0bn higher than that of UBS AG consolidated as of 30 September 2022, mainly reflecting Deferred Contingent Capital Plan awards granted at the Group level to eligible employees for the performance years 2017 to 2021, partly offset by four loss-absorbing AT1 capital instruments on-lent by UBS Group AG to UBS AG.

Use the scroll bar below the table to see the full content.
Comparison between UBS Group AG consolidated and UBS AG consolidated
  As of or for the quarter ended 30.9.22 As of or for the quarter ended 30.6.22 As of or for the quarter ended 31.12.21
USD m, except where indicated

UBS Group AG

consolidated

UBS AG

consolidated

Difference

(absolute)

UBS Group AG

consolidated

UBS AG

consolidated

Difference

(absolute)

UBS Group AG

consolidated

UBS AG

consolidated

Difference

(absolute)

   
Income statement  
Total revenues 8,236 8,308 (73) 8,917 9,036 (119) 8,705 8,819 (114)
Credit loss expense / (release) (3) (3) 0 7 7 0 (27) (27) 0
Operating expenses 5,916 6,152 (236) 6,295 6,577 (282) 7,003 7,227 (224)
Operating profit / (loss) before tax 2,323 2,159 164 2,615 2,452 163 1,729 1,619 109
of which: Global Wealth Management 1,453 1,434 18 1,157 1,130 27 563 541 22
of which: Personal & Corporate Banking 442 437 5 413 409 4 365 362 3
of which: Asset Management 140 139 1 959 959 0 334 328 6
of which: Investment Bank 447 436 11 410 388 22 713 710 3
of which: Group Functions (158) (287) 129 (324) (433) 110 (246) (321) 75
Net profit / (loss) 1,742 1,608 135 2,118 1,974 144 1,359 1,266 93
of which: net profit / (loss) attributable to shareholders 1,733 1,598 135 2,108 1,964 144 1,348 1,255 93
of which: net profit / (loss) attributable to non-controlling interests 9 9 0 10 10 0 11 11 0
   
Statement of comprehensive income  
Other comprehensive income (1,791) (1,753) (38) (1,039) (1,009) (30) (181) (197) 16
of which: attributable to shareholders (1,773) (1,735) (38) (1,011) (981) (30) (177) (194) 16
of which: attributable to non-controlling interests (17) (17) 0 (28) (28) 0 (4) (4) 0
Total comprehensive income (48) (145) 97 1,079 965 114 1,178 1,069 109
of which: attributable to shareholders (40) (137) 97 1,097 982 114 1,171 1,062 109
of which: attributable to non-controlling interests (8) (8) 0 (17) (17) 0 7 7 0
   
Balance sheet  
Total assets 1,111,753 1,111,926 (172) 1,113,193 1,112,474 719 1,117,182 1,116,145 1,037
Total liabilities 1,055,666 1,056,985 (1,319) 1,056,010 1,057,390 (1,380) 1,056,180 1,057,702 (1,522)
Total equity 56,087 54,941 1,146 57,184 55,085 2,099 61,002 58,442 2,559
of which: equity attributable to shareholders 55,756 54,610 1,146 56,845 54,746 2,099 60,662 58,102 2,559
of which: equity attributable to non-controlling interests 330 330 0 339 339 0 340 340 0
   
Capital information  
Common equity tier 1 capital 44,664 42,064 2,600 44,798 42,317 2,481 45,281 41,594 3,687
Going concern capital 59,359 55,733 3,626 59,907 56,359 3,548 60,488 55,434 5,054
Risk-weighted assets 310,615 308,571 2,044 315,685 313,448 2,238 302,209 299,005 3,204
Common equity tier 1 capital ratio (%) 14.4 13.6 0.7 14.2 13.5 0.7 15.0 13.9 1.1
Going concern capital ratio (%) 19.1 18.1 1.0 19.0 18.0 1.0 20.0 18.5 1.5
Total loss-absorbing capacity ratio (%) 33.7 32.8 1.0 33.7 32.8 0.9 34.7 33.3 1.3
Leverage ratio denominator 989,787 989,909 (122) 1,025,422 1,024,811 612 1,068,862 1,067,679 1,183
Common equity tier 1 leverage ratio (%) 4.51 4.25 0.26 4.37 4.13 0.24 4.24 3.90 0.34

Significant regulated subsidiary and sub-group information

Unaudited

Financial and regulatory key figures for our significant regulated subsidiaries and sub-groups

 

UBS AG

(standalone)

UBS Switzerland AG

(standalone)

UBS Europe SE

(consolidated)

UBS Americas Holding LLC

(consolidated)

All values in million, except where indicated USD CHF EUR USD
Financial and regulatory requirements

Swiss GAAP

Swiss SRB rules

Swiss GAAP

Swiss SRB rules

IFRS

EU regulatory rules

US GAAP

US Basel III rules

As of or for the quarter ended 30.9.22 30.6.22 30.9.22 30.6.22 30.9.22 30.6.221 30.9.22 30.6.22
 
Financial information2
Income statement
Total operating income3 2,642 6,056 2,113 2,194 399 230 3,348 3,264
Total operating expenses 1,761 2,608 1,305 1,364 192 201 2,925 3,270
Operating profit / (loss) before tax 882 3,448 808 831 207 29 423 (6)
Net profit / (loss) 907 3,361 656 677 147 28 253 (139)
Balance sheet
Total assets 486,070 498,351 318,038 323,248 57,803 49,496 201,285 212,582
Total liabilities 430,416 443,604 303,298 309,164 54,234 46,045 175,640 186,829
Total equity 55,654 54,747 14,741 14,084 3,569 3,452 25,645 25,753
 
Capital4
Common equity tier 1 capital 53,480 54,146 12,520 12,718 2,438 2,427 12,588 12,454
Additional tier 1 capital 13,669 14,042 5,419 5,406 600 600 4,055 4,055
Total going concern capital / Tier 1 capital 67,149 68,188 17,939 18,124 3,038 3,027 16,643 16,509
Tier 2 capital 2,949 2,997 144 152
Total capital 3,038 3,027 16,786 16,661
Total gone concern loss-absorbing capacity 45,375 46,330 11,336 11,301 2,1565 2,1465 7,4006 7,4006
Total loss-absorbing capacity 112,524 114,518 29,275 29,425 5,194 5,173 24,043 23,908
 
Risk-weighted assets and leverage ratio denominator4
Risk-weighted assets 323,364 327,846 109,163 107,344 11,977 11,412 73,043 74,651
Leverage ratio denominator 553,215 569,794 334,765 340,969 51,727 47,364 191,695 198,332
Supplementary leverage ratio denominator 214,292 224,259
 
Capital and leverage ratios (%)4
Common equity tier 1 capital ratio 16.5 16.5 11.5 11.8 20.4 21.3 17.2 16.7
Going concern capital ratio / Tier 1 capital ratio 20.8 20.8 16.4 16.9 25.4 26.5 22.8 22.1
Total capital ratio 25.4 26.5 23.0 22.3
Total loss-absorbing capacity ratio 26.8 27.4 43.4 45.3 32.9 32.0
Tier 1 leverage ratio 5.9 6.4 8.7 8.3
Supplementary tier 1 leverage ratio 7.8 7.4
Going concern leverage ratio 12.1 12.0 5.4 5.3
Total loss-absorbing capacity leverage ratio 8.7 8.6 10.1 10.9 12.5 12.1
Gone concern capital coverage ratio 117.8 115.2
 
Liquidity coverage ratio4
High-quality liquid assets (bn) 105.8 104.6 89.0 93.7 20.1 19.1 30.3 34.1
Net cash outflows (bn) 55.8 55.4 63.1 66.2 12.2 11.6 21.6 24
Liquidity coverage ratio (%)78 190.2 189.3 141.2 141.4 166.2 165.8 140.3 144.4
 
Net stable funding ratio49
Total available stable funding (bn) 241.5 244.8 224.1 225.2 13.9 13.9
Total required stable funding (bn) 263.3 265.6 158.9 156.2 9.2 9.3
Net stable funding ratio (%) 91.710 92.2 141.110 144.1 151.1 148.3
 
Other
Joint and several liability between UBS AG and UBS Switzerland AG (bn)11 4 4
  1. Comparative figures have been restated to align with the regulatory reports as submitted to the European Central Bank (the ECB).
  2. The financial information disclosed does not represent financial statements under the respective GAAP /​ IFRS.
  3. The total operating income includes credit loss expense /​ release.
  4. Refer to the 30 September 2022 Pillar 3 Report, available under “Pillar 3 disclosures” at ubs.com/​​investors, for more information.
  5. Consists of positions that meet the conditions laid down in Art. 72a–b of the Capital Requirements Regulation (CRR) II with regard to contractual, structural or legal subordination.
  6. Consists of eligible long-term debt that meets the conditions specified in 12 CFR 252.162 of the final TLAC rules. Total loss-absorbing capacity is the sum of tier 1 capital (excluding minority interest) and eligible long-term debt.
  7. In the third quarter of 2022, the liquidity coverage ratio (the LCR) of UBS AG was 190.2%, remaining above the prudential requirements communicated by FINMA.
  8. In the third quarter of 2022, the LCR of UBS Switzerland AG, which is a Swiss SRB, was 141.2%, remaining above the prudential requirement communicated by FINMA in connection with the Swiss Emergency Plan.
  9. For UBS Americas Holding LLC consolidated, the NSFR requirement became effective as of 1 July 2021 and related disclosures will come into effect in the second quarter of 2023.
  10. In accordance with Art. 17h para. 3 and 4 of the Liquidity Ordinance, UBS AG standalone is required to maintain a minimum NSFR of at least 80% without taking into account excess funding of UBS Switzerland AG and 100% after taking into account such excess funding.
  11. Refer to the “Capital, liquidity and funding, and balance sheet” section of our Annual Report 2021 for more information about the joint and several liability. Under certain circumstances, the Swiss Banking Act and FINMA’s Banking Insolvency Ordinance authorize FINMA to modify, extinguish or convert to common equity liabilities of a bank in connection with a resolution or insolvency of such bank.

UBS Group AG is a holding company and conducts substantially all of its operations through UBS AG and subsidiaries thereof. UBS Group AG and UBS AG have contributed a significant portion of their respective capital to, and provide substantial liquidity to, such subsidiaries. Many of these subsidiaries are subject to regulations requiring compliance with minimum capital, liquidity and similar requirements. The tables in this section summarize the regulatory capital components and capital ratios of our significant regulated subsidiaries and sub-groups determined under the regulatory framework of each subsidiary’s or sub-group’s home jurisdiction.

Supervisory authorities generally have discretion to impose higher requirements or to otherwise limit the activities of subsidiaries. Supervisory authorities also may require entities to measure capital and leverage ratios on a stressed basis and may limit the ability of an entity to engage in new activities or take capital actions based on the results of those tests.

Following the completion of the annual Dodd–Frank Act Stress Test (DFAST) and the Comprehensive Capital Analysis and Review (CCAR), UBS Americas Holding LLC was assigned a stress capital buffer (an SCB) of 4.8% (previously 7.1%) under the SCB rule as of 1 October 2022, resulting in a total common equity tier 1 (CET1) capital requirement of 9.3%.

Standalone regulatory information for UBS AG and UBS Switzerland AG, as well as consolidated regulatory information for UBS Europe SE and UBS Americas Holding LLC, is provided in the 30 September 2022 Pillar 3 Report, available under “Pillar 3 disclosures” at ubs.com/​investors.

Selected financial and regulatory information for UBS AG consolidated is included in the key figures table below. Refer also to the UBS AG third quarter 2022 report, which will be available as of 28 October 2022 under “Quarterly reporting” at ubs.com/​investors.

UBS AG consolidated key figures
  As of or for the quarter ended As of or year-to-date
USD m, except where indicated 30.9.22 30.6.22 31.12.21 30.9.21 30.9.22 30.9.21
Results
Total revenues 8,308 9,036 8,819 9,210 26,838 27,008
Credit loss expense / (release) (3) 7 (27) (14) 22 (121)
Operating expenses 6,152 6,577 7,227 6,512 19,644 19,785
Operating profit / (loss) before tax 2,159 2,452 1,619 2,712 7,171 7,345
Net profit / (loss) attributable to shareholders 1,598 1,964 1,255 2,154 5,566 5,777
Profitability and growth
Return on equity (%) 11.7 13.9 8.7 15.3 13.2 13.6
Return on tangible equity (%) 13.2 15.7 9.8 17.3 14.8 15.3
Return on common equity tier 1 capital (%) 15.2 18.7 12.1 21.1 17.7 19.5
Return on leverage ratio denominator, gross (%) 3.3 3.4 3.3 3.5 3.4 3.5
Cost / income ratio (%) 74.0 72.8 81.9 70.7 73.2 73.3
Net profit growth (%) (25.8) 2.6 (19.7) 6.8 (3.6) 24.7
Resources
Total assets 1,111,926 1,112,474 1,116,145 1,088,246 1,111,926 1,088,246
Equity attributable to shareholders 54,610 54,746 58,102 57,085 54,610 57,085
Common equity tier 1 capital1 42,064 42,317 41,594 41,356 42,064 41,356
Risk-weighted assets1 308,571 313,448 299,005 299,612 308,571 299,612
Common equity tier 1 capital ratio (%)1 13.6 13.5 13.9 13.8 13.6 13.8
Going concern capital ratio (%)1 18.1 18.0 18.5 18.5 18.1 18.5
Total loss-absorbing capacity ratio (%)1 32.8 32.8 33.3 32.6 32.8 32.6
Leverage ratio denominator1 989,909 1,024,811 1,067,679 1,044,438 989,909 1,044,438
Common equity tier 1 leverage ratio (%)1 4.25 4.13 3.90 3.96 4.25 3.96
Other
Invested assets (USD bn)2 3,706 3,912 4,596 4,432 3,706 4,432
Personnel (full-time equivalents) 47,429 46,807 47,067 47,293 47,429 47,293
  1. Based on the Swiss systemically relevant bank framework as of 1 January 2020. Refer to the “Capital management” section of this report for more information.
  2. Consists of invested assets for Global Wealth Management, Asset Management and Personal & Corporate Banking. Refer to “Note 32 Invested assets and net new money” in the “Consolidated financial statements” section of our Annual Report 2021 for more information.

Appendix

Alternative performance measures

Alternative performance measures

An alternative performance measure (an APM) is a financial measure of historical or future financial performance, financial position or cash flows other than a financial measure defined or specified in the applicable recognized accounting standards or in other applicable regulations. We report a number of APMs in the discussion of the financial and operating performance of the Group, our business divisions and our Group Functions. We use APMs to provide a more complete picture of our operating performance and to reflect management’s view of the fundamental drivers of our business results. A definition of each APM, the method used to calculate it and the information content are presented in alphabetical order in the table below. Our APMs may qualify as non-GAAP measures as defined by US Securities and Exchange Commission (SEC) regulations.

APM label Calculation Information content

Active Digital Banking clients in Corporate & Institutional Clients (%)

– Personal & Corporate Banking

Calculated as the average number of active clients for each month in the relevant period divided by the average number of total clients. “Clients” refers to the number of unique business relationships or legal entities operated by Corporate & Institutional Clients, excluding clients that do not have an account, mono-product clients and clients that have defaulted on loans or credit facilities. At the end of each month, any client that has logged on at least once in that month is determined to be “active” (a log-in time stamp is allocated to all business relationship numbers or per legal entity in a digital banking contract). This measure provides information about the proportion of active Digital Banking clients in the total number of UBS clients (within the aforementioned meaning) which are serviced by Corporate & Institutional Clients.

Active Digital Banking clients in Personal Banking (%)

– Personal & Corporate Banking

Calculated as the average number of active clients for each month in the relevant period divided by the average number of total clients. “Clients” refers to the number of unique business relationships operated by Personal Banking, excluding persons under the age of 15, clients who do not have a private account, clients domiciled outside Switzerland and clients who have defaulted on loans or credit facilities. At the end of each month, any client that has logged on at least once in that month is determined to be “active” (a log-in time stamp is allocated to all business relationship numbers in a digital banking contract). This measure provides information about the proportion of active Digital Banking clients in the total number of UBS clients (within the aforementioned meaning) who are serviced by Personal Banking.

Active Mobile Banking clients in Personal Banking (%)

– Personal & Corporate Banking

Calculated as the average number of active clients for each month in the relevant period divided by the average number of total clients. “Clients” refers to the number of unique business relationships operated by Personal Banking, excluding persons under the age of 15, clients who do not have a private account, clients domiciled outside Switzerland and clients who have defaulted on loans or credit facilities. At the end of each month, any client that has logged on via the mobile app at least once in that month is determined to be “active” (a log-in time stamp is allocated to all business relationship numbers in a digital banking contract). This measure provides information about the proportion of active Mobile Banking clients in the total number of UBS clients (within the aforementioned meaning) who are serviced by Personal Banking.
Cost / income ratio (%) Calculated as operating expenses divided by total revenues. This measure provides information about the efficiency of the business by comparing operating expenses with gross income.

Fee and trading income for Corporate & Institutional Clients (USD and CHF)

– Personal & Corporate Banking

Calculated as the total of recurring net fee and transaction-based income for Corporate & Institutional Clients. This measure provides information about the amount of fee and trading income for Corporate & Institutional Clients.

Fee-generating assets (USD)

– Global Wealth Management

Calculated as the sum of discretionary and nondiscretionary wealth management portfolios (mandate volume) and assets where generated revenues are predominantly of a recurring nature, i.e., mainly investment, mutual, hedge and private-market funds where we have a distribution agreement, including client commitments into closed-ended private-market funds from the date that recurring fees are charged. Assets related to our Global Financial Intermediaries business are excluded, as are assets of sanctioned clients. This measure provides information about the volume of invested assets that create a revenue stream, whether as a result of the nature of the contractual relationship with clients or through the fee structure of the asset. An increase in the level of fee-generating assets results in an increase in the associated revenue stream. Assets of sanctioned clients are excluded from fee-generating assets.

Fee-generating asset margin (bps)

– Global Wealth Management

Calculated as revenues from fee-generating assets (a portion of which is included in recurring fee income and a portion of which is included in transaction-based income, annualized as applicable) divided by average fee-generating assets for the relevant mandate fee billing period. For the US, fees have been billed on daily balances since the fourth quarter of 2020 and average fee-generating assets are calculated as the average of the monthly average balances. Prior to the fourth quarter of 2020, billing was based on prior quarter-end balances, and the average fee-generating assets were thus the prior quarter-end balance. For balances outside of the US, billing is based on prior month-end balances and average fee-generating assets are thus the average of the prior month-end balances. This measure provides information about the revenues from fee-generating assets in relation to their average volume during the relevant mandate fee billing period.

Gross margin on invested assets (bps)

– Asset Management

Calculated as total revenues (annualized as applicable) divided by average invested assets. This measure provides information about the total revenues of the business in relation to invested assets.

Impaired loan portfolio as a percentage of total loan portfolio, gross (%)

– Global Wealth Management,

Personal & Corporate Banking

Calculated as impaired loan portfolio divided by total gross loan portfolio. This measure provides information about the proportion of impaired loan portfolio in the total gross loan portfolio.

Invested assets (USD and CHF)

– Global Wealth Management,

Personal & Corporate Banking,

Asset Management

Calculated as the sum of managed fund assets, managed institutional assets, discretionary and advisory wealth management portfolios, fiduciary deposits, time deposits, savings accounts, and wealth management securities or brokerage accounts. This measure provides information about the volume of client assets managed by or deposited with UBS for investment purposes.

Investment products for Personal Banking (USD and CHF)

– Personal & Corporate Banking

Calculated as the sum of investment funds (including UBS Vitainvest third-pillar pension funds), mandates and third-party life insurance operated in Personal Banking. This measure provides information about the volume of investment funds (including UBS Vitainvest third-pillar pension funds), mandates and third-party life insurance operated in Personal Banking.

Net interest margin (bps)

– Personal & Corporate Banking

Calculated as net interest income (annualized as applicable) divided by average loans. This measure provides information about the profitability of the business by calculating the difference between the price charged for lending and the cost of funding, relative to loan value.

Net new fee-generating assets (USD)

– Global Wealth Management

Calculated as the sum of the net amount of fee-generating asset inflows and outflows, including dividend and interest inflows into mandates and outflows from mandate fees paid by clients during a specific period. Excluded from the calculation are the effects on fee-generating assets of strategic decisions by UBS to exit markets or services. This measure provides information about the development of fee-generating assets during a specific period as a result of net flows, excluding movements due to market performance and foreign exchange translation, as well as the effects on fee-generating assets of strategic decisions by UBS to exit markets or services.

Net new fee-generating asset

growth rate (%)

– Global Wealth Management

Calculated as the sum of the net amount of fee-generating asset inflows and outflows recorded during a specific period (annualized as applicable) divided by total fee-generating assets at the beginning of the period. This measure provides information about the growth of fee-generating assets during a specific period as a result of net new fee-generating asset flows.

Net new investment products for Personal Banking (USD and CHF)

– Personal & Corporate Banking

Calculated as the sum of the net amount of inflows and outflows of investment products during a specific period. This measure provides information about the development of investment products during a specific period as a result of net new investment product flows.

Net new money (USD)

– Global Wealth Management,

Asset Management

Calculated as the sum of the net amount of inflows and outflows of invested assets (as defined in UBS policy) recorded during a specific period. Excluded from the calculation are the effects on invested assets of strategic decisions by UBS to exit markets or services. Net new money for Global Wealth Management is disclosed on an annual basis. Net new money is not measured for Personal & Corporate Banking. This measure provides information about the development of invested assets during a specific period as a result of net new money flows and excludes movements due to market performance, foreign exchange translation, dividends, interest and fees, as well as the effects on invested assets of strategic decisions by UBS to exit markets or services.
Net profit growth (%) Calculated as the change in net profit attributable to shareholders from continuing operations between current and comparison periods divided by net profit attributable to shareholders from continuing operations of the comparison period. This measure provides information about profit growth since the comparison period.
Pre-tax profit growth (%) Calculated as the change in net profit before tax attributable to shareholders from continuing operations between current and comparison periods divided by net profit before tax attributable to shareholders from continuing operations of the comparison period. This measure provides information about pre-tax profit growth since the comparison period.

Recurring net fee income

(USD and CHF)

– Global Wealth Management,

Personal & Corporate Banking

Calculated as the total of fees for services provided on an ongoing basis, such as portfolio management fees, asset-based investment fund fees and custody fees, which are generated on client assets, and administrative fees for accounts. This measure provides information about the amount of recurring net fee income.
Return on attributed equity (%) Calculated as annualized business division operating profit before tax divided by average attributed equity. This measure provides information about the profitability of the business divisions in relation to attributed equity.
Return on common equity tier 1
capital (%)
Calculated as annualized net profit attributable to shareholders divided by average common equity tier 1 capital. This measure provides information about the profitability of the business in relation to common equity tier 1 capital.
Return on equity (%) Calculated as annualized net profit attributable to shareholders divided by average equity attributable to shareholders. This measure provides information about the profitability of the business in relation to equity.
Return on leverage ratio denominator, gross (%) Calculated as annualized total revenues divided by average leverage ratio denominator. This measure provides information about the revenues of the business in relation to the leverage ratio denominator.
Return on tangible equity (%) Calculated as annualized net profit attributable to shareholders divided by average equity attributable to shareholders less average goodwill and intangible assets. This measure provides information about the profitability of the business in relation to tangible equity.

Tangible book value per share

(USD)

Calculated as equity attributable to shareholders less goodwill and intangible assets divided by the number of shares outstanding. This measure provides information about tangible net assets on a per-share basis.

Total book value per share

(USD)

Calculated as equity attributable to shareholders divided by the number of shares outstanding. This measure provides information about net assets on a per-share basis.

Transaction-based income

(USD and CHF)

– Global Wealth Management,

Personal & Corporate Banking

Calculated as the total of the non-recurring portion of net fee and commission income, mainly composed of brokerage and transaction-based investment fund fees, and credit card fees, as well as fees for payment and foreign exchange transactions, together with other net income from financial instruments measured at fair value through profit or loss. This measure provides information about the amount of the non-recurring portion of net fee and commission income, together with other net income from financial instruments measured at fair value through profit or loss.

Abbreviations frequently used in our financial reports

A

ABS
asset-backed securities
AGM
Annual General Meeting of shareholders
A-IRB
advanced internal ratings-based
AIV
alternative investment vehicle
ALCO
Asset and Liability Committee
AMA
advanced measurement approach
AML
anti-money laundering
AoA
Articles of Association
APM
alternative performance measure
ARR
alternative reference rate
ARS
auction rate securities
ASF
available stable funding
AT1
additional tier 1
AuM
assets under management

B

BCBS
Basel Committee on Banking Supervision
BIS
Bank for International Settlements
BoD
Board of Directors

C

CAO
Capital Adequacy Ordinance
CCAR
Comprehensive Capital Analysis and Review
CCF
credit conversion factor
CCP
central counterparty
CCR
counterparty credit risk
CCRC
Corporate Culture and Responsibility Committee
CDS
credit default swap
CEA
Commodity Exchange Act
CEO
Chief Executive Officer
CET1
common equity tier 1
CFO
Chief Financial Officer
CFTC
US Commodity Futures Trading Commission
CGU
cash-generating unit
CHF
Swiss franc
CIO
Chief Investment Office
CLS
Continuous Linked Settlement
C&ORC
Compliance & Operational Risk Control
CRD IV
EU Capital Requirements Directive of 2013
CRM
credit risk mitigation (credit risk) or comprehensive risk measure (market risk)
CST
combined stress test
CUSIP
Committee on Uniform Security Identification Procedures
CVA
credit valuation adjustment

D

DBO
defined benefit obligation
DCCP
Deferred Contingent Capital Plan
DM
discount margin
DOJ
US Department of Justice
DTA
deferred tax asset
DVA
debit valuation adjustment

E

EAD
exposure at default
EB
Executive Board
EC
European Commission
ECB
European Central Bank
ECL
expected credit loss
EGM
Extraordinary General Meeting of shareholders
EIR
effective interest rate
EL
expected loss
EMEA
Europe, Middle East and Africa
EOP
Equity Ownership Plan
EPS
earnings per share
ESG
environmental, social and governance
ESR
environmental and social risk
ETD
exchange-traded derivatives
ETF
exchange-traded fund
EU
European Union
EUR
euro
EURIBOR
Euro Interbank Offered Rate
EVE
economic value of equity
EY
Ernst & Young Ltd

F

FA
financial advisor
FCA
UK Financial Conduct Authority
FCT
foreign currency translation
FINMA
Swiss Financial Market Supervisory Authority
FMIA
Swiss Financial Market Infrastructure Act
FSB
Financial Stability Board
FTA
Swiss Federal Tax Administration
FVA
funding valuation adjustment
FVOCI
fair value through other comprehensive income
FVTPL
fair value through profit or loss
FX
foreign exchange

G

GAAP
generally accepted accounting principles
GBP
pound sterling
GCRG
Group Compliance, Regulatory & Governance
GDP
gross domestic product
GEB
Group Executive Board
GHG
greenhouse gas
GIA
Group Internal Audit
GMD
Group Managing Director
GRI
Global Reporting Initiative
G-SIB
global systemically important bank

H

HQLA
high-quality liquid assets

I

IAS
International Accounting Standards
IASB
International Accounting Standards Board
IBOR
interbank offered rate
IFRIC
International Financial Reporting Interpretations Committee
IFRS
International Financial Reporting Standards
IRB
internal ratings-based
IRRBB
interest rate risk in the banking book
ISDA
International Swaps and Derivatives Association
ISIN
International Securities Identification Number

K

KRT
Key Risk Taker

L

LAS
liquidity-adjusted stress
LCR
liquidity coverage ratio
LGD
loss given default
LIBOR
London Interbank Offered Rate
LLC
limited liability company
LoD
lines of defense
LRD
leverage ratio denominator
LTIP
Long-Term Incentive Plan
LTV
loan-to-value

M

M&A
mergers and acquisitions
MiFID II
Markets in Financial Instruments Directive II
MRT
Material Risk Taker

N

NAV
net asset value
NII
net interest income
NSFR
net stable funding ratio
NYSE
New York Stock Exchange

O

OCA
own credit adjustment
OCI
other comprehensive income
ORF
operational risk framework
OTC
over-the-counter

P

PD
probability of default
PIT
point in time
P&L
profit or loss
POCI
purchased or originated credit-impaired
PRA
UK Prudential Regulation Authority
PRV
positive replacement value

R

RBA
role-based allowance
RBC
risk-based capital
RbM
risk-based monitoring
REIT
real estate investment trust
RMBS
residential mortgage-backed securities
RniV
risks not in VaR
RoCET1
return on CET1 capital
RoTE
return on tangible equity
RoU
right-of-use
rTSR
relative total shareholder return
RWA
risk-weighted assets

S

SA
standardized approach
SA-CCR
standardized approach for counterparty credit risk
SAR
Special Administrative Region of the People’s Republic of China
SBC
Swiss Bank Corporation
SDG
Sustainable Development Goal
SE
structured entity
SEC
US Securities and Exchange Commission
SEEOP
Senior Executive Equity Ownership Plan
SFT
securities financing transaction
SI
sustainable investing or
SIBOR
Singapore Interbank Offered Rate
SICR
significant increase in credit risk
SIX
SIX Swiss Exchange
SME
small and medium-sized entities
SMF
Senior Management Function
SNB
Swiss National Bank
SOR
Singapore Swap Offer Rate
SPPI
solely payments of principal and interest
SRB
systemically relevant bank
SRM
specific risk measure
SVaR
stressed value-at-risk

T

TBTF
too big to fail
TCFD
Task Force on Climate-related Financial Disclosures
TIBOR
Tokyo Interbank Offered Rate
TLAC
total loss-absorbing capacity

U

UoM
units of measure
USD
US dollar

V

VaR
value-at-risk
VAT
value added tax

This is a general list of the abbreviations frequently used in our financial reporting. Not all of the listed abbreviations may appear in this particular report.

Information sources

Reporting publications

Annual publications

Annual Report (SAP No. 80531): Published in English, this single-volume report provides descriptions of: our Group strategy and performance; the strategy and performance of the business divisions and Group Functions; risk, treasury and capital management; corporate governance, corporate responsibility and our compensation framework, including information about compensation for the Board of Directors and the Group Executive Board members; and financial information, including the financial statements.

Geschäftsbericht (SAP No. 80531): This publication provides a German translation of selected sections of our Annual Report.

Annual Review (SAP No. 80530): This booklet contains key information about our strategy and performance, with a focus on corporate responsibility at UBS. It is published in English, German, French and Italian.

Compensation Report (SAP No. 82307): This report discusses our compensation framework and provides information about compensation for the Board of Directors and the Group Executive Board members. It is available in English and German.

Quarterly publications

The quarterly financial report provides an update on our strategy and performance for the respective quarter. It is available in English.

How to order publications

The annual and quarterly publications are available in a fully digital and.pdf format at ubs.com/​investors, under “Financial information.” Printed copies of our Annual Report (in English) and our Compensation Report (in English and German), as well as a German translation of selected sections of our Annual Report, can be requested from UBS free of charge. For annual publications, refer to the “Investor services” section at ubs.com/​investors . Alternatively, they can be ordered by quoting the SAP number and the language preference, where applicable, from UBS AG, F4UK–AUL, P.O. Box, CH-8098 Zurich, Switzerland.

Other information

Website

The “Investor Relations” website at ubs.com/​investors provides the following information about UBS: results-related news releases; financial information, including results-related filings with the US Securities and Exchange Commission (the SEC); information for shareholders, including UBS share price charts, as well as data and dividend information, and for bondholders; our corporate calendar; and presentations by management for investors and financial analysts. Information is available online in English, with some information also available in German.

Results presentations

Our quarterly results presentations are webcast live. Recordings of most presentations can be downloaded from ubs.com/​presentations.

Messaging service

Email alerts to news about UBS can be subscribed for under “UBS News Alert” at ubs.com/​global/​en/​investor-relations/​contact/​investor-services.html. Messages are sent in English, German, French or Italian, with an option to select theme preferences for such alerts.

Form 20‑F and other submissions to the US Securities and Exchange Commission

We file periodic reports and submit other information about UBS to the SEC. Principal among these filings is the annual report on Form 20‑F, filed pursuant to the US Securities Exchange Act of 1934. The filing of Form 20‑F is structured as a wraparound document. Most sections of the filing can be satisfied by referring to the combined UBS Group AG and UBS AG annual report. However, there is a small amount of additional information in Form 20‑F that is not presented elsewhere and is particularly targeted at readers in the US. Readers are encouraged to refer to this additional disclosure. Any document that we file with the SEC is available on the SEC’s website: sec.gov. Refer to ubs.com/​investors for more information.

Cautionary Statement Regarding Forward-Looking Statements | This report contains statements that constitute “forward-looking statements,” including but not limited to management’s outlook for UBS’s financial performance, statements relating to the anticipated effect of transactions and strategic initiatives on UBS’s business and future development and goals or intentions to achieve climate, sustainability and other social objectives. While these forward-looking statements represent UBS’s judgments, expectations and objectives concerning the matters described, a number of risks, uncertainties and other important factors could cause actual developments and results to differ materially from UBS’s expectations. Russia’s invasion of Ukraine has led to heightened volatility across global markets, to the coordinated implementation of sanctions on Russia and Belarus, Russian and Belarusian entities and nationals, and to heightened political tensions across the globe. In addition, the war has caused significant population displacement, and if the conflict continues, the scale of disruption will increase and may come to include wide-scale shortages of vital commodities, including causing energy shortages and food insecurity. The speed of implementation and extent of sanctions, as well as the uncertainty as to how the situation will develop, may have significant adverse effects on the market and macroeconomic conditions, including in ways that cannot be anticipated. This creates significantly greater uncertainty about forward-looking statements. Other factors that may affect our performance and ability to achieve our plans, outlook and other objectives also include, but are not limited to: (i) the degree to which UBS is successful in the ongoing execution of its strategic plans, including its cost reduction and efficiency initiatives and its ability to manage its levels of risk-weighted assets (RWA) and leverage ratio denominator (LRD), liquidity coverage ratio and other financial resources, including changes in RWA assets and liabilities arising from higher market volatility; (ii) the degree to which UBS is successful in implementing changes to its businesses to meet changing market, regulatory and other conditions; (iii) increased interest rate volatility in major markets; (iv) developments in the macroeconomic climate and in the markets in which UBS operates or to which it is exposed, including movements in securities prices or liquidity, credit spreads, and currency exchange rates, the effects of economic conditions, including increasing inflationary pressures, market developments, and increasing geopolitical tensions, and changes to national trade policies on the financial position or creditworthiness of UBS’s clients and counterparties, as well as on client sentiment and levels of activity, including the COVID-19 pandemic and the measures taken to manage it, which have had and may also continue to have a significant adverse effect on global and regional economic activity, including disruptions to global supply chains and labor market displacements; (v) changes in the availability of capital and funding, including any changes in UBS’s credit spreads and ratings, as well as availability and cost of funding to meet requirements for debt eligible for total loss-absorbing capacity (TLAC); (vi) changes in central bank policies or the implementation of financial legislation and regulation in Switzerland, the US, the UK, the European Union and other financial centers that have imposed, or resulted in, or may do so in the future, more stringent or entity-specific capital, TLAC, leverage ratio, net stable funding ratio, liquidity and funding requirements, heightened operational resilience requirements, incremental tax requirements, additional levies, limitations on permitted activities, constraints on remuneration, constraints on transfers of capital and liquidity and sharing of operational costs across the Group or other measures, and the effect these will or would have on UBS’s business activities; (vii) UBS’s ability to successfully implement resolvability and related regulatory requirements and the potential need to make further changes to the legal structure or booking model of UBS Group in response to legal and regulatory requirements, or other external developments; (viii) UBS’s ability to maintain and improve its systems and controls for complying with sanctions in a timely manner and for the detection and prevention of money laundering to meet evolving regulatory requirements and expectations, in particular in current geopolitical turmoil; (ix) the uncertainty arising from domestic stresses in certain major economies; (x) changes in UBS’s competitive position, including whether differences in regulatory capital and other requirements among the major financial centers adversely affect UBS’s ability to compete in certain lines of business; (xi) changes in the standards of conduct applicable to our businesses that may result from new regulations or new enforcement of existing standards, including measures to impose new and enhanced duties when interacting with customers and in the execution and handling of customer transactions; (xii) the liability to which UBS may be exposed, or possible constraints or sanctions that regulatory authorities might impose on UBS, due to litigation, contractual claims and regulatory investigations, including the potential for disqualification from certain businesses, potentially large fines or monetary penalties, or the loss of licenses or privileges as a result of regulatory or other governmental sanctions, as well as the effect that litigation, regulatory and similar matters have on the operational risk component of our RWA, as well as the amount of capital available for return to shareholders; (xiii) the effects on UBS’s business, in particular cross-border banking, of sanctions, tax or regulatory developments and of possible changes in UBS’s policies and practices; (xiv) UBS’s ability to retain and attract the employees necessary to generate revenues and to manage, support and control its businesses, which may be affected by competitive factors; (xv) changes in accounting or tax standards or policies, and determinations or interpretations affecting the recognition of gain or loss, the valuation of goodwill, the recognition of deferred tax assets and other matters; (xvi) UBS’s ability to implement new technologies and business methods, including digital services and technologies, and ability to successfully compete with both existing and new financial service providers, some of which may not be regulated to the same extent; (xvii) limitations on the effectiveness of UBS’s internal processes for risk management, risk control, measurement and modeling, and of financial models generally; (xviii) the occurrence of operational failures, such as fraud, misconduct, unauthorized trading, financial crime, cyberattacks, data leakage and systems failures, the risk of which is increased with cyberattack threats from nation states; (xix) restrictions on the ability of UBS Group AG to make payments or distributions, including due to restrictions on the ability of its subsidiaries to make loans or distributions, directly or indirectly, or, in the case of financial difficulties, due to the exercise by FINMA or the regulators of UBS’s operations in other countries of their broad statutory powers in relation to protective measures, restructuring and liquidation proceedings; (xx) the degree to which changes in regulation, capital or legal structure, financial results or other factors may affect UBS’s ability to maintain its stated capital return objective; (xxi) uncertainty over the scope of actions that may be required by UBS, governments and others to achieve goals relating to climate, environmental and social matters, as well as the evolving nature of underlying science and industry and the possibility of conflict between different governmental standards and regulatory regimes; and (xxii) the effect that these or other factors or unanticipated events may have on our reputation and the additional consequences that this may have on our business and performance. The sequence in which the factors above are presented is not indicative of their likelihood of occurrence or the potential magnitude of their consequences. Our business and financial performance could be affected by other factors identified in our past and future filings and reports, including those filed with the US Securities and Exchange Commission (the SEC). More detailed information about those factors is set forth in documents furnished by UBS and filings made by UBS with the SEC, including UBS’s Annual Report on Form 20-F for the year ended 31 December 2021. UBS is not under any obligation to (and expressly disclaims any obligation to) update or alter its forward-looking statements, whether as a result of new information, future events, or otherwise.

Rounding | Numbers presented throughout this report may not add up precisely to the totals provided in the tables and text. Percentages and percent changes disclosed in text and tables are calculated on the basis of unrounded figures. Absolute changes between reporting periods disclosed in the text, which can be derived from numbers presented in related tables, are calculated on a rounded basis.

Tables | Within tables, blank fields generally indicate non-applicability or that presentation of any content would not be meaningful, or that information is not available as of the relevant date or for the relevant period. Zero values generally indicate that the respective figure is zero on an actual or rounded basis. Values that are zero on a rounded basis can be either negative or positive on an actual basis.

UBS Group AG
P.O. Box
CH-8098 Zurich

ubs.com